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Abstract 
Gastrulation, a critical stage of embryogenesis, converts a group of relatively undifferentiated 
cells into the body plan of the growing foetus. Embryonic cells are allocated to one of three 
definitive germs layers and are organised with respect to three embryonic axes (anterior-
posterior, dorsal-ventral and left-right). By the end of gastrulation the primordia of most organs 
and physiological systems have been established. In mammals, gastrulation occurs just after the 
embryo implants into the uterine wall. The small size of the mammalian gastrula and its 
inaccessibility means that, despite its central importance to embryonic development, 
gastrulation remains one of the most challenging and underexplored areas of mammalian 
biology. The study of other complex biological processes has been greatly facilitated by the use 
of genetic screens, which employ a powerful mutagen to introduce mutations into the germline 
of an organism and then examine descendants for altered biology (i.e. an abnormal phenotype) 
followed by post-hoc identification of the underlying genetic alteration. The utility of these 
screens is dependent upon quick, robust assays to identify pheno-deviants and it has long been 
thought that practical issues prevent this approach being applied to mammalian gastrulation. In 
this thesis, I examine this notion. In the first part of the thesis, I use phenotype analysis to infer 
the function of the gene altered in the katun mouse strain which was identified in a screen for 
mutations that alter embryonic development and was found to have a gastrulation phenotype. 
I show that the left-right axis defects in this strain are likely caused by dysregulated Wnt 
signalling at gastrulation which interferes with endoderm development. This confirms that 
mutants recovered from genetic screens can be used to infer gene function at gastrulation. In 
the second part of the thesis, I report results form a prototype, genome-wide, screen for 
recessive mutations that alter gastrulation. The screen was able to overcome the perceived 
difficulties of small litter sizes, of isolating a large number of gastrulation stage embryos, of 
distinguishing phenotypes from natural embryonic loss and of working with limiting amounts of 
genomic DNA. I demonstrate that mutant pedigrees can be identified, they can be maintained 
vi 
 
in the absence of genetic markers via test breeding protocols and that low-resolution meiotic 
mapping can be combined with next generation sequencing technologies to identify the 
causative mutation. This confirms that gastrulation is amenable to genetic dissection by 
mutagenesis and I suggest a protocol that could be used to conduct a larger scale, efficient 
screen to identify the genes that direct mammalian gastrulation. 
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Chapter 1: Introduction 
“It is not birth, marriage, or death, but gastrulation which is truly the most important 
time in your life." -Lewis Wolpert 
1.1 Gastrulation and its importance in mammalian embryogenesis 
One of the most profound biological questions is how an egg develops into a complete 
animal. This process is known as embryogenesis and it occurs when a fertilised egg, a 
single cell, eventually gives rise to a complex multicellular organism. Embryogenesis is 
orchestrated by genetics and cell communication via signalling pathways. Pioneering 
experiments demonstrated that this communication enables cells to differentiate into 
various cell types, which in turn will develop into specialised tissues and organs (Ingham, 
1988, Harland et al., 1997). For example, the initial diploid cell formed by fertilisation, 
the zygote, undergoes rapid cell division to produce a large number of totipotent cells. 
It is essential that all of these cells are programmed correctly during development to 
make the appropriate changes in their shape and position in order to form a specific part 
of the body. The core of this phenomenon, cell fate, is affected by the activities of genes 
encoding proteins and different RNAs that influence cell identity and control cell 
proliferation, migration, differentiation, and/or programmed cell death (Whitman et al., 
1989). Therefore, to ensure that each cell will fulfil its purpose, genes must be expressed 
at the correct time and place (McLaren, 1976, Hart et al., 1985). 
Abnormalities in the expression of genes that control embryonic development can lead 
to perturbations in critical processes, resulting in either severe developmental defects 
or embryo death (Kasarskis et al., 1998, Garcia-Garcia et al., 2005). Thus, it is critical to 
identify the genes and their genetic pathways that regulate embryogenesis to 
understand why these defects accrue. Importantly, every embryonic process is highly 
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dependent upon the success of the previous step. Consequently, minor aberrancies at 
an early stage are amplified as embryonic development progresses. This is illustrated by 
gastrulation.  
1.1.1 Pre-gastrulation stage 
During zygote formation, it takes multiple rounds of cleavages to establish two distinct 
cell lineages: the trophectoderm (TE) and the inner cell mass (ICM), which form the 
blastocyst between 3.5 and 4.5 days post coitum (dpc) (Figure 1.1). During implantation 
the TE gives rise to tissues in the placenta by invading the mother’s uterine lining. After 
implantation, the ICM gives rise to the three main germ layers- the ectoderm, mesoderm 
and endoderm- ultimately generating all of the tissues in the animal body (Tam et al., 
2007). This is termed gastrulation. From this process a small number of cells can produce 
a whole animal within three days (in the mouse) (Tam et al., 2006).  
Positioning of the progenitor cell populations in the embryo is fundamental to 
establishing tissue lineage. These progenitors later delineate embryonic axes and 
coordinate morphogenetic cell and tissue movements (Tam et al., 2007). The blastocyst 
is built as a vesicular structure (Figure 1.1), where the blastocyst epithelium encloses a 
cavity called the blastocoel. A cluster of cells attached to the wall on one side of the 
blastocoel constitutes the ICM, which further segregated into the epiblast (which gives 
rise to the entire embryo) and some components of the fetal extraembryonic 
membranes and the primitive endoderm (which lines the luminal surface of the cluster 
of epiblast cells). 
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The primitive endoderm forms by the time the embryo implants in the uterus at 4.5 dpc 
(Tam et al., 2007). It is formed from the blastocoel surface of the ICM and gives rise to 
both mural trophectoderm and the visceral endoderm, which later forms the epithelium 
on the surface of the epiblast and extra embryonic ectoderm (EXE) (Tam et al., 2007). 
Gene expression studies showed that GATA-binding protein 6 (GATA6) positive cells are 
the progenitors of the primitive endoderm and that Nanog expressing cells form the 
epiblast (Arman et al., 1998, Mesnard et al., 2004). In addition, it was found that growth 
factor receptor bound protein 2 (GRB2), a receptor-binding adaptor protein and member 
of mitogen-activated protein (MAP) kinase signalling pathways, is required for the 
expression of Gata6 in the ICM and the formation of the primitive endoderm (Arman et 
al., 1998, Chazaud et al., 2006). This indicates a role for the receptor tyrosine of kinase 
signalling in the early stages of primitive endoderm formation. However, the precise 
mechanism by which cells of the primitive endoderm and other cell types resolve their 
fate remains unclear (Tam et al., 2007). 
1.1.2 Axis establishment 
By 5.0 dpc the mouse embryo is called the egg cylinder (Figure 1.1 b). The prospective 
dorsal-ventral (D-V) axis becomes apparent, with the proamniotic cavity surface of the 
epiblast corresponding to the dorsal side of the embryo and the outer surface of the 
visceral endoderm corresponding to the ventral side of the embryo (Mohamed et al., 
2004). Asymmetric gene expression has been observed in the visceral endoderm of the 
mouse embryo at the distal visceral endoderm stage when Nodal antagonists Cer1 
(Cerberus 1 homologue) and Lefty1 are highly expressed on the anterior side of the 
definitive endoderm (DVE) (Tam et al., 2007). Similarly, Wnt3 is expressed 
asymmetrically where the epiblast meets the extraembryonic endoderm. Recent studies 
showed that the distal visceral endoderm contributes mostly to the proximal portion of 
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anterior visceral endoderm as well as the visceral endoderm in lateral regions, but not 
to entire anterior visceral endoderm (AVE). The extensive movement of the visceral 
endoderm cells is initiated by the distal visceral endoderm at 5.5 dpc. Experiments 
showed that when the definitive endoderm is ablated by genetic manipulation, AVE cells 
formed at the distal end but fail to migrate (Takaoka et al., 2011). Thus, the definitive 
endoderm guides the AVE to the anterior side of the embryo by initiating extensive 
movement of visceral endoderm cells (Takaoka et al., 2011). 
Before the formation of anterior-posterior (A-P) axis, the visceral endoderm becomes 
polarised in the proximal-distal direction. Between the pre-distal visceral endoderm and 
the definitive endoderm there is differentiation in gene expression. Nodal signalling, 
which originates in the epiblast and is transduced by SMAD2 in the extraembryonic 
tissues, is required for the formation of the DVE (Waldrip et al., 1998, Brennan et al., 
2001). There is an inductive interaction between the extra-embryonic and embryonic 
tissues which is essential for lineage specification and embryonic patterning. These are 
mediated by both WNT and TGFβ signalling pathways (Tam et al., 2006). In the mouse, 
the initial process to develop A-P axis is poorly understood, although several recent 
reports showed that early A-P molecular asymmetry could be tracked back to the pre-
implantation stage (Stuckey et al., 2011). Many genes determine the A-P axis formation 
in the pre-gastrulation stage. For example, endoderm-associated antigen (VE-1) is one 
of the earliest markers of the A-P axis at 5.5 dpc and can be detected on one side of the 
visceral endoderm. It is later localised to the anterior visceral endoderm (Rosenquist and 
Martin, 1995). Similarly, Wnt3 expression, which will later lead to the formation of the 
primitive streak at gastrulation, is detected at the DVE (Tam et al., 2006). 
The expression pattern of genes such as Evx1, Fgf8, Goosecoid (Gsc) and Nodal are 
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posteriorly restricted in pre-gastrula mouse embryos. Prior to the primitive streak 
formation, both Evx1 and Fgf8 are expressed in the posterior epiblast and the 
extraembryonic ectoderm (Dush and Martin, 1992, Crossley and Martin, 1995). In 
addition, before gastrulation, Gsc expression is detected in the proximal-posterior 
epiblast, the prospective site of primitive streak formation (Faust et al., 1995). Via a lacZ 
reporter, Nodal expression was identified in the presumptive posterior region of the 
epiblast prior to the formation of the primitive streak (Varlet et al., 1997). As Nodal and 
Evx1 are required for epiblast development/function, early embryonic lethality prior to 
gastrulation can occur as result of losing either proteins (Conlon et al., 1991, 
Spyropoulos and Capecchi, 1994). Conlon et al. (1994) suggested that NODAL has a 
primary role in the induction and maintenance of the primitive streak. In contrest, Gsc 
is dispensable in mouse gastrulation (Rivera-Pérez et al., 1995, Yamada et al., 1995). 
Similarly, if a ligand or a receptor of the fibroblast growth factor (FGF) family (such as 
Fgf8) is absent the resulting mutant embryos exhibit gastrulation defects. The precise 
nature of these abnormalities, however are still under investigation (Crossley, 1995, Sun 
et al., 1999). The observations that discrete A-P restricted expression domains in visceral 
endoderm and the epiblast exist in the pre-gastrula mouse embryo demonstrate that a 
molecular A-P asymmetry exists before the initiation of gastrulation (Tam et al., 1997). 
1.1.3 Gastrulation stage 
Before primitive streak formation at 6.0 dpc, the newly established A-P axis changes its 
orientation and the polarity of bilateral symmetry as the embryo remodels its shape 
(Perea-Gomez et al., 2004). Pre-gastrulation studies showed that the A-P axis of the 
embryo itself shifts to align with the long pass through axis at gastrulation (Mesnard et 
al., 2004). The A-P axis becomes morphologically identifiable via primitive streak 
formation at the posterior side of the embryo at 6.5 dpc (Mohamed et al., 2004) (Figure 
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1.1). Formation of the streak is the first overt morphologically distinct structure that 
breaks the bilateral symmetry of the embryo (Stuckey et al., 2011). It forms within the 
epiblast at the extra-embryonic boundary diagonally to the anterior visceral endoderm 
and in doing this, it defines the future posterior of the embryo and the site of 
gastrulation at 6.5 dpc (Stuckey et al., 2011). At the early primitive streak stage, 
Mohamed et al., (2004) showed the Catenin beta-1 (Ctnnb1) expression is restricted to 
the primitive streak. The Ctnnb1 gene encodes the β-CATENIN protein which is the 
central protein in the canonical Wnt signalling pathway. However, Maretto (2003) 
showed that, aside from being present in the primitive streak, Ctnnb1 expression is also 
present in the proximal epiblast region. However, confirmation via sectioning is required. 
The transcriptional activity of β-CATENIN was detected in the primitive streak and the 
mature node of murine embryo, indicating that WNT signalling precedes formation of 
the epiblast cells that will go on to form primitive streak (Mohamed et al., 2004). The 
transcriptional activity is sustained in the primitive streak of later staged embryo 
(Stuckey et al., 2011). 
Prior to gastrulation, Wnt3 is expressed before gastrulation at the proximal epiblast at 
the junction between the embryonic and extra-embryonic ectoderm with higher levels 
detected posteriorly (Liu et al., 1999). By 7.0 dpc the restricted expression of Wnt3, 
Wnt2b and Ctnnb1 in the distal visceral endoderm and/or the posterior epiblast indicate 
the prospective site of the primitive streak. Wnt3 plays a role in the formation and 
maintenance of the primitive streak, and the subsequent production of the mesoderm 
and definitive endoderm (Liu et al., 1999). Wnt3-\- mice developed an egg cylinder 
shaped embryo but cannot form the primitive streak, mesoderm or node (Nodal was not 
expressed at 7.5 dpc) (Liu et al., 1999). The epiblast continues to multiply in an 
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undifferentiated state that lacks anterior-posterior neural pattering, whilst the anterior 
visceral endoderm markers are expressed at the correct level and at the right position 
(Liu et al., 1999). The expression of Hex1, which identifies the AVE as well as the earliest 
population of anterior definitive endoderm to emerge from the anterior primitive streak 
(Martinez Barbera et al., 2000; Thomas et al., 1998), is not detected in Wnt3-/-  embryos 
at 7.5 dpc, reflecting an undifferentiated ectoderm rather than an anterior neural 
phenotype. These mutants also expressed Pou5f1 in the ectoderm, which suggests that 
it has not differentiated beyond epiblast state (Liu et al., 1999). These mutations 
illustrate how  the regional pattering of the visceral endoderm is independent of the 
primitive streak, but the subsequent establishment of A-P neural patterning in the 
ectoderm is dependent on derivatives of the streak. 
Studies have shown a role for the AVE in anterior neural pattering. The initial 
development of AVE occurs normally, but the overlying ectoderm does not acquire an 
anterior neural identity, which indicates that the AVE alone is not sufficient for anterior 
neural patterning (Thomas et al., 1996). In the mouse, the requirement of the primitive 
streak derived anterior neural fate was suggested by experiments that explored germ 
layers. For example, Lhx1 expression in AVE and primitive streak-derived anterior 
mesendoderm is essential for forebrain development. Similarly, β-CATENIN is required 
at the time of axis formation for correct positioning of the AVE. Although some AVE 
genes are expressed in embryos lacking β-CATENIN, the expressing cells remain at the 
distal tip of the embryo and fail to migrate to future anterior regions (Huelsken et al., 
2000). Similarly, a null allele of Dickkopf1 (Dkk1), a WNT signalling inhibitor, results in 
anterior head truncations, suggesting it has a critical role in head formation 
(Mukhopadhyay et al., 2001). 
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1.1.4 Node formation 
At 7.0 dpc the mid-streak (MS) stage (Figure 1.1) a group of cells located near the anterior 
end of the primitive streak form the murine organiser structure, the node (Lee et al., 
2008). The formation of the node is the first sign of the embryonic left-right (L-R) midline 
axis establishment. At this stage, the node is invisible, with the outer surface of the 
embryo covered by squamous endoderm cells. However, morphogenesis of the mouse 
node becomes visible near the distal tip of the embryo at the late streak stage (Sulik et 
al., 1994, Lee, 2008). Groups of cells at the anterior side of the embryonic midline with 
small apical surfaces begin to appear in the node at no bud (OB) stage (Poelmann, 1981, 
Sulik et al., 1994). These cell clusters are separated by squamous endoderm cells with 
larger surfaces (Sulik et al., 1994). These clustered cells develop cilia, which are 
approximately 2 µm at the OB stage and often appear to extend vertically from the 
surface of the node.  
It is only recently that the transition mechanism between these two configurations - 
multiple small fields of constricted cells separated by endoderm cells and a single field 
of ventral node cells was explored. It is proposed that clusters of streak-derived, putative 
node cells insert between the endoderm cells (Poelmann, 1981). The arrangement of 
these node cells was documented via live imaging experiments following the expression 
of eGFP into the Noto locus (Yamanaka et al., 2007). In the mouse embryo the expression 
of Noto is restricted in both the node and notochord, and the Noto-GFP allele 
recapitulates this pattern (Abdelkhalek et al., 2004). Prior to node formation, Noto-GFP+ 
cells exist in the anterior primitive streak (Yamanaka et al., 2007), indicating that these 
cells adopt a node or trunk notochord fate as they begin to divided from the streak 
(Yamanaka et al., 2007). Presumably the Noto-expressing precursors of the node become 
mesenchymal as they exit from the primitive streak, but then reform an epithelium (with 
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the opposite polarity as the epiblast) beneath the endodermal layer, before the 
endoderm cells move away to reveal the node. Yamanaka et al. (2007) reported that 
prior to the node becoming visible on the ventral surface of the mouse embryo, Noto-
GFP+ cells are already arranged in a sheet beneath the endodermal layer. Lee (2008) 
documented ciliated cells beneath the endoderm (via both scanning electron 
microscope (Semenov et al. 2000) and confocal microscopy) of the late streak (LS) stage 
in the mouse embryo. Therefore, the initial patchy appearance of ciliated, columnar cells 
may reflect the gradual removal of overlying endoderm cells, either by cell death or 
movement, although the organization of the node precursor cells prior to their complete 
emergence is unknown. Additionally, it is not known whether the field of node precursor 
cells change shape as the mature node forms or if the node progenitor cells are present 
in a single field or several clusters (Lee et al., 2008). Importantly, these observations 
indicate that the ventral node and the endoderm are somehow coordinated. 
Consequently, the endoderm cells migrate off of the presumptive ventral node, at the 
same time that the ventral node cells converge toward the midline and assemble into 
the teardrop-shaped pit. The node epithelium eventually becomes connected with the 
adjacent epithelium of the definitive endoderm. The mechanism on what regulates 
epithelialisation of the ventral node and insertion into the endoderm is not explored and 
remains unclear (Lee et al., 2008). Additionally, it is yet to be establishing how the signals 
between these two tissue layers might coordinate these behaviours. 
By the late bud (LB) stage, the region of the node is flat and set below neighbouring 
crown cells. At the early head fold (EHF) stage (~7.75 dpc) the final shape of the node is 
formed, as well as the ciliated pit cells of the node. By this stage the cilia are 3–4 µm long 
and become posteriorly polarised over time. Signalling molecules, such as Nodal which 
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is the first molecule expressed at the start of the L-R axis, are expressed in the 
surrounding crown cells. If these signalling molecules are disrupted, congenital defects 
can form and be lethal for the embryo (Conlon et al., 1994, Varlet et al., 1997, Shen, 
2007). The molecular mechanisms of L-R axis development is explained further in 
chapter 3.  
It is important for ventral node cells, to have their apical surface facing ventrally (the 
opposite of the epiblast) to establish into a columnar epithelium. During gastrulation life 
is defined by the events of these morphological processes. By the end of gastrulation, 
the entire animal body is organised into its proper structure. The three major phases of 
body axis formation, anterior-posterior (A-P), dorsal-ventral (D-V), and left-right (L-R) are 
established. In addition, the formation of the three embryonic germ layers- the 
endoderm, mesoderm, and ectoderm- in response to gene expression organise the entire 
animal body into its proper structure (Figure 1.1) (Tam et al., 1997). All adult tissues in 
the mouse are generated from these three germ layers; the ectoderm will eventually 
form the skin and neural tissues, the mesoderm forms muscle, blood, bone, and 
connective tissues, and the endoderm gives rise to the gut, intestinal tract, and organs 
such as the liver (Figure 1.2) (Arkell et al., 2012). Thus, without correct gastrula 
progression, cells cannot assume their proper positions, leading to deformation and 
incorrect embryo development.  
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Figure 1.1: The mouse embryo development tree. This describes the mouse embryo 
developmental stages starting from the early stage (the zygote) through formation of the 
three germ layers (ectoderm, mesoderm and endoderm) at gastrulation to the ultimate adult 
tissues. 
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1.2 Identifying genes involved in mammalian embryogenesis 
Genes required for normal gastrulation have previously been identified in studies of 
mouse genetics (Sun et al., 1999). To generate the mutant phenotypes, researchers 
evaluated the roles of genes and signalling pathways in directing normal embryonic 
formation. The results showed that it is not individual gene activity, but rather complex 
genetic networking that has a crucial role in normal biological processes (Tam et al., 
2007). The process of gastrulation is difficult to study, however, because of the small 
size of the gastrula, making the mouse embryo inaccessible to manipulation during this 
stage. Additionally, rapid biological changes occur over a very short period time. Thus, 
our current understanding of the molecular mechanisms driving gastrulation is limited. 
Mutagenesis is a powerful tool for determining the function of any gene in any organism: 
by inactivating or otherwise altering the function of a gene and observing the 
consequences to the organism, the normal function of the gene and gene product can 
be inferred. Numerous biological and biomedical studies have focussed on 
understanding gene function in mammalian organisms, and the mouse has become the 
most widely used mammalian organism for experimental genetics. Not only can the 
mouse genome be easily manipulated, but the biological and genetic similarities 
between mice and humans make it an excellent model for many aspects of human 
biology, including embryonic development (Denny et al., 2000). Generally, efforts to 
understand gene function using mutagenesis fall into two categories: reverse genetics 
and forward genetics (Figure 1.3). 
2.1.1 Reverse genetics 
Reverse genetics (also known as a genotype-driven strategy), assesses gene function by 
modifying or disrupting a known gene of interest. The ability to use reverse genetics   
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Figure 1.3: Common strategies for investigating gene function. Reverse genetics is used 
to evaluate the phenotypes resulting from mutation of a specific gene. It starts with 
selecting and mutating a gene of interest within the germline of an animal. The mutant 
animal is then assessed for phenotypes. In contrast, forward genetics is used to 
determine the genetic basis of a phenotype or trait. This method starts with generating 
random mutations by utilising a powerful mutagen. Next, screening is carried out to 
identify mutations that cause a phenotype. The mutated gene is then mapped to a 
minimal critical region (MCR) on a chromosome and the MCR sequenced to identify the 
gene responsible for the phenotype of interest.  
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in a mammalian organism was heralded by the discovery of murine embryonic stem (ES) 
cells (Evans et al., 1981); subsequent studies demonstrated that genes could be 
specifically modified in ES cells via homologous recombination (Thomas et al., 1987) 
before incorporation of ES cells back into a mouse embryo (Koller et al., 1989). The ES 
cells are incorporated into an embryo via injection into the blastocoel cavity of a pre-
implantation stage mouse embryo. The embryo is then transferred to the uterus of a 
pseudo-pregnant surrogate female mouse. The genetically modified ES cells mix with 
host embryonic cells to form a chimeric embryo. All tissues of the embryo can become 
chimeric, including the germ cells. When a chimeric mouse is mated with a wild-type 
animal, some progeny will be derived from the modified ES cells resulting in a mouse in 
which all cells carry the introduced mutation (Thompson et al., 1989). This process is 
known as germline transmission. Gene function can ultimately be inferred by assessing 
the phenotypes of mice that are heterozygous or homozygous for the mutation. 
The ability to target desired mutations to nearly any region of the mouse genome 
enabled reverse genetics to become the mainstay of mouse mutagenesis efforts for 
many years (Capecchi, 1989, Magin et al., 1992, Bradley et al., 1996, Muller, 1999, 
Capecchi, 2005, Bouabe et al., 2013). Up until recently, all reverse genetic strategies in 
the mouse relied up the culture of, and genome manipulation in, ES cells. This powerful 
strategy does, however, have some drawbacks. Firstly, the germline transmission of ES 
cells through mice is labour-intensive and time-consuming. Moreover, extended culture 
of ES cells is associated with gross chromosomal rearrangements in ES cells. For 
example, compound trisomy 8 and 11 is often detected in ES cells, and the proportion 
of aneuploid cells increases with passage number. Aneuploidy does not appear to 
impact the ability of the cells to differentiate (Mallon et al., 2004) but does, however, 
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affect the rate of germline transmission, with two recent studies demonstrating that the 
efficiency of germline transmission decreases markedly when ES cultures contain less 
than 50% euploid cells (Mallon et al., 2004, Gaztelumend and Nogues, 2014) 
More recently, the ability to directly modify genomic DNA within a zygote via 
CRISPR/Cas9-mediated genome editing has revolutionised reverse genetics. 
Circumventing the need for ES cells means that reverse genetics can now efficiently be 
applied to any organism for which the genome is well-characterised and a method exists 
for transduction of exogenous nucleic acids. Researchers have developed CRISPR/Cas9, 
an RNA-guided targeted genome technique, as a successful tool for introducing a wide 
range of genomic modifications in several cells and organisms (Doudna et al., 2014). 
Moreover, Wang et al. (2013) showed that a one-cell mouse embryo (zygote) can be 
modified by CRISPR injection and this technique can be applied to produce mice carrying 
biallelic mutations in a specific gene, circumventing the need for homologous 
recombination in ES cells for targeting modification of the mouse genome. 
CRISPR/Cas9 is a simple programming tool in which CRISPR (Clustered Regularly 
Interspaced Short Palindromic Repeats) is associated with nuclease CRISPR-associated 
protein 9 (Cas9) to introduce site-specific DNA double-strand breaks, which are typically 
repaired by non-homologous end-joining or homology-directed repair with high 
accuracy and efficiency (Deriano et al., 2013). Double-strand breaks occur via a synthetic 
single guide RNA (Jinek et al., 2012), which guides Cas9 to a specific location in the 
genome and vie this method, the generation of insertion or deletion (indels) mutations 
can result in a loss-of-function allele (Jinek et al., 2012). This technique has revealed the 
functional organisation of the genome at the systems level and established linkages 
between genetic variations and biological phenotypes. A major advantage of CRISPR is 
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the ability to design mutations by targeting/reporter specific loci to create knock-in of 
human single-nucleotide variants (SNV) (He et al., 2016).  
This method is only applicable when the function of the targeted gene is already known, 
however, this remains difficult to predict. For example, targets for reverse genetics are 
often selected because of previous work such as the knowledge of the gene expression 
pattern. Gene expression patterns, while suggestive, are not sufficient to distinguish 
sites of non-redundant expression. As such, reverse genetics often produces unexpected 
findings such as a different effect on the organism than expected from the genes 
function. Therefore, given that there are approximately 25,000 protein-coding genes in 
the mouse genome for which gene function must be described, reverse genetics needs 
to be complemented with other approaches (Rathkolb et al., 2000).  
2.1.2  Forward genetics 
Forward genetics (also known as a phenotype-driven strategy) begins with an abnormal 
phenotype and subsequently identifies the genetic mutation causing the phenotype 
(Figure 1.3). Generally, a series of random mutations are introduced across the genome 
and the resulting animals are screened for a phenotype of interest (Rathkolb et al., 
2000). The major advantage of forward genetics is that it makes no a priori assumptions 
about gene function (Brown et al., 2001). When applied systematically, forward genetics 
is theoretically capable of dissecting the genetic basis of any complex biological process 
in various organisms. This was dramatically demonstrated in simple organisms such as 
yeast and nematodes. For example, a forward genetic screen in the yeast 
Schizosaccharomyces pombe identified 14 unlinked genes that are essential for cell cycle 
progression (Nurse et al., 1976). Similarly, large-scale screening of the nematode 
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Caenorhabditis elegans led to the characterisation of ~100 genes that generated viable, 
visible phenotypes (Brenner, 1974).  
Despite the obvious utility of genetic screens for lethal mutations were, however, 
considered daunting because of the need to maintain each lethal mutation as a 
heterozygous strain. Additionally, a large proportion of genes and/or biological 
processes are essential for embryogenesis, suggesting that large numbers of mutations 
must be screened to recover multiple mutations giving rise to the same phenotype. 
Thus, it was several years before the Heidelberg mutagenesis screen generated 
thousands of lethal phenotypes in the fruit fly Drosophila melanogaster and 
revolutionised the understanding of how genes control developmental patterning 
(Nusslein-Volhard et al., 1980, Wieschaus et al., 1984). The success of this approach was 
increased by the availability of balancer chromosomes, which suppress recombination 
along the length of a chromosome and enable efficient maintenance of lethal mutations 
in the heterozygous state. 
One of the most striking findings from these systematic forward genetics approaches 
was that different genes mutate to give the same or similar phenotypes. This resulted in 
the generation of ‘phenotype classes’ where several mutant strains were placed in the 
same group. For example, in the Drosophila screen, the segment-polarity mutants lack 
a particular region of each segment of the Drosophila embryo, whereas pair rule 
mutants all lack structures in alternate segments (Nusslein-Volhard et al., 1980, 
Wieschaus et al., 1984, St Johnston, 2002). Subsequent molecular identification of the 
genes altered in these mutants confirmed regulatory interactions between their gene 
products. Similarly, in C. elegans screens, 95 mutations affecting vulval development 
(either vulvaless or multivulva) were detected and were found to correspond to 22 
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genes. Subsequent molecular analysis showed that these mutants were involved in two 
signalling pathways (Ferguson et al., 1985, Wang et al., 2001). Thus, when forward 
genetics is applied on a large-scale, it is possible to group genes in pathways and 
networks. Furthermore, these screens demonstrated that in large collections of mutants 
the same gene can be mutated more than once, giving rise to an allelic series in which 
different mutant alleles of a gene cause a range of phenotypes. The power of genetic 
functional analysis is maximised when large collections of mutations are amassed such 
that both phenotype classes (same phenotype, multiple genes) and allelic series (same 
gene, multiple phenotypes) are generated. 
The success of forward genetics in invertebrate organisms initiated the search of a 
vertebrate model system suitable for application of a large-scale forward genetics 
approach. This led to the development of the zebrafish, Danio rerio, as a model system 
(Streisinger et al., 1981) and establishment of multiple large-scale mutagenesis screens 
(de Angelis et al., 2000). The zebrafish is ideal for the phenotyping component of genetic 
screens because it produces large clutches of embryos (~100 per mating pair) and the 
externally fertilised eggs develop synchronously and much more rapidly than those of 
other related fish species studied in some laboratories (such as Medaka). Importantly, 
for the study of embryonic development, zebrafish embryos remain transparent 
through much of their embryonic development, permitting detailed microscopic 
observation throughout these stages.  
However, there are limitations to using zebrafish for studying genetics to increase the 
understanding of human biology. One confounding factor is that zebrafish have 
maternal contribution to their embryonic development and patterning (Driever et al., 
1996, Heasman, J. 1997). At the early developmental stages, the normal genome of 
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fertilised zebrafish embryos is not transcriptionally active; thus, maternally derived 
products regulate early development (Jimenez et al., 1982, Perrimon et al., 1989). This 
maternal contribution (RNAs and proteins) can partially mask the effects of zygotic 
mutations in the zebrafish. To overcome this problem, Ciruna et al. (2002) developed a 
method for the production of maternal-zygotic zebrafish mutants by germline 
replacement. In contrast, zygotic transcription starts at the two-cell stage in mammals. 
The consequence for this on early development is shown by the recovery of cilia mutants 
in mouse genetic screens which firmly established a link between the formation and 
function of the primary cilium and Hh signalling (Huangfu and Anderson, 2005, Huangfu 
et al., 2003, May et al., 2005). The lack of cilia mutants from the zebrafish screens was 
initially interpreted to mean that this link was not conserved between fish and 
mammals, but maternal-zygotic mutation of a zebrafish cilia gene revealed this 
requirement (Huang and Schier, 2009). 
Another minor point is  because zebrafish are pseudo-tetraploid due to a partial genome 
duplication that occurred at the beginning of teleost radiation (Postlethwait et al., 
1998). Gene duplication facilitates redundancy and divergent function, meaning that 
functional relationships between sequence homologs cannot be presumed. Thus, the 
likelihood that a particular zebrafish gene mutates to give the same phenotype as the 
orthologous human gene is lower than that in diploid laboratory organisms such as mice. 
This is particularly important in the analysis of mammalian gene function during 
embryogenesis as the in utero development of the mammalian embryo precludes 
analysis of this period in human subjects. Despite the difficulties of working with mice 
(relative to vertebrate and invertebrate model organisms), efforts to understand mouse 
biology will remain central to the analysis of human clinical issues. 
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2.1.3 Forward genetic screens in mice 
Phenotype-driven screens require that large numbers of the target organism be bred 
and analysed. The number of animals analysed in a genetic screen is inversely 
proportional to mutagen efficiency; for a more efficient mutagen, fewer animals are 
required. Any attempt at forward genetics in mice should therefore employ the most 
efficient mutagen possible. The effect of mutagens on the mouse genome can be 
quantified using specific test (T) stocks in which multiple recessive, visible alleles 
affecting easily recognisable traits are segregating. Two stocks have been generated for 
this purpose. One was developed at the Oak Ridge Laboratories (USA) in 1948 that 
harbours six alleles affecting coat colour: a (nonagouti, chromosome 2), b (brown, 
chromosome 4), cch (chinchilla at albino, chromosome 7), d (dilute, chromosome 9), p 
(pink-eyed dilution, chromosome 7), and s (piebald-spotting, chromosome 14) and one 
that controls ear morphology: se (short-ear, chromosome 9). The second was generated 
at The Harwell Laboratories (UK) in 1966 and harbours four alleles affecting the coat: fz 
(fuzzy, chromosome 1), ln (leaden, chromosome 1), pa (pallid, chromosome 2), and pe 
(pearl, chromosome 13), and one that alters the appendicular skeleton bp 
(brachypodism, chromosome 2). To use these stocks to calculate the rate at which a 
mutagen induces heritable gene mutations in mouse germ cells, a wild-type male is 
treated with the mutagen and crossed with T-stock females (N.B. the male germ cells 
are spermatogonial stem cells). Mutations in the T-stock are recessive, and thus (in the 
absence of a new mutation) all progeny appear to be wild-type, but induced, heritable 
mutations at any one of the test loci are immediately apparent. This specific locus test 
(SLT) enables calculation and comparison of the rate of mutation caused by different 
compounds. 
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Historically, mice were treated with X-rays to study the effects of radiation on the 
genome. In 1951, SLT was used to calculate the rate of radiation-induced mutation in 
mammals (Russell, 1951). Subsequently, SLT was used to assay for the harmful effects 
of chemicals, but the mouse was found to be surprisingly refractory to mutations in 
spermatogonial stem cells (Davis et al., 1998). However, in 1979, a small pilot 
experiment showed that the rate of mutation induction by the chemical N-ethyl-N-
nitrosourea (ENU) was 5-fold higher than the maximal rate obtained with X-rays (Russell 
et al., 1979, Hitotsumachi et al., 1985). Once ENU-treatment was optimised, it could 
induce mutations at a frequency of one per locus in every 700 gametes (12-fold more 
frequently than X-rays), (Russell et al., 1982a, Russell et al., 1982b, Hitotsumachi et al., 
1985) suggesting that ENU can be used in forward genetic approaches in mice. ENU 
creates lesions across the genome by transferring its ethyl group to oxygen or nitrogen 
radicals in DNA. The ethylated base is sometimes not properly recognised during the 
next round of DNA replication and can (after a second round of DNA replication) lead to 
the introduction of a base pair alteration that is invisible to cellular repair systems 
(Figure 1.4) (Noveroske et al., 2000). Analysis of ENU-induced alterations in the mouse 
genome showed that AT to TA transversions (44%) and AT to GC transitions (38% ) are 
the most common mutations induced by ENU (Justice et al., 1999). Under typical 
conditions, treatment with ENU can produce approximately one mutation per gene 
within a cohort of 700 gametes (Favor et al., 1988). 
One feature of ENU that is both an advantage and disadvantage is that it introduces 
point mutations. Thus, ENU can accurately model subtle alleles (e.g., domain-specific or 
hypomorphic) associated with the single-nucleotide variants most often found in human 
disease (Justice, 2000). However, a significant limitation of using ENU as a mutagen is 
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that point mutations, which leave behind no molecular tag, make it difficult to efficiently 
identify the mutated gene responsible for a phenotype (Justice, 2000, Rathkolb et al., 
2000). To increase the efficiency of gene identification, many studies have adopted 
genetic strategies in ENU-mutagenesis experiments. One such strategy is to conduct 
saturation mutagenesis at a defined region of the genome using specialised genetic 
resources such balancer chromosomes (also known as inversions) or deficiencies (also 
known as deletions). In mice, these reagents do not cover the entire genome. Thus, 
region-specific screens, while valuable, do not allow investigation of the entire mouse 
genome. Another feature of mouse genetics that facilitates the localisation of ENU-
induced alleles in genome-wide genetic screens is the availability of inbred strains of 
mice. Inbred mouse strains are the product of 20 generations of brother-sister mating 
(Potter et al., 1995), which renders animals of the strain homozygous at all loci and 
enables the continued production of genetically identical mice. 
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Figure 1.4: Mutagenic action of N-ethyl-N-nitrosourea (ENU). ENU can introduce 
point mutations in the mouse genome. The ethyl group of ENU (red) can be 
transferred to numerous reactive sites on any one of the four DNA nucleic acids. This 
generates a lesion that, if DNA repair mechanisms fail, can cause mispairing during 
DNA replication. This can result in the introduction of a heritable point mutation. 
Here, the ethyl group is transferred to a thymine (green). During the first round of 
DNA replication, this ethyl group may be repaired, preventing mutation. However, if 
repair fails, thymine will mispair with guanine (blue), creating a mutation and causing 
a transition from an A-T pair to a G-C pair (Harland et al., 1997, Noveroske et al., 2000). 
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Gene identification in an ENU-based genetic screen is facilitated by crossing two distinct 
inbred strains. Some regions of the genome are different (polymorphic) between the 
two inbred strains. These polymorphic regions are easy to track by recombination 
mapping (described below) to localise the induced mutation. The availability of different 
inbred strains also allows for selection of specific strains that are particularly suitable for 
the objectives of the screen. For example, when screening for embryonic phenotypes, a 
large litter size can be prioritised by using more fecund strains or a particular strain may 
be chosen because it is known to be permissive for the particular phenotype of interest. 
1.3 Forward genetic strategies for isolating mutations affecting murine 
embryonic development 
To initiate a genetic screen for ENU-induced mutations, male mice are injected 
intraperitoneally with ENU. ENU will act on all somatic and germ-line cells to introduce 
random point mutations (Hitotsumachi et al., 1985, Justice et al., 1999). Mutations in 
spermatogonial stem cells (i.e. the male germ-line) can be transmitted through the 
germ-line by mating an ENU-treated male mouse with a wild-type female animal. The 
progeny of these mice can be used in a variety of breeding and screening strategies 
depending upon the desired outcome of the genetic screen. To identify genes required 
for mammalian gastrulation, the Arkell laboratory has employed three different genetic 
screening strategies. 
1.3.1 Region-specific screen for mutations affecting embryonic development 
Region-specific screens employ either chromosome inversions or chromosome 
deletions to limit the region in which homozygous mutations are assayed. The use of 
inversions in mouse mutagenesis has been described previously (Justice, 2000). Its use 
in the mouse has largely been restricted to one screen across an engineered inversion 
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involving most of Mus musculus chromosome 11 (Mmu 11) (Kile et al., 2003). The utility 
of chromosome deletions in genetic screens was demonstrated by fine-scale functional 
analysis of genes at the c and p locus containing deletions of Mmu 7 (Rinchik et al., 1990, 
Rinchik et al., 1995). Chromosome deletions render one part of the genome hemizygous, 
causing the animal to be heterozygous null for each gene that normally lies within the 
deleted region. Mutation of the remaining allele behaves as a homozygous mutation. By 
conducting a two-generation screen, the effect of new, recessive alleles at genes within 
the deleted region can be observed. These screens are particularly efficient if the 
deletion removes one copy of a recessive allele for a visible trait such as for the 
Del(13)Svea36H deletion on Mmu 13. The deleted material includes a forkhead 
transcription factor, which is required for hair differentiation. Homozygous loss-of-
function of this gene produces mice with a glossy coat referred to as satin (sa). This 
serves as a visible marker that enables the Del(13)Svea36H mouse, along with satin 
homozygous mice, to be used for two-generation genetic screening to identify viable 
and lethal recessive mutations within the segment of the mouse genome defined by the 
deletion (Figure 1.5). 
In this type of screen, the absence of the coat colour class in a new pedigree of G2 
animals indicates that the F0 male harbours a new mutation causing embryonic lethality. 
These types of screen rapidly identify genes essential for embryogenesis, but do not 
focus phenotype recovery efforts on a particular stage or biological process.  
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Figure 1.5: Isolation of ENU-induced mutations utilising a region-specific screen. First,  
the mutagenised male mouse (from the satin strain), with a visible phenotype such as coat 
colour, is crossed with a wild-type female (from the BALB/c strain). Each male progeny of this 
cross represents the F1 with the mutations inherited from their father. The F1 male is crossed 
with a female heterozygous for a deletion region to produce G2 animals. G2 animals fall into 
four genetic classes; animals with satin coat have inherited the deletion and the mutagenised 
v genome. These animals can be screened for phenotypes and their absence indicates new 
recessive lethal. v: visible coat colour, Del: deletion. 
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The Arkell laboratory conducted a two-generation screen across the Del (13) Svea36H 
deletion, which spans 12.7 Mb of Mmu 13 (Mallon et al., 2004). From a sample of 1709 
pedigrees, 13 strains carrying heritable recessive lethal mutations linked to sa were 
recovered. Most of these alleles led to phenotypes that were first evident at mid-
gestation (Bogani et al., 2005) and were not followed up as part of the doctoral studies 
reported here. 
1.3.2 Screen for semi-dominant mutations altering embryonic patterning 
Genetic screens for dominantly acting ENU-induced mutations require only one 
generation of breeding from the ENU-injected male mouse to reveal mutant phenotypes 
(Figure 1.6) and have been conducted on a large-scale (de Angelis et al., 2000; Nolan, 
2000 ). Dominant mutations may appear to be irrelevant to the study of embryonic 
lethality, but because of incomplete dominance, it is possible that these screens reveal 
some relevant phenotypes. In simple or complete dominance, the heterozygote and 
homozygote have the same phenotype. However, the phenotype of the heterozygote is 
often different from that of the homozygote. In mice, mutant strains displaying this type 
of incomplete dominance are referred to as semidominant. Two phenotype classes that 
are frequently associated with a semidominant mode of inheritance are tail phenotypes 
and coat pigmentation phenotypes. A survey of previously identified mouse mutants in 
the Mouse Locus Catalogue revealed 79 loci with phenotypic effects on either the tail or 
on coat spotting. Of these, three were modifier loci and 76 were mutant alleles with 37 
of these being dominant. Of the dominant mutations, 35 exhibited semidominance 
(Blake et al., 2003). 
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Figure 1.6: Isolation of ENU-induced mutations utilising a dominant screen. To identify the 
dominant mutation, the mutagenised male mouse is first crossed with a wild-type female 
from a different mouse strain. Each animal in G1 of this cross contains inherited mutations 
from the father. If any G1 animals show a visible phenotype (eg. curled tail), this indicates 
that a gene important for normal development has been mutated. Thus, the animal with a 
dominantly functioning mutation is selected for further breeding to determine if the 
mutation is semidominant and leads to aberrant gastrulation. M: mutation.  
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Although both tail and spotting phenotypes arise through patterning and/or 
morphogenesis defects at the end of gastrulation, because of the iterative nature of 
gene use during development, at least some of these mutants may reveal genes 
required for gastrulation. To test this hypothesis, a group of 13 newly recovered mouse 
mutants with dominantly inherited tail and/or spotting phenotypes were studied to 
determine what proportion were semidominant and whether loci required for 
gastrulation were uncovered by these mutations. All mutations were semidominant; for 
eight strains, the function of the mutated gene was traced to gastrulation (Bogani et al., 
2004, Fossat et al., 2011). Two of these mutations, Katun (Ka) and Batface (Bfc), will be 
examined in this thesis and are further described in chapter 3.  
1.3.3 Genome-wide screen for recessive mutations affecting gastrulation 
Neither of the screens described above can recover all genes functioning in gastrulation 
and genome-wide screening is required to detect recessive mutations important in 
gastrulation. To identify recessive mutations amongst the progeny of ENU-treated 
animals, a three-generation breeding protocol is required (Figure 1.7). Individual male 
progeny of the ENU-injected animal are used as founder (F0) animals for a new pedigree. 
Each founder is crossed with a wild-type female to produce G2 animals. Each G2 animal 
has a 50% chance of inheriting any single mutation carried by the F0 male and will 
therefore be heterozygous for a subset (~50%) of the newly-induced mutations. These 
mutations can be brought to homozygosity using one of two approaches: backcross of 
G2 females to their F0 father (Figure 1.7) or intercross between G2 siblings (not shown). 
If the mutation segregation obeys Mendelian genetics, then using the backcross 
strategy, 25% of G3 progeny are expected to be homozygous for the mutation. Because 
only 50% of G2 animals are carriers for each mutation, the expected overall frequency   
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Figure 1.7: Isolation of ENU-induced mutations utilising a recessive screen. To identify 
recessive mutations, pedigrees must be established from individual F1 animals. First, the 
mutagenised male mouse is crossed with a wild-type female from a different strain. Each 
male progeny of this cross represents the F1. Each F1 male is crossed with a wild-type female 
to produce G2 animals. G2 females, which are 50% wild-type and 50% heterozygous for the 
mutations inherited from their father, are backcrossed to the F1 male. If both the F1 male 
and G2 female are heterozygous for the same recessive mutation, 25% of their G3 progeny 
will be homozygous for the mutation. 
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 of homozygotes amongst all G3 progeny is 12.5%. Calculations have shown that the G2 
female backcross protocol requires fewer mice to be bred than the G2 intercross 
strategy (Barbaric et al., 2007) and the backcross protocol is most commonly employed 
for screening of embryonic phenotypes. 
The utility and feasibility of genome-wide recessive screens for mouse developmental 
phenotypes was first demonstrated by Karsarkis et al., (1998) who conducted a pilot 
screen of 86 pedigrees, in which each G2 female was backcrossed in timed mating to 
their F0 fathers and litters were dissected at early organogenesis (9.5 dpc). This 
procedure generated five pedigrees with new, heritable mutations, which caused 
defects observable by visual inspection under a dissecting microscope. Four pedigrees 
were readily mapped to a single locus by low-resolution recombination mapping (see 
section 1.4), whereas one pedigree was not, suggesting it had a more complex genetic 
basis. Since then, tens of genome-wide screens for recessive mutations affecting various 
aspects of mouse embryonic developments have been conducted (Table 1.1). On 
average, these screens identify one mutant pedigree among every ten screened.  
None of these screens have directly sought to identify genes that function during 
gastrulation. Many pedigrees have been screened by dissection at 9.5 dpc because it is 
reasoned that mutations which affect post-implantation development can be identified 
by aberrant morphology at this stage, but will not have been completely resorbed 
(Kasarskis et al., 1998). This is not entirely true, as mutations with a severe effect on the 
early stages of gastrulation (rather than on later patterning processes) are generally fully 
resorbed by 9.5 dpc. Therefore, the Arkell laboratory initiated a small screen aimed at 
recovering these early-acting mutations.  
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Table 1.1: Overview of mutations found in recessive screens. 
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The time of dissection was shifted 36 h earlier to 8.0 dpc. At this stage, embryos that 
have failed to initiate gastrulation as well as those which initiate but do not progress 
through gastrulation remain present. Additionally, some early patterning defects are 
already evident. The screen design and associated technical challenges are described in 
chapter 4 of this thesis, as are the experiments used to localise newly induced point 
mutations captured in the screen. In chapter 5, cloning of one mutant line is described. 
Together, these experiments demonstrated that a screen aimed directly at recovering 
mutations affecting the onset and progress of gastrulation is feasible in mice. 
1.4 Identification of causal ENU-induced mutation 
Positional candidate cloning refers to the process by which the gene responsible for a 
phenotype is identified (Hedrich, 2004). The steps involved in this process are (1) 
recombination mapping, (2) identification of pathogenic variants in the mapped interval, 
and (3) confirmation of the causal relationship between the gene mutation (i.e. the 
pathogenic variant) and mutant phenotype. The first step of recombination mapping 
(also known as linkage analysis) tracks meiotic events to identify recombination 
breakpoints that lie close to the mutation in a panel of progeny from a cross segregating 
the mutation and marker loci. The principle of recombination mapping is shown in Figure 
1.8 (Avner et al., 1988). In a cross designed for recombination mapping, the first 
generation requires that a mutant mouse is crossed with a wild-type animal from a 
different inbred strain (known as the mapping strain). The progeny of this cross are F1 
hybrids, having inherited one complete set of chromosomes from each parent. In the 
next generation, F1 animals can be either intercrossed or backcrossed to the mapping 
strain. In all work presented in this thesis, the backcross strategy was used and will be 
described here. When backcrossed, meiotic recombination events events in germ cells   
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 Figure 1.8: Principle of recombination mapping. In the first generation, a mutant strain is 
crossed with a wild-type animal from a different inbred strain (mapping strain). The F1 
progeny inherit an entire chromosome from both the mapping (white) and mutant (purple) 
parental strains and may inherit the mutation (in red). In the next (G1) generation, an F1 
animal is backcrossed to the mapping strain. Meiotic recombination events in germ cells of 
the F1 parent can be identified in G2 progeny using polymorphic markers. Animals carrying 
the mutation (red) regions close to the mutation (i.e. linked) will retain the mutant (purple) 
genome, whereas unlinked regions will generally show homozygosity for the mapping 
(white) genome. Adapted from (Avner et al., 1988, Harland et al., 1997). G: generation. 
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of the F1 parent can be identified using genomic loci (or markers), which are known to 
vary between the mapping and mutant strains (i.e. are polymorphic). This process can 
establish the combination of alleles along the length of a chromosome, which is known 
as a haplotype. 
To identify recombination events, different types of polymorphic markers can be 
utilised. First, many simple sequence repeats occur across the genome of all eukaryotic 
organisms (Tautz, 1989). These repeat regions can, for example, be stretches of di-, tri- 
or tetranucleotide repeats known as microsatellites (MIT) (Love et al., 1990). Expansions 
of these repeats occur at sufficient frequency that size differences exist between inbred 
strains of mice (Tautz, 1989). This variation in length, often referred to as a fragment 
length polymorphism, can be readily analysed by PCR across the repeats and therefore 
utilised to distinguish inbred strains of mice (Tautz, 1989). MIT markers have become 
widely used in genetic mapping (Love et al., 1990) and more than 6000 known 
differences between inbred strains are curated on the Mouse Genome Informatics 
database, which serves as a reference for identifying MIT markers suitable for particular 
recombination mapping experiments. The mouse genome is approximately 300 Mb in 
size, leading to an estimate of the average spacing of microsatellite markers as one per 
500 Kb. Not all markers will be polymorphic for the two strains used in any 
recombination mapping experiment and MIT markers are not evenly distributed across 
the genome. Thus, it may be difficult to identify a sufficient number of polymorphic MIT 
markers for high-resolution mapping (Love et al., 1990). A second type of marker, which 
is more abundant across the genome, is the single-nucleotide polymorphism (SNP). 
However, SNPs are more difficult to detect and often require advanced technologies, 
which are more costly than simple PCR approaches that can distinguish MIT markers 
(Fairfield et al., 2011). The most suitable panel of markers for recombination mapping 
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will be determined by a range of practical considerations, such as resolution of mapping 
required, local availability of specialised SNP detection techniques, and cost (Neuhaus 
et al., 1998). 
Once a genomic interval known to contain the mutation (i.e. the minimal critical region; 
MCR) has been established via recombination mapping, the next step is to identify 
pathogenic variants within the interval. This is generally accomplished by DNA 
sequencing of all exons and splice sites within the MCR. If recombination mapping has 
been carried out to high resolution, it may be feasible to use Sanger sequencing to scan 
all exons and exon/intron boundaries. The recent advent of low-cost, high-throughput 
sequencing (known as next-generation sequencing) has enabled a modified approach, 
in which low-resolution mapping is combined with whole exome sequencing (WES) 
(Arnold et al., 2011). The exome is the set of all exons (or coding regions) in a genome 
and WES approaches cover not only coding regions, but also intron/exon boundaries 
(Fairfield et al., 2011). WES data is then assessed for pathogenic variants that fall within 
the MCR. In both approaches, ENU-induced mutations in the non-coding regions will not 
be included in the analysis. Empirically, most ENU-induced mutations that cause 
abnormal phenotypes appear to lie in coding regions (Blake et al., 2011, Fairfield et al., 
2011), with current data suggesting 2/3 of the mutations alter sequencing itself and 1/3 
mRNA splicing. Reagents for WES therefor cover both exons and splice junction. 
The final step in the positional candidate approach is to confirm the causal relationship 
between the pathogenic variant and mutant phenotype. The exact scope of this task 
varies with each project, but commonly involves compiling a variety of genetic and 
functional data that together provide evidence of causality. This may include evidence 
of tight linkage between the mutation and phenotype, such as non-segregation in a large 
38 
 
number (>1000) of meiosis. It could also include gene expression data, protein modelling 
approaches, and cell-based biochemical studies to compare functional attributes of the 
wild-type and mutant proteins. The strongest support, however, stems from additional 
mouse genetic experiments such as a complementation test with a second allele and/or 
transgenic rescue of the mutant phenotype. 
1.5 Scope of this thesis 
This thesis aims to contribute to the identification of genes that direct murine 
gastrulation by: 
1. Employing a pre-existing genetic mutant, isolated from a screen aimed at ENU-
induced semi-dominant alleles, to infer the function of the identified gene during 
gastrulation.  
A genetic screen, aimed at identifying mutations that affect embryogenesis, isolated a 
mouse strain, katun (Ka), carrying a nonsense mutation in the zinc finger of the 
cerebellum 3 (Zic3) gene that generates a null allele (Ahmed et al ., 2013). This gene is a 
member of the zinc finger of the cerebellum (ZIC) family of transcriptional regulators; 
previous work has shown that ZIC proteins can inhibit Wnt signalling pathway in vitro 
(Aruga, 2004, Pourebrahim et al., 2011). My research project is concerned with 
determining if Zic3 inhibits canonical Wnt signalling in vivo. Toward that, katun mice 
were crossed with the batface (Bfc) activating allele of β-catenin. This increased the 
penetrance and severity of elevated Wnt-associated phenotypes, providing the first 
evidence that the ZIC proteins function as novel in vivo Wnt signalling inhibitors. In 
mouse and human, mutation of Zic3/ZIC3 is associated with Heterotaxy, a disorder of 
left-right axis formation. My analysis of the Ka and Bfc strains will provide an insight to 
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the role, if any, of Wnt signalling in the development of Heterotaxy. These data are 
presented in chapter3. 
 
2. Evaluating the feasibility of genetic screen aimed at ENU-induced recessive 
alleles that alter gastrulation.  
Random point mutations were introduced into the genome of an inbred strain of mouse 
by the chemical mutagen ENU. The mutagenised mouse strain was crossed with the 
wild-type inbred strain to generate pedigrees with new mutations. Subsequent 
generations were examined at the end of gastrulation to determine if any of the denovo 
mutations altered gastrulation. The new mutant strains were selected by comparing the 
overt morphology of embryos, as viewed under a light microscope, at a stage close to 
the end of gastrulation. The mutant phenotypes selected, fell into different phenotypic 
classes. My project aims at taking each of the newly identified mutant strains through 
to the next stages of investigation: (i) to identify the location of the newly induced point 
mutation within the mouse genome of each of the eight strains and (ii) to determine the 
role of the mutated gene, during normal embryo development, by characterising the 
phenotype of mutant embryos. This study is likely to identify genes that have an 
important, but previously unrecognised, role in directing mammalian gastrulation. 
These data are presented in chapters 4 and 5. 
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Chapter 2: Materials and Methods 
2.1 General molecular techniques 
2.1.1 Bacterial transformation 
Plasmid DNA was transformed into DH5α electro-competent Escherichia coli (E. coli) 
bacteria via electroporation. For electroporation ~20 ng of plasmid DNA was added to 
ice-cold E. coli cells. The mixture was transferred to an ice-cold cuvette and shocked at 
2.5 kV using a BioRad E. coli Pulser (BioRad). Immediately after pulsing, 500 µL of Luria-
Bertani (LB) Broth media (Bacto; Cat. No. 244620) was added to revive the bacteria and 
the solution was incubated for 1 hour on a rotating platform at 37°C. The bacterial 
solution was then plated on to LB Agar (Bacto; Cat. No. 244520) containing 0.1 mg/mL 
of the appropriate antibiotic (Ampicillin: Sigma-Aldrich; Cat. No. A9518-5G, or 
Kanamycin: Sigma-Aldrich; Cat. No. 60615-5G) and incubated for 16 hours at 37°C. 
2.1.2 Plasmid isolation 
Depending on the amount of DNA required, plasmid DNA was isolated using two 
methods: 
1. For small scale isolation, single colonies from LB Agar plates were picked and 
each incubated in 4 mL of LB Broth (containing 0.1 mg/mL of the appropriate 
antibiotic) at 37°C for 16 hours on a rotating platform. 3 mL of this overnight 
culture was then used to isolate plasmid DNA via a High Pure Plasmid 
Isolation kit (Roche; Cat. No. 11754785001) (average yield: 7-10 µg). 
2. To obtain a higher quantity and/or purity of plasmid DNA, single colonies 
from LB Agar plates were picked and each incubated in 2 mL of LB Broth 
(containing 0.1 mg/mL of the appropriate antibiotic) at 37°C for 6-8 hours on 
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a rotating platform. This culture was added to 100 mL of LB Broth (containing 
0.1 mg/mL of the appropriate antibiotic) and incubated at 37°C for 16 hours 
on a rotating platform. Plasmid DNA was isolated using a NucleoBond® Xtra 
Midi kit (Macherey-Nagel; Cat. No. 740410.50). 
In each case DNA was resuspended in Analar H2O, instead of the supplied buffer. 
2.1.3 Restriction enzyme digestion 
DNA was digested with restriction enzymes for the preparation of riboprobes and 
analysis of plasmid inserts. For plasmids, 1 µg of DNA was digested using 5 U of the 
appropriate restriction enzyme (Table 2.1). Reactions were performed with the 
appropriate NEBuffer (10X stock), Bovine Serum Albumin (BSA; 10X stock) and enough 
Analar H2O such that the final volume was 10-20 times greater than the volume of 
restriction enzyme added. Reactions were incubated as per the enzyme manufacture 
instruction and digestion was confirmed via agarose gel electrophoresis. 
2.1.4 Agarose gel electrophoresis 
After DNA was digested using restriction enzymes or amplified using PCR, the size of the 
resulting bands was visualised using agarose gel electrophoresis. Agarose gels were 
made by dissolving Ultrapure Agarose (Life Technologies) in TBE buffer (0.1 M Tris-HCl, 
0.09 M Boric acid and 0.001 M EDTA; Amersco) to create 1-3% gels, dependant on the 
band size being resolved. Once dissolved and cooled slightly, RedSafeTM Nucleic Acid 
Staining Solution (Intron Biotechnology) was added at a 1:20,000 dilution to allow 
visualisation of the DNA and the gel was allowed to set within a mould. To prepare the 
DNA for gel electrophoresis, 1 μL of 4X loading dye was added for every 4 μL of sample 
with pipetting or vortexing to mix. The samples were then loaded into separate wells of 
the agarose gel. In an adjacent well, 0.6 μg of 1 Kb Plus DNA ladder (Invitrogen) was 
42 
 
loaded into the gel to indicate band sizes. Once all the samples and the ladder had been 
loaded, a voltage of 5-6 Vcm-1 was applied to the gel for 25-50 minutes to separate the 
DNA fragments. The gel was then photographed by a Gel Doc XR (Bio-Rad), which 
exposes the gel to a UV light source so that the DNA fragments are visible. 
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Table 2.1: Restriction enzymes used to digest plasmid 
DNA. All enzymes were purchased from New England 
BioLabs® / = denotes cut site. 
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2.1.5 Microsatellite marker selection 
As oligonucleotide primer information was available for MIT markers in MGI; these 
sequences were utilised for primer design (Blake JA, 2011). For those MIT markers with 
no oligonucleotide sequence available, a pair of primers (forward and reverse) was 
designed by inspecting the genomic sequence surrounding the microsatellite. Markers 
within approximately 30 Mb from the most proximal and distal regions of each 
chromosome (MMu 1- MMu 19) were identified and selected for analysis along with 
additional medical markers for MMu 1, MMu 2 and MMu 3. Utilising the online resource 
Ensembl, the sequence of each MIT marker was obtained, with 200 bp of 5’ (upstream) 
and 3’ (downstream) flanking sequence in (See Table 1 and Table 2 in Appendix A). PCR 
was used to reactions were optimised for each microsatellite (MIT) marker. Primer pairs 
for each MIT marker were tested in two different PCR buffers (ABgene Buffer I and 
ABgene Buffer IV), and at two different Touchdown PCR conditions, with initial annealing 
temperatures of 60°C and 65°C . 
2.1.6 Primer design 
17-mer forward and reverse primers were designed by visual inspection of this sequence 
according to the following guidelines: the base composition of each primer was either 9 
G/C and 8 A/T bases or 8 G/C and 9 A/T (with each member of a primer pair of matching 
composition); each primer had a G/C clamp at the 3’ end such that a minimum of three 
of the five 3’ most bases was G or C; consideration of the melting temperatures (Tm) of 
primers which should be between 45-65°C for a successful PCR; and primer pairs, e.g. 
forward and revers primers used in the same PCR reaction, should have Tm within 55°C 
of each other. The primers used as MIT markers were designed to generate an amplicon 
of 200 – 300 bp in size.  
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2.1.7 Polymerase chain reaction (PCR) 
DNA fragments for cloning or sequencing were amplified using PCR. PCR products were 
amplified from approximately 40 ng of plasmid DNA or 30 ng genomic DNA in the 
presence of 0.8 μM each oligonucleotide (Primers are listed in Table 2.2 and Table 1 and 
2 in appendix A) and a commercial PCR buffer. Three commercial buffers were used: PCR 
Buffer I (BI) (AbGene) lead to final reaction conditions of 10 mM Tris-HCL (pH8.3 at 25oC), 
50 mM KCl and 1.5 mM MgCl2; PCR Buffer IV (Kemp et al.) (AbGene) lead to final reaction 
conditions of 75 mM Tris-HCL (pH8.8 at 25oC), 20 mM (NH4)2SO4, 0.01 % (v/v) Tween 20 
and 1.5 mM MgCl2; and Immomix lead to final reaction conditions of 10x ImmoBuffer. 
160 mM (NH4)2 SO4, 1M Tris-HCI pH8.3 and enhancers. Thermal cycling was performed 
using a Touchdown (TD) PCR program (Don et al., 1991) with an initial annealing 
temperature of either 60oC (TD60) or 65oC (TD65). Once prepared, the reaction mixture 
was cycled through the PCR amplification program (Table 2.3) using an Eppendorf 
Mastercycler PCR machine. Success of the PCR was analysed via gel electrophoresis. 
2.1.8 Purification of DNA products 
PCR fragments and digested plasmids were purified using the Nucleospin® Extract II 
purification kit (Scientifix) according to the manufacturer’s instructions. PCR fragments 
were run directly through the kit for purification, whilst digested plasmid DNA was 
separated from contaminating DNA via gel electrophoresis and then purified. PCR 
fragments amplified for sequencing were purified using the Agencourt AMPure PCR 
purification system following the manufacturer’s instructions. The concentration and 
purity of the eluted DNA were determined using a spectrophotometer (NanoDrop 1000 
v8.1) and stored at -20°C until required. 
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Table 2.2: Primers used for genotyping and sequencing 
assays.  
F: forward primer; R: reverse primer. 
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Table 2.3: Thermal cycling conditions of PCR programs used for 
optimisation of genotyping assay. 
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2.2   Mouse colonies 
2.2.1 Mouse husbandry 
All mouse strains were maintained at the Australian Phenomics Facility at The Australian 
National University according to Australian Standards for Animal Care under ethics 
protocol A2015/10. Mice were maintained in a light cycle of 12 h light: 12 h dark, the 
midpoint of the dark cycle being 12 a.m. For the production of staged embryos, 12 p.m. 
on the day of the appearance of the vaginal plug is designated 0.5 dpc. 
2.2.2 Low-quality genomic DNA preparation 
Low-quality genomic DNA preparation was routinely used for genotyping of either ear 
biopsy tissue or embryonic tissue. Ear notches were collected in 50 μL of lysis solution 
[50 mM Tris(hydroxymethyl)aminomethane (Tris)-HCl (pH 8.5), 1 mM 
Ethylenediaminetetraacetic acid (EDTA), and 5% Tween 20] containing 2 μL of 
Proteinase K (10 μg/μL; Sigma Aldrich, Cat. No. P2308) and incubated at 55°C for 60 
minutes, followed by 95°C for 10 minutes to inactivate Proteinase K. Tissue debris was 
pelleted by centrifuging at 2,000 g for 5 minutes and each sample was diluted 1:10 in 
Analar H2O. Embryos were genotyped using a fragment of extra embryonic 
tissue/ectoplacental cone (7.5 dpc) or yolk sac (8.5 dpc and 9.5 dpc). Tissue was 
collected in 20 μL (7.5 dpc), 25 μL (8.5 dpc) or 35 μL (9.5 dpc) of lysis buffer (50 mM Tris-
HCl, pH 8.5, 1 mM EDTA, 0.5% Tween 20) containing 1 μL of Proteinase K (10 μg/μL), 
followed by incubation at 55°C for 25 minutes and 95°C for 5 minutes to inactivate 
Proteinase K. 
2.2.3 High-quality genomic DNA preparation  
Approximately 0.5 cm of the tail or one ear were biopsied and homogenised in 1.5 mL 
of TE-SDS (50 mM Tris-HCl, pH 8.0, 1 mM EDTA, 1% SDS) containing 0.5 µg/µL proteinase 
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K (PK)  in a 12 mL glass corex tube on ice. The sample was sealed and incubated overnight 
at 55oC. Cellular debris was precipitated by the addition 8M KOAc to a final 
concentration of 1.2 M, and the specimen was centrifuged in a Sorvall HB-4 rotor at 
(23,000 g, 4oC) for 20 minutes to pellet debris. To precipitate the DNA 1.5 mL of the 
supernatant transferred to 3.75 mL of 100% EtOH in a 15 mL Falcon tube. The sample 
was inverted 10 times, and the DNA precipitate removed by spooling onto a glass 
Pasteur pipette with a flame sealed end. DNA was washed by immersion in 1 mL of 70% 
EtOH, allowed to air dry, after which it was resuspended in 500 µL of TE. DNA was 
quantified by measurement of the optical density at 260 nm via NanoDrop (NanoDrop 
1000 v8.1) DNA preparations were diluted to 10 ng/µL for further PCR analysis. 
2.2.4 Genotyping assays 
Genotyping of adults and embryos from the ENU, katun, batface and atp1a1 mouse 
strains was done using the following techniques: 
2.2.4.1 High resolution melt analysis (HRMA) 
Digested ear biopsies were genotyped using a previously described High Resolution Melt 
Analysis (HRMA) assay (Thomsen et al., 2012) with no deviations. HRMA genotyping 
primers are shown in Table 2.2. 
2.2.4.2 Allelic discrimination 
PCR for allelic discrimination was done using TaqMan® Universal PCR Master Mix (Life 
Technologies; Cat. No. 4304437). All reactions were carried out in a final volume of 15 
μL with ~30 ng of digested ear notch DNA in the presence of 0.9 μM of primers (Table 
2.2). Additionally 0.25 μM of allele-specific probes (Applied Biosystems®) were used to 
identify the wild-type alleles and mutant allele (Figure 2.1, Table2.4). Reactions were set 
up in 96-well Half-Skirted PCR Microplates (Axygen®; Cat. No. PCR-96-LP-AB-C) covered 
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with Axygen Microplate Sealing Film (Fisher Scientific; Cat. No. UC500) and performed 
using the StepOnePlus™ Real-Time PCR System (Applied Biosystems®). The StepOne 
Software (version 2.2.2; Applied Biosystems®) was used to run the assay using the 
following conditions: an initial pre-PCR read at 60°C for 30 seconds to record background 
fluorescence, followed by 95°C for 10 minutes to denature the template and a cycling 
stage of 95°C for 15 seconds and of 60°C for 1 minute for 50 cycles. A post-PCR read was 
performed at 60°C for 30 seconds to collect data after completion of the PCR. Data was 
analysed using the same software that records the pre- and post-PCR reads and 
calculates normalised dye fluorescence (∆Rn) from the wild-type and mutant alleles as 
a function of cycle number. Based on this data the software called the sample as 
homozygous for either wild-type or mutant allele, or heterozygous with both alleles. 
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Figure 2.1: Allelic discrimination using fluorogenic probes. Wild-type and mutant alleles 
were distinguished using non-extendable oligonucleotide fluorogenic probes (Livak, 1999). 
The FAM™ (6-carboxyfluorescein) probe complemented the wild-type allele, while the VIC® 
(4,7,2'-trichloro-7'-phenyl-6-carboxyfluorescein) probe complemented the mutant allele. 
The probes differed by only one nucleotide (at the site of the mutation lucs), and at the 5' 
end were labelled with the reporter (VIC® or FAM™) dye and at the 3' end with the quencher 
(MGBNFQ: minor groove binding non-fluorescent quencher). The proximity of the reporter 
dye to the quencher reduced fluorescence via the reporter. During PCR as the forward primer 
extended the target specific probe was degraded by the 5'-3' exonuclease activity of the Taq 
DNA polymerase (Arya et al., 2005), which released the reporter dye allowing it to fluoresce. 
Both probes were included in the same well for each PCR reaction thus fluorescence was only 
observed when target allele for the probe was present (McGuigan et al., 2002). As PCR cycles 
increased, the fluorescence intensity increased that was proportional to the accumulation of 
the PCR product. The fluorescence was measured using a Real-Time PCR machine. This figure 
was adapted from Applied Biosystems’ Allelic Discrimination Getting Started Guide. 
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Table 2.4: Probes used for allelic discrimination.  
wt: wildt-ype, mt: mutant, FAM™: 6-carboxyfluorescein, VIC: 4,7,2'-
trichloro-7'-phenyl-6-carboxyfluorescein and MGBNFQ: minor groove 
binding non-fluorescent quencher. 
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2.3   Carrier identification  
Within each strain from the gastrulation screen, female animals were mated to an 
identified affected (carrier) male (F1 founder male or N2 male) and each litter was 
dissected and examined by the Arkell laboratory (Figure 1.3). Where mutant embryos 
were identified in a litter both adult parents were scored as affected. 
2.4   Sequencing of Atp1a1 exon 8 
The Atp1a1 exon 8 amplicon was amplified from genomic DNA (30 ng) in a 15 μL reaction 
volume as described in section 2.2.4.2 with the following specific conditions (AbGene 
Buffer IV, TD60) and the primers 5’TGAGGTGGATGAAATGC 3’ (forward) and 
5’CCAAGCACATTTTCTGG 3’ (reverse). PCR products were purified as per section 2.1.8. 
For sequence analysis, the purified products (3-10 ng) were amplified in 80 mM Tris-HCL 
(pH 9 at 25oC) and 2 mM MgCl2 with 1 μL BigDye Terminator v3.0 Cycle Sequencing 
Ready Reaction (Applied Biosystems) and 3.2 pmol of the primer 
5’CCAAGCACATTTTCTGG 3’ in a total volume of 20 μL. Thermal cycling conditions were 
94˚C for 5 minutes and 96˚C for 10 seconds, 50˚C for 5 seconds, 60˚C for 4 minutes for 
30 cycles, 4˚C hold. The extension products were precipitated by the addition of EDTA 
(pH 8.0) to a final concentration of 10 mM and 3M NaOAc (pH 5.2) to a final 
concentration of 0.4 M together with 2 x the final volume of 100 % ethanol. Samples 
were incubated at room temperature for 15 minutes before centrifugation (3200 x g, 
4°C) for 10 minutes. The supernatant was discarded and pellet washed with 250 μL of 
70% EtOH before centrifugation (3200 g, 4°C) for 10 minutes. The supernatant was 
discarded and samples air dried to remove any additional EtOH. The reaction products 
were analysed using an ABI 3730 sequencer (Applied Biosystems) by the Biomolecular 
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Resource Facility (BRF; John Curtin School of Medical Research, Australian National 
University). The resulting sequence files were analysed using Geneious (Biomatters). 
2.5   Embryo collection 
All embryos were dissected from maternal tissue and Reichert's membrane removed in 
10% (v/v) foetal bovine serum in phosphate buffered saline (PBS). The recovered 
embryos were staged according to Downs and Davies (1993). For ENU embryos, photos 
for analysis were taken after dissection, prior to fixing. Embryos were transferred to 4% 
paraformaldehyde (PFA) in PBS for overnight fixation at 4°C. 
2.6   Whole Mount In Situ Hybridisation analysis 
WMISH was performed as previously described (Elms et al., 2003) using riboprobes 
listed in Table 2.5. Template DNA was linearised and an antisense probe in vitro 
transcribed with the enzyme and RNA polymerase listed respectively. For each probe 
and stage of embryogenesis examined a minimum of four embryos were compared to 
precisely stage-matched littermates. Upon completion of the WMISH procedure, 
embryos were postfixed in 4% PFA and transferred via a glycerol series in PBS (50%, 80%, 
100%) for 15 minutes each. For photography, embryos were flat-mounted under a glass 
coverslip or placed on 1.5% agarose plate in PBS and photographed by a Nikon SMZ 
21500 Stereomicroscope and DS-Ri1 camera (Nikon). 
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Table 2.5: Probes used for WMISH.  
LPM: lateral plate mesoderm. 
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2.7   Scanning Electron Microscopy (SEM) 
Mouse embryos at 8.0 dpc were dissected in 10% (v/v) fetal bovine serum in PBS and 
fixed overnight in fresh 2% paraformaldehyde/2.5% gluteraldehyde/0.1 M cacodylate 
buffer (pH 7.4) at 4oC. After rinsing with 0.1 M cacodylate buffer, embryos were 
postfixed in 1% OsO4/0.1 M cacodylate for 20 minutes at room temperature. They were 
dehydrated through a graded EtOH series and dried at a critical point with a CPD010 
(Balzers Union). Embryos were coated in platinum by an EMTECH K550X sputter coater. 
All imaging was performed on a Hitachi 4300SE/N FESEM at 3 kv. 
2.7.1 SEM analysis 
Node shape and border were outlined in Adobe Photoshop CS5 on a minimum of three 
embryos of Ctnnb1+/+, Ctnnb1Bfc/+ and Ctnnb1Bfc/Bfc at 8.5 dpc. Cilia length was measured 
in a minimum three embryos from each genotype (Ctnnb1+/+, Ctnnb1Bfc/+, and 
Ctnnb1Bfc/Bfc) using SEM. For cilia length analysis, SEM images were recorded at 15,000× 
magnification. The file name of each image was altered to a number and the file order 
randomised by an independent worker so that the genotype of the embryo was 
unknown to the worker calculating cilia frequency and length. Cilia length was 
determined by measuring pixel length in Adobe Photoshop CS5 and conversion to μm 
(using a factor determined by the number of pixels per μm). In total, 10 node cilia were 
measured in a minimum of three embryos per genotype. 
2.8   Statistical analysis 
A two-way ANOVA with Fischers Unprotected LSD post hoc test was performed in 
Genstat in order to analyse cilia length. Statistical significance was determined when 
p<0.05. A Chi-square was performed in order to identify the linked regions on a 
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chromosome of the ENU induced mutation. Statistical significance was determined 
when p<0.05.  
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Chapter 3: The katun allele fails to inhibit 
canonical Wnt/β-catenin signalling in vivo 
3.1 INTRODUCTION 
3.1.1 The Zic gene family 
The Zic (zinc finger of the cerebellum) gene family (named for the vertebrate tissue from 
which they were first isolated) has been found in a range of both vertebrate and 
invertebrate species (Aruga et al., 1994). The initial homologous invertebrate gene was 
discovered in Drosophila and named odd-paired (opa) (Benedyk et al., 1994). This gene 
was isolated in a genetic screen for mutations that disrupt segmentation of the 
Drosophila embryo (Nusslein-Volhard et al., 1980); it was proposed that it may encode 
a transcription factor, as it contains a zinc finger domain (ZFD) (Benedyk et al., 1994). 
Flies with mutated opa failed to generate alternate segments during embryonic 
patterning and fell into the group of mutants known as pair-rule mutants. Further 
analysis of opa mutant flies revealed that the protein also regulates the expression of 
genes required for the development of the visceral mesoderm and midgut 
morphogenesis (Benedyk et al., 1994). 
Mice and humans have five paralogous Zic genes (named Zic1-5); each shows a high level 
of homology with the invertebrate opa gene and their respective Zic orthologues (Ali et 
al., 2012). Mutational analyses in a variety of vertebrate and mammalian organisms have 
shown that Zic genes play important roles in the differentiation of ectoderm and 
mesoderm-derived structures during early embryogenesis (Houtmeyers et al., 2013). 
However, much remains unknown about the molecular mechanisms of Zic gene function 
and regulation. Moreover, the long-standing uncertainty regarding whether ZIC proteins 
act as bona fide transcription factors, or as co-factors, is only now beginning to be 
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clarified with evidence that they can act as either class of molecule in a context-
dependent manner (Figure 3.1) (Ali et al., 2012, Ahmed et al., 2016). 
The first evidence that ZIC proteins may act as transcription factors or co-factors was 
found using a candidate approach, based on the fact that the ZIC ZFD shows high 
homology with GLI proteins (Aruga, 2004). GLI proteins are the vertebrate orthologues 
of the cubitus interruptus gene of Drosophila, which is a transcriptional mediator of the 
developmentally important Hedgehog signalling pathway (Koebernick et al., 2002). ZIC 
proteins can bind GLI DNA binding sites (GLI-BS), albeit with much lower affinities, but 
do not stimulate transcription from GLI-BS (Mizugishi et al., 2001). Furthermore, ZIC and 
GLI proteins can form heterodimers, where both proteins interact through their C2H2 
zinc fingers (ZF) 3-5 (Koyabu et al., 2001); however, no heterodimer formation has been 
observed between ZIC paralogues (Brown et al., 2005). This interaction promotes the 
translocation of GLI proteins, which are predominantly localised in the cytoplasm, to the 
nucleus. Consequently, the ZIC-GLI heterodimers stimulate transcription at GLI-BS at 
higher levels than those observed in the presence of monomeric GLI proteins (Mizugishi 
et al., 2001). Although GLI-ZIC heterodimers have never been purified from an in vivo 
model, Zic3 loss-of-function rescues the digit phenotype of the Gli3 mouse mutant 
known as ‘extra toes’, implying a functional relationship between these two molecules 
(Quinn et al., 2012). 
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Figure 3.1: ZIC proteins can act as transcription factors and/or co-factors. (A) As 
transcription factors, ZIC proteins directly bind DNA. (B) As co-factors, ZIC proteins interact 
with and modulate the activity of other transcription factors (TF). Either scenario can result 
in enhancement or repression of target gene transcription, depending on the cellular 
context. Figure adapted from Ali et al. (2012). 
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Genomic arrangement 
Phylogenetic sequence analysis has revealed that Zic genes have an unusual 
arrangement within the genomes of all vertebrates examined; the majority of genes are 
arranged as divergently transcribed gene pairs (Houtmeyers et al., 2013). For example, 
in mammals, Zic1 and Zic4 exist as a divergently transcribed tandem gene pair (on 
human Chr3, mouse Chr9), as do Zic2 and Zic5 (on human Chr13, mouse Chr14), while 
Zic3 is an X-linked singleton in both humans and mice (Figure 3.2) (Ali et al., 2012, 
Houtmeyers et al., 2013). Based on similarities in their nucleotide sequences, exon-
intron boundaries, and protein sequences, the Zic genes are divided into two 
subclasses—subclass A and subclass B (Houtmeyers et al., 2013). A hypothetical model 
of Zic gene evolution by Aruga et al. (2006) proposes that the ancestral single copy Zic 
gene contained one intron and a set of conserved structural domains. Tandem 
duplication of the ancestral gene and sequence modifications led to the generation of 
two isoforms: one that acquired an additional intron and another that underwent 
sequence divergence accompanied by the loss of certain structural domains. Additional 
genome duplication events presumably produced eight Zic genes organised into four 
gene clusters, with each cluster containing a Zic gene from subclass A (Zic1, Zic2, and 
Zic3) and subclass B (Zic4 and Zic5). The maximum number of Zic genes identified in any 
species to date is seven in the zebrafish (Grinblat et al., 1998, Toyama et al., 2004). The 
variation in Zic gene copy numbers observed across vertebrate species is thought to 
have arisen through a combination of gene loss and de novo duplication events 
(Houtmeyers et al., 2013). 
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Figure 3.2: Genomic alignment of human and mouse Zic genes. The diagram illustrates the 
arrangement of Zic genes in both human and mouse genomes, as shown in the Ensembl 
genome browser. In humans, Zic1 and Zic4 are located on chromosome (Chr) 3, while Zic2 
and Zic5 are located on Chr 13. In the mouse, Zic1 and Zic4 are located on Chr 9, while Zic2 
and Zic5 are located on Chr 14. The Zic3 gene is located on the X-chromosome in both human 
and mouse. UTR: untranslated region; ZF-NC: zinc finger N-terminal conserved region; ZOC: 
Zic-Opa conserved region; ZF: zinc finger. Figure adapted from Houtmeyers et al., (2013).  
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The retention of some Zic genes as tandem pairs has implications for their function and 
study. This is because it is likely that the gene pairs share regulatory sequences and have 
overlapping expression patterns. For example, Zic2 and Zic5 show largely overlapping 
expression domains during murine gastrulation, with initial expression observed in the 
embryonic and extra-embryonic ectoderm (Furushima et al., 2000, Elms et al., 2004). 
This provides the potential for functional redundancy and/or other modes of paired 
activities, such as dominant-negative interference between co-expressed family 
members. Additionally, it is difficult to produce animal models in which more than one 
Zic gene is mutated; the common approach of crossing single mutant strains is 
impractical owing to the low probability of a crossover occurring between individual 
mutations. 
The protein structure of the Zic gene family 
The defining feature of ZIC proteins is the highly conserved ZFD which consists of five 
ZFs (Figure 3.3). This type of ZF contains two cysteine and two histidine residues that 
ligate the zinc ion (Zn2+), enabling the protein to bind DNA (Iuchi, 2001). ZF1 is highly 
conserved in ZIC1, ZIC2, and ZIC3, but shows more divergence in ZIC4 and ZIC5 (Aruga et 
al., 2006); this difference forms part of the distinction between subclass A and B (Table 
3.1). It has been shown that the ZIC ZFD can bind DNA and participate in protein-protein 
interactions in a variety of contexts. It also appears to be responsible for localising ZICs 
to the nucleus, although this has only been demonstrated for ZIC3 (Bedard et al., 2007, 
Houtmeyers et al., 2013). Therefore, mutations within the ZFD can drastically affect the 
function of these proteins (Bedard et al., 2007). 
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Figure 3.3: Schematic illustration of the protein structure of the human ZICs. All 
human ZICs contain a highly conserved zinc finger domain made of five C2H2-type 
zinc fingers. The Zic genes are divided into two subclasses (Subclass A and B). ZIC4 and 
ZIC5 exhibit a divergence in the first zinc finger. ZIC1, ZIC2, and ZIC3 share the ZOC, 
SANC, and SACC domains, but these are not found in ZIC4 or ZIC5. All five proteins 
contain a short highly conserved domain immediately upstream of the zinc fingers, 
called the ZFNC domain, as well as low complexity regions; the major amino acid 
found at each low complexity region is shown by its associated letter (A: alanine tract, 
H: histidine tract, P: proline tract, and S/G: serine/glycine tract, SANC: subclass A N-
terminal conserved, SACC: subclass A C-terminal conserved). Figure adapted from 
Houtmeyers et al. (2013). 
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Biochemical experiments have revealed some information regarding the DNA- and 
protein-binding activities of ZFs. Structural analysis of ZIC3, for instance, suggests that 
ZF1 and ZF2 may not be canonical (DNA-binding) C2H2-type ZFs. Both ZFs form a single 
structural unit called the tandem CWCH2 motif, which is characterised by the presence 
of a tryptophan (W) residue between the two canonical cysteines of each ZF (Aruga et 
al., 2006). This motif is present in the first and second ZFs of ZIC3 in a wide range of 
metazoan species; this may have a biological impact, as a missense mutation of the 
tryptophan in ZF1 of ZIC3 is associated with congenital heart malformation (Chhin et al., 
2007). Although the molecular role of the CWCH2 motif is unknown, it is proposed that 
the motif modulates the DNA-binding capability of the other canonical ZFs, and/or 
participates in protein-protein interactions (Houtmeyers et al., 2013). Furthermore, 
mutational analysis of Zic2 has revealed that mutation of ZF4 ablates DNA-binding 
(Brown et al., 2005) and causes in vivo loss-of-function (Elms et al., 2003) without 
necessarily affecting protein-protein interactions (Pourebrahim et al., 2011). Further 
work is required, however, to clearly delineate individual and cooperative ZF functions. 
The N- and C-terminal sequences that flank the ZFs vary significantly amongst family 
members. There is one short region (14–21 amino acid) at the N-terminus of the ZFD—
the zinc-finger N-terminal conserved region (ZFNC)—that is found in all family members 
across a wide range of species (Aruga et al., 2006), but the function of this region is 
currently unknown. Additionally, a small (9-10 amino acids) N-terminally located domain 
is conserved in the subclass A ZIC proteins. The Drosophila orthologue, OPA, also 
contains this domain; hence, it was named the ZIC/Odd-paired conserved (ZOC) motif 
(Landy, 1989, Aruga et al., 1996). This domain is required for protein-protein 
interactions (Mizugishi et al., 2004, Himeda et al., 2013). Aside from these conserved 
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domains, several low complexity domains, including poly-alanine, -histidine, -proline, 
and -serine/-glycine tracts have been found within individual ZICs (Figure 3.3). Although 
the function of these domains in ZICs is not well characterised, expansion mutations in 
the C-terminal alanine tract of ZIC2 (Brown et al., 2005) and the N-terminal alanine tract 
of ZIC3 (Wessels et al., 2010) are associated with pathological effects in humans. In 
addition, there is evidence that the number of protein binding partners is generally 
higher in proteins which contain low-complexity domains at the terminal regions 
(Coletta et al., 2010), suggesting that these domains confer protein binding capabilities. 
Moreover, the Arkell laboratory has identified two previously unannotated regions that 
are only conserved in subclass A ZIC proteins. The first domain is a ten-amino acid 
sequence in the N-terminal region referred to as the subclass A N-terminal conserved 
(SANC) region. The second domain is a fourteen-amino acid sequence in the C-terminal 
region referred to as the subclass A C-terminal conserved (SACC) region. These two 
conserved domains contribute to the trans-activation of Zic3 in a context-dependent 
manner (Ahmed et al., 2016). 
3.1.2 The Zic3 gene 
The Zic3 gene is X-linked 
The Zic3 gene is the only mammalian Zic gene family member that is X-linked and 
unpaired in both human and mouse. X-linkage results in a specific pattern of inheritance, 
as X-linked genes have no allelic counterpart in males: a condition known as 
hemizygosity. Different progeny classes are generated depending on whether the 
mutation is passed through the female or the male (Figure 3.4). Both hemizygous males 
and heterozygous females inherit one copy of the mutant allele. However, in general, 
male carriers display more severe phenotypes than females. This is due to a   
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combination of two factors: firstly, male cells have only one copy of the X-chromosome, 
meaning that hemizygous mutations are functionally equivalent to a homozygous 
autosomal mutation. Secondly, female cells have only one active X-chromosome; owing 
to the random nature of X-inactivation, female tissues will contain mosaics of cells that 
are either wild-type or mutant.  
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Figure 3.4: Schematic illustration of X-linked inheritance. A) When the Zic3 mutation is 
passed through a carrier female (X
m
X), the potential progeny are heterozygous female, 
hemizygous male, or wild-type male and female. B) When the Zic3 mutation is passed 
through a hemizygous male (X
m
Y), he produces only heterozygotic females and wild-type 
males who cannot transmit the mutation.  
70 
 
Zic3 expression during murine gastrulation 
The expression pattern of murine Zic3 has previously been examined by the Arkell 
laboratory and published in Elms et al. (2004). The information below has been 
reproduced in its entirerty from the publication and is included here for ease of 
reference. Their findings showed that expression of Zic3 is initiated prior to gastrulation; 
transcripts were found throughout the extra-embryonic ectoderm of 5.0 dpc stage 
embryos and within some epiblast cells (Figure 3.5 A). In all pre-gastrulation stages 
examined, distal epiblast cells did not express Zic3, and there was no expression in the 
endoderm. This was confirmed through sectioning of pre-gastrulation stage embryos 
(Figure 3.5 B–D). This pattern of expression is maintained until the onset of gastrulation 
(Figure 3.5 E, F). Upon initiation of gastrulation, expression in the ectoderm recedes 
from the anterior half portion of the embryo. Instead, Zic3 is expressed in the region of 
the embryo lined by the mesoderm, emerging from the primitive streak to encircle the 
embryonic portion of the egg cylinder (compare Figure 3.5 E, G). The mesoderm that 
moves into the extra-embryonic region does not contain Zic3 transcripts, and expression 
at the posterior end of the embryo during this stage occurs in the ectoderm of the 
posterior amniotic fold (arrow in Figure 3.5 G). Whole-mount in situ hybridisation 
showed that mid- and late-streak stage embryos express Zic3 at the furthest anterior 
region of the embryo: at the junction between the embryonic and extra-embryonic 
region. Sectioning of embryos revealed that this expression occurs in the anterior 
definitive endoderm (Figure 3.6 H, P). As the node forms at the anterior end of the 
primitive streak, it can be seen that the node cells at the external surface of the embryo 
do not express Zic3, although the ectoderm in this region contains transcripts (Figure 
3.5 H). As gastrulation proceeds, the pattern of Zic3 expression remains relatively 
constant; transcripts are located in the wings of the embryonic mesoderm, as well as   
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Figure 3.5: Zic3 expression during mouse gastrulation. In all pictures of intact embryos at 
stages where the anterior can be distinguished (after 6.0 dpc), anterior is on the left, except 
L and M, where anterior is at the top. Anterior is on the left in the sections shown in H and 
P. The intact embryos in A–K are shown from the lateral view; those in L–O are shown from 
the dorsal view. (A) A 5.0 dpc pre-streak stage embryo. (B) A transverse section through the 
extra-embryonic region of a pre-streak stage embryo at the level shown in E. (C) A transverse 
section through the proximal embryonic region of a pre-streak stage embryo at the level 
shown in E. (D) A transverse section through the distal embryonic region of a pre-streak stage 
embryo at the level shown in E. (E) A 6.0 dpc pre-streak stage embryo. (F) A 6.25 dpc embryo 
prior to the onset of gastrulation. (G) A 6.75 dpc mid-streak stage embryo, showing formation 
of the posterior amniotic fold. (H) A longitudinal section through the 7.0 dpc late-streak stage 
embryo shown in I. (I) A 7.0 dpc late-streak stage embryo. (J) A 7.25 dpc early allantoic bud 
stage embryo. (K) A 7.75 dpc early headfold stage embryo. (L) A flat-mount of the trunk 
neurectoderm of a headfold pre-somite stage embryo showing diminished transcription in 
the midline neurectoderm. (M) The posterior of a headfold pre-somite stage embryo with 
transcripts in the neurectoderm and at the edge of the node. (N) A 7-somite stage embryo; 
note regionalisation of expression in the cranial neurectoderm. (O) A higher power view of 
the posterior of a 7-somite stage embryo in which some transcripts are visible at the edge of 
the node and some signal is observed within the node itself. (P) A transverse section through 
the embryonic portion of a 6.75 dpc mid-streak stage embryo at the level shown in G. (Q) A 
transverse section through the trunk of a 1-somite stage embryo. (R) A transverse section 
through a 7-somite embryo at the level of the node. (S) A transverse section through the 
trunk of a 7-somite embryo anterior to the node. mn: midline neurectoderm, r3: prospective 
rhombomere 3, n: node. Scale bars: 50 μm (A), 90 μm (B–D), 100 μm (E–G), 150 μm (H–M, 
O), 300 μm (N), 170 μm (P), 120 μm (Q–S). Figure reproduced from Elms et al. (2004). 
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the primitive streak and ectoderm adjacent to the expressing mesoderm (Figure 3.5 I–
K). In the posterior region of the embryo, expression can be seen in the ectoderm (arrow 
in Figure 3.5 I, J). The mesoderm in this region moves into the extra-embryonic portion 
of the embryo and does not express Zic3, as shown in Figure 3.5 H. Zic3 expression was 
not observed in the ventral node at any of these primitive streak stages, or in the axial 
mesendoderm, which emerges from the node. 
As the headfolds develop, Zic3 expression is lost at the midline neurectoderm cells along 
the length of the axis, but continues throughout the rest of the neural plate (Figure 3.5 
L, Q). In the cranial region, neurectoderm expression of Zic3 begins to become 
regionalised, with areas of lower signal including the prospective midbrain and future 
hindbrain (Figure 3.5 N). In early somite embryos, the hindbrain contains one region 
with considerably lower expression levels. This region is immediately caudal of the 
periotic sulcus that is known to mark the junction of future rhombomere 2 and 3 (Trainor 
et al., 1995); it has been identified as the prospective rhombomere 3. In later stage 
embryos, when rhombomeres can be clearly distinguished, it can be seen that Zic3 
transcripts are also down-regulated in rhombomere 5, which was identified by the 
location of the otic sulcus that marks the rhombomere 5/6 boundary (Trainor et al., 
1995). Additionally, during headfold stages, Zic3 transcripts disappear from the primitive 
streak, but can be found in a group of cells anterior to the primitive streak that constitute 
the node (Figure 3.5 M). Node expression continues, becoming more prominent in 
embryos with seven somites (Figure 3.5 N, O, R) and is still present in embryos with 
twelve somites (data not shown). Inspection of node expression in both whole-mount 
specimens and sections failed to detect any evidence of asymmetric localisation of Zic3 
transcripts. During the somite stages of development, Zic3 expression is also detected 
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in the paraxial mesoderm at the level of the node and, more rostrally, in the segmenting 
paraxial mesoderm (Figure 3.5 R, S). 
Zic3 and situs ambiguus (heterotaxy)  
Most organisms have several internal asymmetries, though they display outward 
symmetry. Humans, for example, have unpaired organs (such as the heart or liver) and 
asymmetrically paired organs (such as the lungs). These asymmetries derive from an 
initial symmetry-breaking event during early embryogenesis, which establishes the 
embryonic left-right (L–R) axis, distinguishing the left side of the embryo from the right 
side. Errors in establishing these differences can lead to laterality disorders known as 
heterotaxy (Figure 3.6), which is a Greek term meaning ‘other arrangement’ (Ware et 
al., 2004). This condition is characterised by abnormally positioned thoracic and/or 
visceral organs, which can cause multiple congenital malformations (Sutherland et al., 
2009). The major cause of morbidity and mortality are complex cardiovascular 
malformations which are sometimes accompanied by defects in the pulmonary, 
gastrointestinal, genitourinary, immune and musculoskeletal systems (Kearns-Jonker, 
2006). Epidemiological surveys show that 3% of congenital heart defects are caused by 
heterotaxy, which has an estimated prevalence of 1:10,000 live births (Lin et al., 2000). 
The true prevalence may be underestimated because of the wide spectrum of possible 
phenotypic abnormalities, variable expressivity, and incomplete penetrance associated 
with laterality defects. 
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Figure 3.6: Schematic of situs ambiguous. Comparison between the normal 
arrangement of visceral organs (known as situs solitus—where the heart, stomach and 
spleen are on the left side and the liver on the right), heterotaxy (also known as situs 
ambiguous—where the heart and visceral organs are oriented independently of each 
other), and situs inversus (mirror image reversal of all organs). Figure adapted from R. 
Arkell. 
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The most common causes of heterotaxy are random genetic and environmental factors. 
Associated environmental factors include maternal diabetes, maternal cocaine use, and 
monozygotic twinning (Kuehl et al., 2002). Mutational analysis in humans has identified 
heterozygous defects in a variety of autosomal genes (such as Nodal, Cfc-1, ActrIIB, 
Foxh1 and LeftyA) in affected children and family members (Carmi et al., 1992, Gebbia 
et al., 1997). Despite the complications associated with studying these genes and their 
roles in L–R axis formation owing to species-specific differences in gene function; animal 
models have greatly advanced our understanding of this phenomenon (Kearns-Jonker, 
2006). In addition, there are more than 100 genes in animal models that are likely to 
play a role in the development of human heterotaxy, as they have been shown to be 
required for the formation of the L–R axis in these models (Sutherland et al., 2009). 
Mutations in the ZIC3 transcription factor are most frequently associated with human 
heterotaxy (Gebbia et al., 1997, Sutherland et al., 2009), contributing to 5% of all familial 
cases of heterotaxy and 1% of cases of sporadic heterotaxy (Ware et al., 2004). In 
humans, twenty-five different mutations in the Zic3 gene have now been definitively 
linked to heterotaxy (Figure 3.7) (Gebbia et al., 1997, Megarbane et al., 2000, 
D'Alessandro et al., 2013, Cowan et al., 2014).  As expected of an X-linked gene, male 
(hemizygous) carriers of Zic3 mutations exhibit situs ambiguus heterotaxy with varying 
degrees of severity, and are affected more severely than heterozygous females (Lin et 
al., 2000). However, some male carriers (from families with a history of ZIC3-related 
congenital defects) have been found to show normal phenotypes (Megarbane et al., 
2000, D'Alessandro et al., 2013), perhaps indicating that other proteins can, in some 
cases, compensate for ZIC3 function. Females heterozygous for deleterious Zic3 
mutations are usually asymptomatic; however, one family has been found to contain 
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females with situs inversus who carry the heterozygous mutation (Gebbia et al., 1997). 
The different phenotypes in females may be due to skewed X-inactivation, where one X-
chromosome carrying normal Zic3 is inactivated while the other X-chromosome carrying 
the mutated allele remains active (Chhin et al., 2007). Notably, this pattern of inheritance 
exhibited by Zic3, along with the fluctuation of phenotypes observed, makes diagnosis 
difficult. It is difficult to pinpoint the specific tissues and the exact stage of development 
where ZIC3 function is required using human clinical data. 
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Figure 3.7: A schematic showing the location and class of all Zic3 heterotaxy-associated 
human mutations. There are twenty-five known heterotaxy-associated human Zic3 
mutations. The N-terminus (defined as the first 252 amino acids before the zinc finger 
domain [ZFD]) contains ten mutations, the ZFD contains fourteen mutations, and the C-
terminus (defined as the 58 amino acids following the ZFD) contains one mutation. There 
are notable shifts in the type of mutations that occur in the different regions of the 
protein. C: Cysteine, H: Histidine, aa: amino acid, Other: insertions, duplications, and 
deletions, N: number, SANC: subclass A N-terminal conserved, SACC: subclass A C-
terminal conserved. Figure adapted from Koula Diamand. 
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Heterotaxy and the left-right axis  
The exact manner by which this occurs remains controversial. This asymmetric gene 
expression is thought to be induced by directional flow of extracellular fluid at the node 
(see 1.1.4 for a description of node formation), a process called nodal flow is shown in 
Figure 3.8. Two models have been proposed for how nodal flow is generated and 
perceived. First is the morphogen gradient model (McGrath and Brueckner, 2003). This 
model proposes the node cell monocilia moves a soluble morphogen towards the left 
side of the node. This establishes a concentration gradient of molecular signals, which 
then interact with their corresponding receptors on the left border of the node, resulting 
in signal transduction and the asymmetric expression of genes such as Nodal and Pitx2. 
Several secreted signals are produced in the node, such as Nodal (Brennan et al., 2002), 
GDF-1 (Rankin et al., 2000) and FGF-8 (Meyers and Martin 1999), however, no evidence 
for the differential distribution of these proteins in the node in response to nodal flow 
has been observed.  
The second model, known as the two cilia model, proposes that the motile cilia of the 
pit cells direct fluid leftward which deflects left-side crown cell (primary, immotile) cilia. 
These cilia are thought to be mechanosensory. The bending of the node monocilia 
against their cell bodies triggers an increase in intracellular Ca2+ signalling in cells on the 
left margin of the node (McGrath et al., 2013), which subsequently results in the 
asymmetric expression of genes such as Nodal on the left border of the node. This model 
is supported by the finding that the polycystic kidney disease 2 (Pkd2) gene and Pkd1-
like 1 (Pkd1l1) gene are expressed in the ciliate cells of the node and are required for 
response to nodal flow and L-R aixs determination in the mouse (Pennekamp et al., 
2002, Field et al., 2011). In the kidney, PKD2 and the related molecule PKD1, form a 
mechanotransducing complex that detects urine flow and generates a Ca2+ signal in   
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Figure 3.8: A schematic of L–R axis formation in the mouse embryo. 1: The node is induced 
to form at mid-gastrulation (7.0 dpc) and, in the next 24 hours, develops into a shallow, 
crescent-shaped depression on the ventral side of the embryo. The cells within the 
depression are termed pit cells, whereas those that form the raised surface that rings the pit 
are called crown cells (Norris, 2012). 2: A monocilium, extending into the extracellular space, 
forms on the apical surface of each pit and crown cell; these become posteriorly polarised 
over time. Signalling molecules (such as Nodal) are expressed in the crown cells. 3: The cilia 
of the pit cells rotate in a clockwise direction, directing first a disorganised, followed by a 
laminar leftward flow of extracellular fluid within the node. It is posited that this leftward 
nodal flow is sensed by crown cell cilia, prompting a Ca2+ flux in the left crown cells which 
modifies gene expression (Norris, 2012). By the end of this 24-hour period (at 8.0 dpc) the 
first known asymmetries in gene expression are detected within node crown cells (Dand5, 
and soon thereafter Nodal, become asymmetrically expressed in the node crown). A Wnt 
ligand is also asymmetrically expressed and canonical signalling then amplifies the initial 
Dand5 asymmetry (Nakamura et al., 2012). 4: The asymmetric signal/s are propagated to the 
left lateral plate mesoderm (LPM) and prevented from spreading to the right LPM by the 
recently formed midline barrier. 5: Nodal signalling in the left LPM controls its own 
expression, and that of other molecules which ultimately direct organ placement and other 
asymmetries (Norris, 2012). A: anterior, P: posterior, D: dorsal, V: ventral, R: right, L: left. 
This figure adapted from R. Arkell. 
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response (Nauli et al., 2003). By analogy it is proposed that that PKD2 and PKD1L1 form 
a complex in the leftsided crown cell cilia and upon deflection by nodal flow generate at 
Ca2+ signal. Despite the observation of asymmetric calcium signalling at the node of 
dissected 7.75 dpc mouse embryos and its disruption in mutant embryos (McGrath et 
al., 2003), however, Delling et al. (2016) reported that the crown cell cilia specific Ca2+ 
release was not observed at a physiological level of fluid flow when measured via a 
transgenic calcium indicator.  
For both models, the outcome is an asymmetric (L greater than R) signal at the node 
which stimulates enhanced left-sided expression of the Nodal secreted growth factor 
and simultaneous decreased left-sided expression of the secreted Dand5 nodal 
antagonist. The down-regulation of Dand5 mRNA levels is accomplished by degradation 
of Dand5 mRNA via the 3′ UTR at the left side of the node in a calcium-dependent 
manner (Nakamura et al., 2012). This suggests a potential role of the RNA-binding 
protein BICC1 because embryos null for this gene have defective L-R development 
(Maisonneuve et al., 2009). Subsequently, an asymmetric Nodal signal is relayed from 
the node to the left lateral plate mesoderm (LPM) via an unresolved mechanism, 
resulting in the activation of the Nodal cascade in the left LPM and asymmetric 
development of organs along the L-R axis (Meno et al., 1998, Nonaka et al., 1998, 
Nonaka et al., 2002, McGrath et al., 2003, Shiratori et al., 2006).  
Despite the long association in both humans and mice between ZIC3/Zic3 and 
heterotaxy, the precise role of this transcription factor in heterotaxy remains unknown. 
Zic3-null embryos are reported to exhibit random expression of Nodal at the early 
somite stage (Purandare et al., 2002) and it has been proposed that Zic3 directly up-
regulates Nodal mRNA expression during the head-fold stages of embryogenesis (Ware 
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et al., 2006a). However, in recent studies, conditional inactivation of Zic3 using a variety 
of Cre strains demonstrated that L–R axis defects results only when Zic3 function is 
ablated at 7.0 dpc in the nascent mesoderm (using TCre) (Sutherland et al., 2009, Jiang 
et al., 2013). 
In addition, it is expressed in an array of developing embryonic tissues, such as those 
that form the central nervous system, muscles, and aspects of the visual system 
(Herman et al., 2002). Overall, it seems that further analysis is needed of the Zic3 mutant 
phenotype and of the molecular mechanisms of Zic3. 
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Mouse models of Zic3 dysfunction  
Multiple mouse strains with Zic3 loss-of-function mutations are available (Table 3.2). In 
each case, mutant embryos displayed similar abnormalities to those observed in human 
patients with heterotaxy (Purandare et al., 2002), indicating that the mouse is an 
excellent system for examining the function of ZIC3 in human heterotaxy. Precisely how 
ZIC3 acts to prevent heterotaxy and its relevance in developmental processes is yet to 
be investigated. Mouse embryos have become the mammalian model for investigating 
congenital defects in humans because of the practical and ethical constraints on 
studying human embryogenesis (Bedell et al., 1997). There is a significant degree of 
sequence conservation between the human and mouse genomes. Thus, there are many 
mutations in the orthologous mouse genome and these mirrors the human phenotype. 
The human ZIC3 gene, for instance, is 1,404 bp long with a protein product (ZIC3) of 467 
amino acids; the mouse Zic3 gene is 1,401 bp long with a protein product of 466 amino 
acids (Figure 3.9). The amino acid sequences of the human and mouse proteins show 
98% identity, with 99.4% homology between their ZFDs. Therefore, due to genetic 
similarities, the mouse is a useful model organism for studying human genetic disorders 
and mammalian developmental genetics (Malakoff, 2000). 
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Table 3.2: Murine alleles for Zic3 (downloaded from MGI: http://www.informatics.jax.org). 
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Figure 3.9: Sequence alignment of human and mouse ZIC3 proteins. The evolutionarily 
conserved five functional C2H2 zinc fingers (ZFs) are highly similar between human and 
mouse. Amino acids coloured in green and blue are the evolutionarily conserved ZIC/Odd-
paired conserved (ZOC) and zinc finger N-terminal conserved (ZFNC) domains, respectively. 
The five C2H2 ZFs are indicated (ZF-1–5). Asterisk (*) = identical residues. 
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The katun mouse strain is a null allele of the Zic3 gene 
The katun (Ka) mouse mutant was isolated in an ENU mutagenesis screen designed to 
assess dominant mutations for semi-dominant phenotypes (Bogani et al., 2004). In the 
pedigree generated within the dominant screen, it was observed that several G1 
progenies exhibited a bent tail phenotype. This suggests that the mutation arose not as 
a consequence of ENU exposure in the male, as repeat mutations are not generally 
recovered with high frequency (Rinchik and Carpenter, 1999), but was instead a 
spontaneous, incompletely penetrant mutation in one of the parents (Bogani et al., 
2004). Inheritance of the mutation was consistent with X-linkage; the phenotypic 
similarities between Ka and deletion of the entire Zic3 gene (known as the Bn allele) 
indicated that Ka was likely to be a new allele of Zic3. The coding region of Zic3 was 
amplified by touchdown PCR from the genomic DNA of a heterozygous female, a 
hemizygous male, a C3H/HeH mouse, and a Balb/c mouse and sequenced. This revealed 
a single base change of G to T at nucleotide position 1,283 of accession no. NM_009575 
in the affected mice (Figure 3.10 A-C). This base change converts codon 248 from a 
glutamate to a stop codon, generating a nonsense mutation that introduces a premature 
termination codon (PTC) (Figure 3.10 D). 
Similar to the phenotypes caused by the Bn allele (Garber, 1952, Carrel et al., 2000), the 
katun phenotype is incompletely penetrant. Females heterozygous for katun 
(Zic3Ka/+) are genetically viable but may exhibit minor defects such as kinked tails (Figure 
3.10 G). In contrast, hemizygote male mutants (Zic3Ka/Y) are more severely affected; 
their body symmetry is altered and they exhibit heart defects in terms of the L–R axis 
(Bogani et al., 2004). As the phenotype is incompletely penetrant, however, not all 
mutants display these defects to the same extent. Homozygous katun females 
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Figure 3.10: The katun mutation is a null allele for Zic3. This mutation converts codon 248 
to a stop codon. (A-C) Sequence traces from exon 1 of murine Zic3 gene of (A) wild-type 
(Zic3+/+), (B) heterozygous female (Zic3Ka/X), and (C) hemizygous male (Zic3Ka/Y) mice with 
arrows indicating the altered base. (D) Protein structure of ZIC3-wt and ZIC3-katun. The katun 
protein lacks the entire zinc finger domain (ZFD) and C-terminus. (E-M) Stage-matched 
Zic3Ka/Y (E-G) and Zic3-null (H-M) embryos showing altered primitive streak, mesoderm, and 
endoderm formation. A lateral view of embryos is shown with anterior on the left, following 
whole-mount in situ hybridisation (WMISH) of the RNA named in each panel. (E-K) Cer1 and 
Lim1 are markers for endoderm and mesoderm formation. In Zic3+/+ embryos, these markers 
are expressed in the anterior visceral endoderm (black arrow). In Zic3Ka/Y and Zic3-null 
embryos, Cer1 expression is lacking, while Lim1 expression is reduced. (G, L, M) Foxa2 shows 
primitive streak formation. Zic3Ka/Y and Zic3-null embryos display ectopic expression of Foxa2 
going into the amniotic cavity (black arrows). Panels (A-G) were adapted from Ahmed et al. 
(2013). Panels (H-M) were adapted from Ware et al. (2006b). 
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 (Zic3Ka/Ka) exhibit similar defects to those seen in hemizygote males (Ahmed et al., 
2013).  
Two sets of analyses conducted by the Arkell laboratory (Ahmed et al., 2013) established 
that katun is a null allele. Molecular evidence indicated that the predicted protein (i.e. 
ZIC3 E249X) does not trans-activate and is unable to elicit transcription at an Apoe 
promoter in cell reporter assays. In addition, unlike the ZIC3 wild-type protein, the katun 
protein was unable to inhibit Wnt-dependent β-catenin-mediated transcription in a 
TopFlash assay. Moreover, phenotypic analysis of katun mutant mice revealed a 
reduction in the expression of markers for both endoderm and mesoderm formation 
(Ahmed et al., 2013), similar to previous results in mice with other Zic3-null alleles 
(Figure 3.10 E-M) (Ware et al., 2006b). As the katun allele behaves as a Zic3-null 
mutation in both human cells and mouse models, it can be used to elucidate the 
molecular role of ZIC3 during gastrulation and determine the mechanisms of ZIC3-
associated heterotaxy.  
3.1.3 The Wnt signalling pathway 
Wnt signalling refers to several pathways activated by secreted Wnt ligands which have 
been separated into two classes: classical Wnts (Wnt1, -3a, -8, and -8b), which activate 
signalling through the canonical pathway; and non-classical Wnts (Wnt4, -5a, and -11), 
which activate signalling through non-canonical pathways such as the planar cell polarity 
(PCP) pathway and the Wnt/calcium signalling pathway (Rao et al. 2010). All three 
pathways require the binding of a Wnt ligand to a Frizzled (Fz) receptor, which sends a 
signal to Dishevelled (Dvl) in the cell cytoplasm. In the canonical pathway, the binding 
of Wnt to Fz results in the accumulation of β-catenin in the cytoplasm and its eventual 
translocation to the nucleus to activate the transcription of Wnt target genes. When 
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Wnt ligands are not bound, however, β-catenin is degraded via a destruction complex 
made up of Axin, glycogen synthase kinase 3 (GSK3), and adenomatous polyposis coli 
(APC). In contrast, the non-canonical pathways do not require β-catenin to function. The 
PCP pathway establishes cellular polarity by asymmetrical and polarised protein 
localisation and regulates polarised cell movements such as gastrulation and neural 
crest migration during embryonic development (Simons et al. 2008). The Wnt/calcium 
signalling pathway involves Wnt activating calcium-dependent pathways, which are 
critical to dorsal-ventral axis formation, intracellular calcium levels, and cardiac cell 
development (Purandare et al., 2002).  
Canonical Wnt/β-catenin signalling  
Studies have shown that canonical Wnt/β-catenin signalling plays an essential role 
during all stages of life, from early embryogenesis to adult homoeostasis (Clevers et al., 
2012). In the early developing embryo, canonical Wnt/β-catenin signalling directs cell 
fate determination, migration, and proliferation in the coordination of tissues, as well 
as organ development during the establishment of the body axis (Hierholzer et al.). 
Mutations in this canonical Wnt pathway, therefore, have potentially lethal 
consequences for the developing embryo, including gastrulation defects (Morkel et al., 
2003), axis formation failure (Huelsken et al., 2000), and embryonic lethality (Haegel et 
al., 1995). In later life, canonical Wnt signalling also plays a critical role in tissue 
homoeostasis, cell renewal, regeneration, and the maintenance of bone health (Valenta 
et al., 2012). Therefore, mutations in the canonical Wnt pathway during adulthood can 
contribute to a significant number of cancers and bone diseases (Nusse, 2005, Grigoryan 
et al., 2008).  
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The central protein in canonical Wnt signalling— β-catenin—is encoded by the Ctnnb1 
gene, which consists of a central region of twelve ‘armadillo’ repeats flanked by N- and 
C-terminal trans-activation domains (TADs). These domains contain various 
phosphorylation and trans-activation sites that regulate β-catenin function (Valenta et 
al., 2012). Because β-catenin does not contain a DNA-binding domain, the N- and C-
terminal TADs of the armadillo repeats are required to support the various DNA-binding 
transcriptional co-activators that facilitate β-catenin-mediated transcription. This 
enables the cell-cell adhesion and signalling functions of β-catenin, such as transcription 
of Wnt target genes in the nucleus (Mosimann et al., 2009). 
As a cell adhesion molecule, β-catenin binds to the cytoplasmic domain of cadherin 
proteins involved in cell-cell adhesion. The β-catenin protein is essential for strong 
cadherin-mediated cellular adhesion, as it indirectly ties cadherin proteins on the 
membrane to the actin cytoskeleton to facilitate signalling events (Heuberger et al., 
2010). However, in the nucleus, β-catenin functions as a transcriptional co-activator by 
interacting with DNA-binding co-activator molecules to activate the transcription of Wnt 
target genes, owing to the lack of β-catenin DNA-binding sites (Henderson et al., 2002, 
Bienz et al., 2003). The primary nuclear partners of β-catenin that activate most 
canonical Wnt signalling pathways are the T-cell factor (TCF)/Lymphoid enhancer-binding 
factor 1 (LEF1) family. When, in the absence of a Wnt ligand, Wnt is not stimulated, TCF 
proteins act as transcriptional repressors by forming a complex with Groucho/TLE 
repressors (Figure 3.11 A) (Arce et al., 2006). However, when Wnt is stimulated in 
response to Wnt ligand binding, the interaction of β-catenin with the N-terminus of TCF 
physically displaces the Groucho protein and, in doing so, transiently converts TCF into a 
transcriptional activator (Figure 3.11 B). 
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Figure 3.11: A schematic of canonical Wnt/β-catenin signalling. A) In the absence of a Wnt 
signal, β-catenin is targeted by a coordinated phosphorylation complex consisting of the 
scaffolding proteins AXIN and adenomatous polyposis coli (APC). AXIN and APC promote 
phosphorylation of β-CATENIN through the action of casein kinase 1 (CK1) and glycogen 
synthase kinase 3 (GSK3), which targets β-CATENIN for ubiquitin dependent degradation via 
the ubiquitin ligase β-TrCP (Cadigan and Peifer, 2009; MacDonald et al., 2009). Without 
nuclear β-catenin, T-cell factor (TCF) proteins act as transcriptional repressors of target 
genes in the nucleus. B) When Wnt is stimulated by an extracellular Wnt protein binding to 
the Frizzled (Fz) receptor and the LRP5/6 co-receptor on the surface of cells, a Wnt/Fz/LRP 
receptor complex is formed, resulting in phosphorylation of the intracellular portion of 
LRP5/6; this, in turn, stops the β-CATENIN degradation complex in a Dishevelled (Dvl)-
dependent manner (Cadigan and Peifer, 2009; MacDonald et al., 2009; Kim et al., 2013). 
Subsequently, β-CATENIN is transported into the nucleus, where it accumulates and binds 
to the TCF protein, subsequently acting as a transcription co-factor to activate target genes. 
Figure adapted from Arkell et al. (2013). 
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Elevation of Wnt/β-catenin signalling phenotypes 
Wnt/β-catenin signalling activity must be tightly controlled during embryogenesis, as 
indicated by the dramatic phenotypes produced by aberrant Wnt signalling in mice. The 
absence of Wnt3a results in the loss of all caudal structures below the forelimbs (Takada 
et al., 1994); embryos lacking the Wnt repressor Dkk1 exhibit partial to complete head 
truncation (Mukhopadhyay et al., 2001, Fossat et al., 2011); and both Dkk1 and Axin 
mutants exhibit duplicated axes (Zeng et al., 1997) (Fossat et al., 2011). Similarly, loss-
of-function of the murine TCF7L1 gene increases Wnt/β-catenin signalling during 
gastrulation, resulting in duplication of axis structures such as the node and notochord. 
This suggests that, in some contexts, the main function of the TCF/LEF is to repress Wnt 
target genes (Merrill et al., 2004).  
Wnt/β-catenin signalling can be inhibited at all levels of the signalling pathway. Proteins 
such as Wnt Inhibitory Factor (WIF) and secreted frizzled-related protein (SFRP), which 
are secreted extra- or intracellularly, contain regions mimicking Wnt receptors and can, 
therefore, bind and modulate the activity/stability of Wnt ligands (Bovolenta et al., 
2008). For instance, secreted proteins such as WISE and DKK inhibit Wnt/β-catenin 
signalling by interacting with the LRP5/6 receptor, thereby disrupting the formation of 
the Wnt/Fz/LRP receptor complex (Semenov et al., 2001, Itasaki et al., 2003). Wnt/β-
catenin signalling antagonists have also been identified at the nuclear level. These 
proteins, which include CHIBBY, inhibitor of β-catenin (ICAT), and transcription factor 4 
(TCF4), negatively regulate Wnt/β-catenin signalling in two ways: by disrupting the 
interaction of β-catenin with TCF, and by promoting the export of β-catenin from the 
nucleus (MacDonald et al., 2009). Although β-catenin degradation usually occurs in the 
cytoplasm, it has also been suggested that SOX9 and OCT3/4 can downregulate Wnt/β-
catenin signalling levels by causing degradation of β-catenin in the nucleus (Topol et al., 
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2009, Abu-Remaileh et al., 2010). 
ZIC proteins can inhibit β-catenin-mediated transcription in vitro  
Recently, two independent studies (using fish embryos, frog embryos, and cultured 
mammalian cells) demonstrated that ZIC proteins can inhibit TCF-dependent 
transcription, which is normally stimulated by Wnt signalling (Pourebrahim et al., 2011, 
Fujimi et al., 2012). Importantly, the study by Pourebrahim et al. demonstrated that this 
repression occurs because ZIC2 interacts with TCFs, rather than directly binding the DNA 
of Wnt targets; this represents a role for the ZIC proteins as co-factors in the Wnt/β-
catenin pathway and provides further evidence that they are multifunctional proteins.  
Both Wnt pathway components and ZICs show similar loss-of-function phenotypes. For 
instance, posterior axis duplications have been observed in Zic3-null mouse embryos 
(Ware et al., 2006b), similar to defects previously associated with elevated/ectopic Wnt 
signalling (Popperl et al., 1997, Zeng et al., 1997). In addition, the kinked tail exhibited 
in adult Zic3 katun heterozygous and hemizygous mice (Bogani et al., 2004, Ahmed et 
al., 2013) was also seen in mice heterozygous for the Wnt-activating gain-of-function 
Lrp6 allele gwazi (Bogani et al., 2004, Fossat et al., 2011). Moreover, it was found that 
ZIC3 prevented the formation of an additional axis by supressing β-catenin in Xenopus 
embryos (Fujimi et al., 2012).  
The Batface mouse strain 
The batface (Bfc) mouse strain was first identified via an ENU recessive genetic screen 
(Nolan et al., 2000); the causative mutation was found to be a C to A point mutation at 
nucleotide position 1,958 of the β-catenin gene, Ctnnb1 (Figure 3.12 A) (Fossat et al., 
2011). The resulting amino acid substitution of threonine (T) to lysine (K) at residue 653 
(T653K) falls within the last armadillo repeat and is a key trans-activation region for the 
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β-catenin protein (Figure 3.12 B) (Fossat et al., 2011). In contrast to β-catenin-null 
mutant embryos, heterozygous Bfc mutant embryos survived beyond early 
embryogenesis and exhibited varying degrees of craniofacial and head formation 
defects (Figure 3.12) (Fossat et al., 2011). 
Despite the potential value of Bfc mutants, the effects of this mutation on β-catenin 
function, as well as the impact of the mutation on Wnt signalling, have not been 
quantitatively determined. Previous studies of early stage Bfc embryos crossed with the 
Tcf-Lef-LacZ reporter strain (BATGal) showed elevated levels of Wnt signalling activity 
during gastrulation compared to stage-matched wild-type embryos (Figure 3.12 C) 
(Fossat et al., 2011). The elevated activity of the Bfc allele was confirmed and quantified 
using a TopFlash assay by the Arkell laboratory (Arkell lab, unpublished data); however, 
the underlying mechanism for this elevation is yet to be elucidated. It has been 
previously shown that replacement of a neutral tyrosine (Y) residue with a charged 
glutamic acid (E) residue at position 654 of β-catenin mimics phosphorylation of Y654 
and results in increased Wnt-dependent transcription (Piedra et al., 2001, van Veelen et 
al., 2011). Because the Bfc mutation involves replacing a neutral threonine (T) residue 
with a charged lysine (K) residue at position 653 of the β-catenin protein, it is 
hypothesised that it acts by mimicking or enhancing phosphorylation of the 
neighbouring residue—Y654—by altering the structure of β-catenin to increase Wnt 
signalling activity. 
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Figure 3.12: The Batface mouse. (A) A point mutation within the Ctnnb1 gene (C to A) results 
in a threonine (T) to lysine (K) amino acid substitution. (B) The position of the Bfc mutation 
within the last armadillo repeat (red arrow) and C-terminal trans-activation domain of the β-
catenin protein at position 653. (C) A later view of mouse embryos with anterior on the left. 
Stages are indicated, showing expression of the Tcf-Lef-lacZ reporter (BATGal) in both wild-
type and Ctnnb1
Bfc/Bfc 
mutant embryos. (D) Mice heterozygous for the Bfc mutation display 
craniofacial and head formation defects, including a squashed face, compared to the wild-
type. (A-C) adapted from Fossat et al. (2011). 
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3.1.4 Aims 
The overall aim is to characterise the phenotype of the katun mouse mutant that 
harbours a Zic3-null allele and to investigate the underlying molecular causes of the 
resultant phenotype. The possibility that the katun mutants fails to inhibit Wnt/β-catenin 
signalling during early embryogenesis will be investigated. Additionally the possibility 
that elevated Wnt/β-catenin signalling can cause L-R axis defects will be examined by 
phenotyping the Bfc allele of β-catenin known to have elevated canonical Wnt activity at 
gastrulation. 
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3.2 RESULTS 
3.2.1 The Zic3 loss-of-function phenotype is indicative of elevated canonical 
Wnt activity at gastrulation 
As described in the introduction, several experimental systems demonstrate the ZIC 
proteins can inhibit Wnt/β-catenin dependent transcription via physical interaction with 
TCF proteins. Published data from the Arkell laboratory has shown the katun protein 
variant of murine ZIC3 is unable to inhibit Wnt/β-CATENIN dependent transcription in 
HEK293T cells (Ahmed et al., 2013). The corresponding mouse strain (a null allele of Zic3) 
therefore provides the opportunity to test whether ZIC3 inhibits Wnt signalling in vivo, 
since loss-of-function of negative regulators of canonical Wnt signalling produces a 
consistent and well documented phenotype (Arkell et al., 2013). Furthermore, previous 
analysis of the murine Zic3 loss-of-function phenotype has already revealed features 
found in mouse strains harbouring activating canonical Wnt pathway alleles. For 
example, animals heterozygous for mutations in Zic3 exhibit tail kinks; a phenotype 
repeatedly associated with elevated canonical Wnt signalling (Bogani et al., 2004, 
MacDonald et al., 2004, Ahmed et al., 2013, Norum et al., 2015, Doi et al., 2016). Some 
subtle phenotypic features in embryos that lack Zic3 are also shared with strains that 
have elevated canonical Wnt activity, such as the ectopic expression of Foxa2 in the 
gastrula seen in embryos that lack Zic3 (Ware et al., 2006, Ahmed et al., 2013) and in 
embryos that lack Tcf7l1 (Merrill et al., 2004). 
To further assess whether elevated canonical Wnt signalling may contribute to the Zic3 
phenotype, embryos were specifically inspected for two features well known to result 
from elevated Wnt signalling at gastrulation: forebrain truncation and posterior midline 
defects. Such as seen in mutation in the Wnt signalling inhibitor Fused locus encoded 
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Axin (AxinFu) exhibited loss of its anterior structure and exhibiting posterior axis defects 
(Zeng et al., 1997). WMISH of 9.5 dpc embryos to genes that delineate axial tissues (T; 
notochord Herrmann et al., (1990), Fst; somites and brain structures, Fgf8; anterior 
neural ridge and midbrain/hindbrain junction [Mahmood et al., 1995]) enabled scoring 
of these phenotypes. As shown in Table 3.3 and Figure 3.13, embryos heterozygous for 
the Ka allele of Zic3 do not show these features, whereas a proportion of embryos 
hemizygous null for Zic3 (Zic3Ka/Y) for this allele exhibit mild anterior truncation (7%, N= 
3/45). Additionally, T expression revealed that a subset of hemizygous null embryos 
(16%, N= 7/45) have bifurcations and/or small regions of duplicated trunk notochord. To 
further investigate the axis defects, embryos were harvested at 8.5 dpc (Figure 3.14) and 
WMISH was conducted for the secreted molecule sonic hedgehog (Shh), which is 
normally expressed in the node and notochord of the headfold stage embryo as well as 
in the floor plate and definitive endoderm during the early somites stages (Echelard et 
al., 1993). This experiment revealed that the notochord bifurcations and small 
duplications observed following T WMISH were already present at earlier stages. 
Additionally, the node is irregularly shaped in hemizygous mutant embryos (data not 
shown), a feature consistent with previously published Zic3 mutants (Sutherland et al., 
2013) and one that may underlie the axis defects seen in mutant embryos. Together the 
analysis implies that the Zic3 phenotype, at least in part, can be attributed to elevated 
Wnt signalling at gastrulation and that one role of ZIC3 is to repress Wnt target gene 
expression. 
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Table 3.3: The frequency of phenotypes typically associated with 
elevated canonical Wnt signalling in 9.5 dpc katun, Bfc and compound 
mutant embryos. 
* Significantly different from the wild-type at p<0.001 by X
2. 
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Figure 3.14: A partial axis duplication in the mutant embryos. Lateral view (A-D) and dorsal 
view (C’-D’’) of mouse embryos at 6 somites following WMISH to Sonic hedgehog (Shh). 
Anterior is to the left side in all images. (A) A wild-type embryo with normal Shh expression in 
the notochord, in the floor plate and in the midbrain ventral neuroectoderm. (B) Ctnnb1
Bfc/+
; 
Zic3
+/+ 
embryo with absence of Shh expression in the midbrain ventral neuroectoderm (black 
arrowhead). (C-C’) Ctnnb1
+/+
; Zic3
Ka/Y 
embryo with reduced mid- and forebrain and axis 
duplication indicated by the red arrowhead. (D-D’) Ctnnb1
Bfc/+
; Zic3
Ka/X
 embryo with reduced 
mid- and forebrain and an axis duplication. The region within the rectangle in D’ is expanded 
in D’’ showing two separate axis duplications as indicated by red arrowheads and an abnormal 
node shape (dotted line). S: somites. 
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3.2.2 Elevation of canonical Wnt signalling exacerbates the Zic3 loss-of-
function phenotype 
As described in the introduction, the Ctnnb1 gene encodes β-CATENIN (the key 
transcriptional mediator for the activity of the Wnt/β-CATENIN signalling cascade) 
(Petersen et al., 2009) and the batface (Bfc) mouse strain harbours a gain-of-function 
allele of Ctnnb1 (Nolan et al., 2000, Fossat et al., 2011). The excess Wnt/β-CATENIN 
signalling activity at gastrulation manifests as anterior truncation in homozygous Bfc 
mutant embryos but not as axial defects (Fossat et al., 2011). If ZIC3 does inhibit Wnt 
signalling at gastrulation then a positive interaction between the Bfc and Ka alleles 
would be expected, such as a more severe phenotype. Compound mutant embryos were 
produced using the strategy shown in Figure 3.15 and again analysed with markers of 
brain and axis development. As shown in Figure 3.13 and Table 3.3, 50% of Ctnnb1Bfc/+; 
Zic3Ka/X embryos displayed various degrees of anterior truncation which is a significant 
increase compared to embryos heterozygous for one or other of these alleles (p<0.01). 
The embryos were also inspected for axial defects via WMISH to T and an increase in the 
penetrance of axis defects was observed amongst the compound embryos versus either 
individual heterozygote (Table 3.3). Likewise, the analysis of compound mutant embryos 
via WMISH to Shh revealed aberrant node morphology as found in the Zic3Ka/Y embryos 
(Figure 3.14). 
Another indication of elevated Wnt signalling is the intrusion of Wnt target gene 
transcripts into the forebrain (the wild-type rostral limit of which is the midbrain). The 
distribution of transcripts from two such target genes (Axin2 and Sp5) was therefore 
analysed in wild-type and mutant embryos at 8.5 dpc. As can be seen in Figure 3.16, both 
genes are expressed not only in the some posterior and/or lateral regions of the embryo 
but also in the anterior neurectoderm, with a rostral limit at the  
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Figure 3.15: The experimental strategy. (A) A genetic cross was set up between a Bfc 
male and a Ka female to generate mutant embryos, genotypes are indicated on panel. 
Genotypes of the following embryos Ctnnb1+/+; Zic3+/+, Ctnnb1+/+; Zic3Ka/Y, Ctnnb1Bfc/+; 
Zic3+/+ and Ctnnb1Bfc/+; Zic3Ka/X were used for downstream phenotypic analysis utilising 
WMISH. This analysis was used to examine phenotypes which are associated with 
elevated level of canonical Wnt/β-catenin signalling during early embryogenesis. (B) The 
genetic cross between a Bfc male and a Bfc female was set up to generate homozygous 
Bfc mutant embryos. These homozygous mutants were used for downstream 
phenotypic analysis utilising WMISH.  
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forebrain/midbrain boundary (Jho et al., 2002). In a proportion of embryos null for Zic3 
(Ctnnb1+/+; Zic3Ka/Y) or trans-heterozygous for the Ka and Bfc alleles (Ctnnb1Bfc/+; Zic3Ka/X) 
the Axin2 and Sp5 expression domains expand into the anterior forebrain of the mutants 
(16%, N=3/18) and Ctnnb1Bfc/+; Zic3Ka/X (20%, N= 2/10) (Figure 3.16 and Table 3.4) 
indicating that presumptive forebrain tissue was instead caudalised. Evidently, the 
mutant embryos decrease in forebrain tissue is a direct result of failing to inhibit the 
Wnt/β-catenin pathway during gastrulation (Fossat et al., 2011). Overall the analysis 
supports the hypothesis that enhanced canonical Wnt signalling at gastrulation 
underpins the head truncation and axis defects associated with Zic3 loss-of-function. 
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Figure 3.16: Zic3 loss-of-function mutant embryos fail to inhibit the canonical Wnt signalling 
pathway at the anterior forebrain. (A-J’) Lateral view of mouse embryos following WMISH to 
Axin2 (A-D’) and trans-acting transcription factor 5 (Sp5) (E-J’). Stages are indicated on the 
panel. Anterior is in the left side in all images. Wnt/β-catenin direct target genes Sp5 and 
Axin2 are not expressed in the anterior forebrain in the wild-type embryos. (A-A’) The normal 
expression of Axin2 in the midbrain. (B-B’) An embryo with a slight ectopic expression 
extended in the forebrain as indicated by the black arrow in panel B’. The same observation 
seen in the mutants embryos Ctnnb1
Bfc/+
; Zic3
+/+
 (C-C’) and Ctnnb1
Bfc/+
; Zic3
Ka/X
 (D-D’) the 
expression of Axin2 has shifted anteriorly as indicated by the black arrows in panels C’ and D’ 
respectively. (E) A wild-type embryo showing the normal expression of Sp5 in the midbrain. 
(F-F’) Ctnnb1 
+/+
; Zic3
Ka/Y
embryo with normal expression of Sp5. (G-G’) Ctnnb1 
+/+
; Zic3
Ka/Y 
embryo showing anterior expression of Sp5 in the forebrain as indicated by the black arrow 
in panel G’. The same observation seen in mutants embryos Ctnnb1
Bfc/+
; Zic3
+/+
 (H-H’ and I-I’) 
and Ctnnb1
Bfc/+
; Zic3
Ka/ 
(J-J’) the expression of Sp5 has shifted anteriorly in the forebrain as 
indicated by the black arrows in panels H’, I’ and J’ respectively. The dashed lines are the 
boundaries of the midbrain. 
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Table 3.4: The frequency of phenotypes typically associated with 
elevated canonical Wnt signalling in 8.5 dpc katun, Bfc and compound 
mutant embryos. 
 
* Significantly different from the wild-type at p<0.001 by X
2 
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3.2.3 Elevation of canonical Wnt/β-catenin signalling during early 
embryogenesis effects cardiac situs 
The experiments described above raised the possibility that elevated Wnt signalling may 
also underpin the left-right axis defects associated with Zic3 loss-of-function in both 
mouse and man. To examine this possibility, I decided to investigate L-R axis formation 
in the Bfc mouse strain, since this strain affects the function of β-CATENIN; the non-
redundant pivot of the canonical Wnt pathway. In contrast, ZIC proteins have been 
shown to interact with transcriptional mediators of the Wnt, Hedgehog and Nodal 
pathways (Cheng, 2006, Fernandes et al., 2007, Pourebrahim et al., 2011, Fujimi et al., 
2012, Houtmeyers et al., 2016) complicating the attribution of phenotypic effects to a 
particular signalling pathway using Zic alleles. The first organ to exhibit L-R  asymmetry 
is the heart (Ramsdell, 2005) and the expression of Nppa in the right atrium and left 
ventricle at 9.5 dpc can be used to examine cardiac situs (Moorman et al., 2003). 
Embryos null for Zic3, and compound heterozygous for Zic3 (Ka) and Ctnnb1 (Bfc) alleles 
were recovered at 9.5 dpc and heart development assessed via WMISH to Nppa. While 
all wild-type embryos showed normal heart formation, 49% of the hemizygous Ka 
mutant embryos showed looping defects consistent with the findings of Ware et al., 
(2006) and Ahmed et al., (2013). In addition, 19% of the female trans-heterozygous 
mutant embryos (Ctnnb1Bfc/+; Zic3Ka/X) exhibited a leftward curve of the heart tube 
(sinistral looping heart, Figure 3.17 C). This result is statistically significant (p<0.001) 
compared to the wild-type embryos (Ctnnb1+/+; Zic3+/+) and indicates that enhanced 
Wnt/β-CATENIN signalling during early embryogenesis may contribute to cardiac 
defects. To further confirm this, homozygous Bfc (Ctnnb1Bfc/Bfc) mutant embryos were 
harvested at 9.5 dpc and Nppa expression analysed (Figure 3.18). Interestingly, two of 
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the 17 embryos showed a completely reversed heart as seen in human cases of 
heterotaxy, indicating that elevated Wnt activity can disrupt L-R axis formation.  
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 Figure 3.17: Heterotaxy might be associated with elevated canonical Wnt/β-catenin 
signalling. Ventral view (A-C) of mouse embryos following WMISH to Nppa to identify the 
heart chambers; the dotted line shows the extent of the heart tube. Genotypes and stages 
are indicated on the panel (A) A wild-type embryo with normal heart formation (dextral 
looping). (B) An embryo with abnormal heart formation (ventral looping). (C) An embryo 
exhibits a reversed heart formation (sinistral looping) comparing to the wild-type embryo. S: 
somites and LV: left ventricle. 
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Figure 3.18: Elevation of canonical Wnt/β-catenin signalling contributes to heterotaxy. 
Images of mouse embryo hearts following WMISH to Nppa to identify the heart chambers. 
Genotype and stage are indicated on the panel. (A-B) Anterior view and (A’-B’) ventral view 
of the heart: dotted line shows the extent of the heart tube. (A-A’) A wild-type embryo 
showing the normal expression of Nppa in the RA and the LV of the heart. This embryo 
represents the normal heart formation (dextral looping). (B-B’) Embryo showing the normal 
expression of Nppa in RA and LV. Mutant embryos exhibit complete reversal of the heart 
chambers (sinistral looping) similar to heterotaxy cases in humans. S: somites, RA: right atrium 
and LV: left ventricle. 
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Besides the two heterotaxic embryos, all of the remaining 15 homozygous Bfc embryos 
exhibited differing cardiac abnormalities as well as severe head truncations (Figure 3.19). 
The most severe defect was the occurrence of cardia bifida (Figure 3.19 C-C”); a failure 
of the bilateral myocardial cells to coalesce into a single central heart tube resulting in 
the presence of two independent hearts (Compernolle et al., 2003). It has been reported 
that this is caused by a failure of the two lateral heart fields to fuse correctly. Qian et al. 
(2011) identified a hypomorphic mutation in Axin2 (Axin2canp) that resulted in the same 
phenotype and was thought to be due to a requirement for high levels of canonical Wnt 
signalling in cardiac progenitors (Qian et al., 2011). Additionally, it could be induced by 
defective neural crest cells (NCC) (Compernolle et al., 2003). Sinistral heart looping was 
present as well as an unusual looping that made it difficult to distinguish the heart 
chambers (Figure 3.19 A and D). Thus, dysregulating expression of Wnt/β-CATENIN 
signalling at early embryogenesis is essential for proper cardiac looping and ventricle 
formation. 
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Figure 3.19: Elevation of canonical Wnt/β-catenin signalling in early embryogenesis can 
cause different cardiac situs defects. Images of Ctnnb1Bfc/Bfc mouse embryos following WMISH 
to Nppa to identify the heart chambers. Stages are indicated on panels. Lateral view (A-D), 
ventral view (A’-D’) and anterior view (A”-D”) of the heart: dotted line shows the extent of the 
heart tube. (A-D) All mutant embryos exhibited severe head truncations (asterisk). (A’-A”) An 
embryo with an abnormal heart formation (ventral looping). (B’-B”) An
 
embryo with a 
completly reversed heart (sinistral looping), similar to a heterotaxy phenotype. (C’-C”) An 
embryo with two separate hearts (numbers indicated on images), this phenotype is called 
cardia bifida. (D’-D’’) An embryo with unidentified/unusual heart formation. S: somite and LV: 
left ventricle. 
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3.2.4 Left-Right axis formation is perturbed in a proportion of 
Ctnnb1Bfc/Bfc embryos 
To determine whether the cardiac situs defects are part of a more generalised defect in 
L-R axis development, the formation of the cardinal vein was examined. Stereotypical 
cardinal vein morphology occurs in response to L-R axis establishment and can be 
independent of heart looping. For example, defects in cardinal vein morphology occur in 
conjunction with other organ asymmetries such as lung isomerisms and mislocation of 
the pancreas in embryos that lack Pitx2 (Shiratori et al., 2006). Normally, Pitx2 is 
expressed in the left (but not right) cardinal vein at 9–9.5 dpc (Meno et al., 1998). This 
marker was therefore used as a surrogate for the correct establishment of asymmetries 
other than heart looping. The expression of Pitx2 in the left cardinal vein was detected 
in all five Ctnnb1Bfc/Bfc embryos examined (Figure 3.20), indicating that this element of 
left-right development is either unaltered or altered at low penetrance in Ctnnb1Bfc/Bfc 
embryos. At later stages of embryogenesis (10.5 dpc), Pitx2 expression initiates in the 
ventral diencephalon (Martin et al., 2002). Interestingly, ectopic expression of Pitx2 was 
detected in the cranial region of all four Ctnnb1Bfc/Bfc embryos examined at 21 or 22 
somites (9.5 dpc) but not in three embryos at 11 and 12 somites (Figure 3.20). A similar 
ectopic expression was noted in embryos that lack Zic2 function (Barratt et al., 2014), 
but in both cases sectioning is required to determine whether this represents early 
ventral diencephalon expression or an entirely ectopic domain. 
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Figure 3.20: Ectopic expression of Pitx2 in the midbrain of Ctnnb1Bfc/Bfc embryos. 
Lateral view of mouse embryos following WMISH to Pitx2. (A) A 23 somite Ctnnb1+/+ 
embryo with normal expression of Pitx2 in the left cardinal vein (black arrow). (B) A 
22 somite Ctnnb1Bfc/Bfc embryo with normal Pitx2 transcription in the left cardinal 
vein (black arrow) along with a severe head truncation and ectopic expression of 
Pitx2 in midbrain (asterisk). s: somites. 
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As described in the chapter introduction, overt organ asymmetry is preceded by the 
asymmetric expression of certain genes in the lateral plate mesoderm (LPM) and the 
establishment of a midline barrier. I therefore determined whether these indicators of 
L-R axis establishment are seen in Ctnnb1Bfc/Bfc embryos using WMISH to known marker 
genes in carefully staged embryos. At the 3-6 somite stage of normal development genes 
encoding the secreted molecule NODAL, it’s secreted antagonist LEFTY2 and the 
downstream transcription factor PITX2 are all expressed in the left LPM and the Nodal 
antagonist LEFTY1 is expressed at the axial midline. In 50% (N= 2/2) of homozygous Bfc 
embryos Nodal expression was present as usual in the LPM but transcripts were absent 
in the remaining 50% (N= 2/2) of homozygotes (Figure 3.21 and Table 3.5). The finding 
of some normal embryos is consistent with the incomplete penetrance of the cardiac 
situs defect documented in Table 3.6. Similarly, Lefty2 expression was normal in 66% (N= 
4/6) of examined homozygotes, but absent in the remaining 33%, whilst expression of 
the downstream transcription factor Pitx2 was normal in 33% of embryos examined, but 
bilateral in the remaining 66% of embryos. Additionally, the expression of Lefty1 which 
marks the midline barrier was normal in 66% (N= 4/6) of Bfc mutant embryos but absent 
in the remaining 33% (N= 2/3). Although the absence of the midline barrier in some 
cases is associated with the bilateral expression of Nodal, Lefty2, and Pitx2 (Meno et al., 
1998, Yamamoto et al., 2003), there is precedent for the situation seen here (a reduction 
in Nodal and Lefty1/2) which most closely resembles the phenotype seen in the Pkd2-/- 
mutant (Pennekamp et al., 2002). The ion channel polycystin-2 is required for L-R axis 
determination in mice (Pennekamp et al., 2002). Overall the data confirms that the 
formation of the L-R axis is perturbed in a proportion of Ctnnb1Bfc/Bfc embryos consistent 
with the finding of incompletely penetrant cardiac situs abnormalities in embryos of this 
genotype. 
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Figure 3.21: Defective formation of the L-R axis nodal cascade. (A-I) Ventral views of 
embryos following WMISH to the genes shown on embryos of the genotypes and stage 
shown. Anterior is to the top in all images. (A-C) The expression of Nodal is normal in the 
left LPM in wild-type embryos; however in Ctnnb1
Bfc/Bfc
 (B-C) Nodal is reduced to varying 
degrees. (D) A wild-type embryo showing normal expression of Lefty1 in the midline of 
the embryo and Lefty2 in the left LPM. (E) Lefty1 is absent (black arrowhead) and Lefty2 
expression is reduced in the left LPM in some Ctnnb1
Bfc/Bfc
 embryos, but the expression 
for both genes (Lefty1/2) is normal in F. (G) The expression of Pitx2 is normally in the 
cranial mesenchyme and in the LPM of wild-type embryos. (H-I) In Ctnnb1
Bfc/Bfc
 embryos, 
Pitx2 is present in the cranial mesenchyme and expressed in the outer layer of the left 
LPM (black arrowhead), along with a slight expression in the right LPM indicated (red 
arrowhead). LPM: lateral plate mesoderm, s: somites. 
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Table 3.5: Molecular phenotypes of Ctnnb1
Bfc/Bfc
 embryos. 
Shown is the number of embryos exhibiting the defect among the 
total examined. L: left, R: right, LPM: lateral plate mesoderm. 
Table 3.6 : The frequency cardiac situs defects in 
9.5 dpc katun, Bfc and compound mutant 
embryos. 
* Significantly different from the wild-type at p<0.001 by X
2 
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3.2.5 Gene expression at the node is perturbed in the Ctnnb1Bfc/Bfc embryos 
At least two possible reasons for the near absence of both the midline barrier and the 
left LPM Nodal cascade exist; either the asymmetric signal from the node is not produced 
or it is not transferred to the LPM. To distinguish between these possibilities, gene 
expression at the node was first examined. The receipt of the leftward nodal flow is 
marked by the establishment of gene expression asymmetries at the node of early 
somite stage embryos. For example, the expression of Nodal itself becomes upregulated 
on the left margin of the node slightly before the initiation of Nodal left LPM expression. 
When analysed, Bfc embryos again show an incompletely penetrant phenotype, with 
50% (N=2/4) of embryos showing normal expression of Nodal and the remaining 50% 
(N= 2/4) showing abnormal expression that fails to become asymmetric and in some 
cases is highly disorganised (Table 3.7 and Figure 3.22). Expression of another secreted 
molecule, the NODAL antagonist DAND5, also becomes asymmetric at the node of wild-
type embryos prior to the initiation of Nodal LPM expression. In Bfc embryos, the 
expression of Dand5 was either absent from the node or was present but failed to 
become elevated in the right margin of the node (Figure 3.22 and Table 3.7) and was 
again sometimes highly disorganised (Figure 3.22). Thus it appears that in Bfc embryos 
an asymmetrical node signal is aberrant in comparison with that seen in wild-type 
embryos. 
The gene Sox17 encodes a Sry-box containing protein and is expressed early in the 
differentiating definitive endoderm of the gastrula and is required for its normal 
formation (Kanai-Azuma M et al., 2002). Hadjantonakis and colleagues (Viotti et al., 
2012) reported that Sox17-null embryos exhibit defective L-R axis and an absence of the 
Nodal cascade in either the left or the right LPM. Gene expression at the node did 
however become asymmetric at the correct developmental stage. This suggests the   
121 
 
 
 
 
 
 
 
 
 
 
  
Table 3.7: Nodal and Dand5 expression pattern in Ctnnb1Bfc/Bfc embryos. 
Figure 3.22: Aberrant expression of node markers (Nodal and Dand5) in Ctnnb1Bfc/Bfc 
embryos. (A-F) Ventral view of mouse embryos following WMISH to Nodal and Dand5. 
Genotypes and stages are indicated on each panel. Anterior is to the top in all images. (A) 
Nodal expression normally becomes asymmetric (leftward) in 4 somite stage wild-type 
embryos. (B-C) In the Ctnnb1Bfc/Bfc the perinodal expression failed to become asymmetric 
or was disorganised (D) Dand5 is expressed asymmetrically (rightward) in the crown cells 
of the node in 3 somite stage wild-type embryos. (E-F) In Ctnnb1Bfc/Bfc embryos the 
perinodal expression failed to become asymmetric or was abcent. S: somites. 
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transmission of the asymmetric signals from the node to the left LPM requires Sox17 
expression to ensure formation of the definitive endoderm (Viotti et al., 2012). 
To investigate whether the definitive endoderm of Ctnnb1Bfc/Bfc mutant embryos appears 
competent to transfer any signal, the expression of Sox17 was investigated. As shown in 
Figure 3.23, all homozygous Bfc embryos appear to have normal expression of Sox17 in 
the definitive endoderm suggesting that the signal is capable of being transferred to the 
left LPM, however a proportion of Bfc embryos (50%, N=4) showed ectopic expression 
of Sox17 in the pit of the node (Figure 3.23 B’). Overall, the analysis of the Ctnnb1Bfc/Bfc 
embryos suggests that that nodal flow is not correctly interpreted in a proportion of 
Ctnnb1Bfc/Bfc embryos, as evidenced by the failure to establish asymmetrical Nodal and 
Dand5 expression at the midline of early somite stage embryos. Additionally, it seems 
the pit of the node may be abnormal in some Ctnnb1Bfc/Bfc embryos, as judged by the 
ectopic expression of Sox17. This finding of ectopic expression of Sox17 at the node of 
mutant embryos may be a possible cause of the failure of L-R establishment.
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Figure 3.23: The expression of Sox17 has expanded ectopically to the node 
in Ctnnb1Bfc/Bfc embryos. (A-B’) Ventral view of embryos following WMISH 
to the gene shown on embryos of the genotypes and stages shown. Anterior 
is to the top in all images. (A-B) Normal expression of Sox17 is in the DE; this 
expression is retained in the Ctnnb1Bfc/Bfc embryos as seen in B. However, 
the expression of Sox17 has expanded ectopically into the node. The 
rectangle in B is expanded in B’ showing DE cells within the node (black 
arrow). DE; definitive endoderm, s: somites. 
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3.2.6 The node of Ctnnb1Bfc/Bfc embryos is morphologically abnormal 
Several assays indicate that the node is abnormal in Bfc homozygotes, therefore in 
collaboration with other lab members, scanning electron microscopy (SEM) (Semenov et 
al., 2001) was used to visualise this structure in embryos at the 3–5 somite-stage. At this 
stage of development, the node pit cells can be recognised, even when not properly 
organised, since each cell has a long cilium and the apical surfaces of the cells are 
strongly constricted (Lee et al., 2008, Lee et al., 2010). The homozygous Bfc embryos 
(N=7) were harvested between 1-4 somite stage and compared with wild-type embryos 
(N=6) using SEM (Figure 3.24). Visual inspection of the overall morphology of the node 
(shape and size) suggested that Ctnnb1Bfc/Bfc nodes were strikingly abnormal (Figure 3.24 
B-D). In the wild-type embryos, a teardrop-shaped depression at the distal tip of the 
embryo formed (Figure 3.24 A). In Ctnnb1Bfc/Bfc embryos, the node margin was irregular 
and non-ciliated, and flat cells were found within the pit. The morphology of these cells 
was the same as those of the surrounding endoderm and in some instances they were 
continuous with the endoderm and appeared to overlay the ciliated, rounded node cells 
(arrow in B’). The node cells appeared relatively normal in Ctnnb1Bfc/Bfc embryos. When 
quantified, it was found that the cilia of node pit cells occurred at the same frequency 
across all genotypes (i.e., ∼1 cilium/cell) (p> 0.05) whereas the cilia length showed a 
small, but significant, decrease in Ctnnb1Bfc/Bfc embryos relative to their stage-matched 
wild-type counterparts (Figure 3.24 E’-F’). 
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Figure 3.24: Elevation of canonical Wnt/β-catenin signalling in early embryogenesis 
disturbs node formation. SEM images of the ventral surface of the node ultrastructure in 0-
2 somite wild-type embryos (A) and Ctnnb1
Bfc/Bfc 
embryos (B-D’). The node in the wild-type 
embryo is a distinct tear-drop shaped depression with a clear edge. However, 
Ctnnb1
Bfc/Bfc
embryos have an abnormal node shape and a disorganised border (dotted line). 
Magnified images (B’-D’) of the outlined areas of the irregular node shape in the Ctnnb1
Bfc/Bfc
 
embryos. Note the expansion of the endoderm cells (white arrow) within the node cells 
(white asterisk). (E-F’) SEM images of the node cilia in 2-4 somite embryos of different 
genotypes shown on the panel. Scale bar: 5 µm (E-F), 1 µm (E’-F’). (G) A column graph 
depicting the mean cilia length in 1-4 somite embryos of different genotypes. Error bars: 
SEM, b: P < 0.05, Fisher's LSD ANOVA. Experiments and data analysis performed with K. 
Barratt.  
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3.2.7 Defective gene expression at the node reveals an early defect in node 
morphology 
The expression of genes required for node ciliogenesis Noto (Beckers et al., 2007) and 
sensory function Pkd1l1 (Field et al., 2011) were examined. To determine whether this 
early defect in mouse node formation may interfere with L-R axis establishment, 
embryos were harvested at two different stages during gastrulation: early bud stage (EB) 
and late head fold stage (LHF), and hybridised with Noto or Pkd1l1. Homozygous 
Ctnnb1Bfc/Bfc embryos (N=5/10, P<0.05) showed an expanded domain of Noto expression 
compared to wild-type embryos (Figure 3.25 A-B and Figure 3.26 A-B). The same was 
observed with Pkd1l1 in homozygous Bfc embryos (N=3/10, P<0.05) (Figure 3.25 C-D and 
Figure 3.26 C-D). The node is normally tear-drop shaped in wild-type embryos however 
in the Ctnnb1Bfc/Bfc mutant embryos the node shape is abnormal and the expression of 
both genes is aberrant and completely irregular. These findings indicate that elevation 
of the Wnt/β-catenin pathway in the early stages of embryogenesis affects node 
structure formation. 
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Figure 3.25: Ectopic expression of Noto and Pkd1l1 genes at the gastrula node in Ctnnb1Bfc/Bfc 
embryos. Lateral view (A-D) of mouse embryos following WMISH to Noto and Pkd1l1. Anterior 
is to the left in all images. (A) No allantoic bud stage embryos. In wild-type embryos Noto 
expression is restricted to the node, but in Ctnnb1Bfc/Bfc
 
embryos the expression is elevated and 
broad. (B) The same abnormality is observed in late allantoic bud stage in Ctnnb1Bfc/Bfc 
embryos. (C) Late allantoic bud stage embryos. In wild-type embryos Pkd1l1 expression is 
restricted to the node, but in Ctnnb1
Bfc/Bfc 
embryos the expression is elevated and broad. (D) 
The same abnormality is observed in late head fold stage Ctnnb1Bfc/Bfc embryos. 
128 
 
 
 
 
 
 
Figure 3.26: Irregular node shape in Ctnnb1Bfc/Bfc embryos with ectopic expression of Noto and 
Pkd1l1 at the node. Ventral view (A-d) of mouse embryos following WMISH to Noto and Pkd1l1. 
Stages are indicated on the panel. Anterior is to the top in all images (A) A wild-type embryo 
showing the normal expression of Noto with a clear edge and normal node shape. (B) A mutant 
embryo exhibiting ectopic expression of Noto with a disorganised node shape in comparison to 
the wild-type. (C) A wild-type embryo showing normal expression of Pkd1l1 with a clear edge 
and normal tear-drop node shape. (D) A mutant embryo exhibiting ectopic expression of Pkd1l1 
with an enlarged and disorganised node shape in comparison to the wild-type. LB: late allantoic 
bud stage, LHF: late head fold stage. 
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3.2.8 The Batface mutation on a C3H/HeH background  
Originally, heterozygous Bfc animals were maintained on a Balb/b background. As 
difficulties were experienced timed-mating these animals, heterozygous Bfc Balb/c were 
backcrossed with C3H/HeH wild-type animals, resulting in C3H/HeH offspring with an 
even distribution between wild-type and heterozygous Bfc genotypes. In comparison to 
the Balb/c Bfc adults which displayed head truncations, additional phenotypes were 
observed in the C3H/HeH Bfc backcross. Namely, a kinked tail (which is commonly 
observed in katun animals) and a white ventral belly spot, indicative of a neural crest 
defect (Figure 3.27) (Silver et al., 2006). Whether the additional phenotypes are due to 
increased penetrance of the Bfc mutation on the C3H/HeH background, or an increase 
in severity of preexisting phenotypes is yet to be established. As the phenotypic 
penetrance and expressivity of a mutation are known to vary due to the combinations 
of modifying alleles present in different genetic backgrounds (Montagutelli, 2000), it is 
possible that the C3H/HeH background exhibits higher levels of Wnt signalling than the 
Balb/c background.  
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Figure 3.27: A C3H/HeH backcross produces additional Wnt phenotypes in Bfc adults. (A) In 
comparison to wild-type adults, some Ctnnb1 
Bfc/+
 adults exhibit a kinked tail (black arrow). (B) 
or ventral belly spot (grey arrow). (C) The expected phenotype associated with elevation of 
Wnt/β-catenin signalling, a head truncation, is exhibited in Ctnnb1Bfc/+ animals regardless of 
their background.   
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3.2.9 Expression of transcription factor Tcf7l1 during gastrulation  
The findings that Zic3 loss-of-function mutation phenotypes were similar to the 
published Tcf7l1 null allele phenotype in several respects.  In addition, the other member 
of the ZIC family, ZIC2 can physically interact with TCF7L2 when it is overexpressed in 
cultured mammalian cells suggests that a physical interaction between Zic3 and Tcf7l1 
may occur during embryogenesis. A pre-requisite for such a scenario is that the two 
proteins be expressed in the same cell. Tcf7l1 protein accumulation has been examined 
in sectioned embryos, but whole-mount images of the Tcf7l1 expression pattern across 
a wide range of embryonic stages relevant to axis formation has not been published. 
Therefore, embryos were harvested between 7.0 and 8.0 dpc (early and performed 
WMISH for Tcf7l1. From the onset of gastrulation until mid-gastrulation Tcf7l1 is 
expressed in the ectoderm, and largely restricted to the anterior and extra-embryonic 
regions, but is not expressed in the extra-embryonic region of the mesoderm. Tcf7l1 is 
not expressed in the node when it forms anterior to the primitive streak (Figure 3.28 B). 
During the early allantoic bud stage, Tcf7l1 expression begins to recede gradually from 
the allantoic bud and embryonic ectoderm beginning from the posterior-most region 
(Figure 3.28 B, C and D). The extra-embryonic ectoderm continues to express Tcf7l1 
throughout the early allantoic bud stage. The expression in both the ectoderm and 
mesoderm continues until the head formation process begins, establishing the domain 
of the brain progenitor. However, to confirm the expression of Tcf7l1 in ectoderm and 
mesoderm, sectioning of these embryos are required. 
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Figure 3.28: Tcf7l1 is expressed anteriorly during mouse gastrulation.  
(A-D) Lateral view of wild-type embryos staged from early-gastrulation to early-head fold 
stage which have been hybridised with Tcf7l1. Anterior is to the left. The stages are 
indicated on the panel, the allontic bud is indicated by the black arrow. LS: late streak, EB: 
early bud, LB: late bud, EHF: early head fold and n: node. 
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3.3 DISCUSSION  
3.3.1 Overview 
The findings of this study suggest a novel basis for ZIC3-associated heterotaxy; namely 
that elevated canonical Wnt signalling perturbs endoderm development, compromising 
the establishment of the molecular asymmetries at the late gastrula node that drive 
organ pattern and position along the L-R axis. I show that during murine gastrulation 
Zic3 loss-of-function precipitates a phenotype that shares features with mouse mutants 
that have elevated canonical Wnt activity. Additionally, a positive genetic interaction is 
seen between the Zic3 loss-of-function allele and a known gain-of-function Ctnnb1 allele 
(Bfc). This is consistent with the normal role of ZIC3 being an inhibitor of canonical Wnt 
signalling. The data raised the possibility that elevated Wnt activity may contribute to 
heterotaxy in the Zic3 mutants. Reasoning that, if this is correct, then L-R axis defects 
should be found in other mutants with elevated Wnt activity such as evaluated embryos 
homozygous for the Bfc mutation. This demonstrated that they do have L-R axis defects 
and that elevated Wnt/β-catenin signalling at gastrulation is a previously unrecognised 
cause of aberrant L-R axis formation. Analysis of these defects indicates that elevated 
Wnt/β-catenin signalling is associated with abnormal node morphology and function. 
One feature of Ctnnb1Bfc/Bfc embryos is that endoderm cells are found in the pit of the 
node and it is possible that the L-R axis defects are secondary to aberrant endoderm 
differentiation. In this case one critical function of Zic3 is to regulate endoderm 
formation early in gastrulation. 
3.3.2  The Zic3 loss-of-function phenotype shows hallmarks of elevated Wnt 
activity at gastrulation 
As described in the introduction, Wnt signalling must be tightly controlled during 
embryogenesis and germline mutations that lead to dysregulated Wnt signalling often 
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cause a phenotype first evident during gastrulation and patterning. When the pathway 
activity is lowered by loss-of-function mutations in activating components of the 
pathway (e.g. ligand, co-receptor, chaperone, signal transducing and trafficking 
molecules) primitive streak formation is blocked. Conversely, gain-of-function 
mutations in activators or loss-of-function mutations of negative regulators of canonical 
Wnt signalling (e.g. antagonist, components of the β-catenin destruction complex and 
transcriptional repressor) result in expansion of the primitive streak, anterior truncation 
and posterior axis duplication. Animals heterozygous for these mutations often have tail 
kinks, likely because Wnt signalling is required to regulate somitogenesis. Studies of 
mouse mutants with altered Wnt activity have led to a model where, at early stages of 
embryogenesis, the Wnt signal is distributed in a graded pattern increasing along the 
anterior-posterior axis of the gastrulation stage embryo (Reviewed in Arkell et al., 2013). 
Previous analysis of embryos null for Zic3 show that a proportion have an expanded 
primitive streak, as evidence by the ectopic expression of Foxa2 and Fgf8 (Ahmed et al., 
2013). In addition, I show here that Zic3 loss-of -function is associated with anterior 
truncation and posterior axis duplication. Although not broadly described as Zic3-
associated phenotypes, these features can be seen in other Zic3 null alleles (Ware et al., 
2006a, Ware et al., 2006b, Jiang et al., 2013, Sutherland et al., 2013). To confirm that 
these phenotypes are indicative of elevated Wnt activity, the consequence of Zic3 loss-
of-function was examined in a background of elevated Wnt activity via cross with a 
known gain of function Ctnnb1 allele (Bfc). The penetrance and severity of anterior 
truncation and axis duplication phenotypes of the Zic3 null embryos increased in this 
background confirming that Zic3 intersects the Wnt pathway and functions to lower 
transcriptional output of the pathway. These genetic investigations were supplemented 
with molecular evidence of altered Wnt target gene expression in the developing 
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forebrain. During normal development, Wnt target genes are absent from the forebrain, 
but expressed in the midbrain. In embryos with elevated Wnt signalling, the anterior 
limit of Wnt target gene expression shifts rostrally. As seen in Figure 3.16 both Axin2 and 
Sp5 expression shifts rostrally when examined by wholemount in situ hybridisation. 
Ideally, this experiment should be augmented by a quantitative approach such as RT-
qPCR from the brain of 9.5 dpc embryos as previously (Fossat et al., 2011). Another 
method used to reveal Wnt pathway activity is via TCF reporter strains of mice. Members 
of the TCF family of transcription factors (Tcf7, Tcf7l1, Tcf7l2 and Lef1) are 
transcriptional mediators of Wnt/β-catenin signalling that bind DNA at a consensus TCF 
binding site. Transgenic animals have been generated in which multiple copies of the 
consensus TCF binding site are placed upstream of a minimal promoter and the β-
galactosidase cDNA to report sites of active Wnt signalling (reviewed in Barolo, 2006). 
The Arkell laboratory has previously used a cross with one such strain (BATGal) to 
demonstrate that Wnt signalling is elevated in Bfc homozygotes (Fossat et al., 2011). 
Since then, a more sensitive Wnt reporter has been produced in which six multimerised 
TCF sites are placed upstream of the hsp68 minimal promoter and a H2B-GFP reporter 
cassette, to produce the TCF/Lef:H2B-GFP mouse strain (Ferrer-Vaquer et al., 2010). The 
Arkell laboratory has recently imported this mouse strain, but time constraints 
prevented me from crossing the katun mouse with this TCF reporter strain to visually 
validate elevated Wnt signalling in this strain. Overall, however, the available genetic 
and molecular evidence suggest that one role of the ZIC3 transcription factor during 
normal embryogenesis is to repress Wnt dependent transcription. 
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3.3.3  ZIC3 may repress Wnt dependent transcription by interaction with 
TCF7L1 
The requirement for repression of Wnt target genes at gastrulation has previously been 
dramatically demonstrated by mutation of the Tcf7l1 transcription factor. Tcf7l1 is the 
only member of the Tcf/Lef family expressed during gastrulation, and loss-of-function of 
Tcf7l1 results in embryos with an expanded primitive streak, anterior truncation, and 
duplicated posterior axis (Merrill et al., 2004). This identifies Tcf7l1 as a negative 
regulator of Wnt activity and demonstrates that repression of TCF mediated 
transcription is critical for normal gastrulation. One interpretation of the similar 
phenotype between Tcf7l1 and Zic3 mutants is that these proteins co-operate to 
mediate repression of transcription at TCF sites. Along with data from others that 
indicates that the ZIC proteins can inhibit Wnt dependent transcription in Xenopus 
embryos and human cell lines via a physical interaction between ZIC and TCF proteins 
(Pourebrahim et al., 2011, Fujimi et al., 2012), I hypothesise that a direct interaction 
occurs between ZIC3 and TCF7L1 during murine gastrulation. Other members of the 
Arkell laboratory have shown (via bimolecular fluorescent complementation and 
proximity linked assays) that these two proteins can interact when overexpressed in cell 
lines (Koula Diamand, unpublished data). To assess whether this occurs in vivo, a 
proximity linked assay should be conducted on embryonic tissue, assuming antibodies 
compatible with this process can be identified. If not, CRISPR mutagenesis could be used 
to generate tagged alleles of ZIC3 and TCF7L1 and antibodies against the tags be used 
to assess in vivo interaction. 
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3.3.4  The L-R axis defects associated with elevated Wnt signalling may be 
secondary to aberrant node and/or endoderm differentiation 
Bfc mutant embryos fail to form a tear-drop shaped, coalesced node and tightly packed 
midline. Instead, the node is irregular with clusters of endoderm cells present in the 
node and the midline is broad. Several studies have identified mutant mice with a similar 
node phenotype. In support of the idea that elevated Wnt signalling disrupts node 
formation, loss of function of the Tcf7l1 Wnt transcriptional repressor leads to 
dysmorphic nodes with surface endoderm cells (Merrill et al., 2004). If node 
dysmorphology is a general, yet previously unidentified, feature of elevated Wnt 
signalling and Zic3-null mutation causes elevated Wnt signalling, the mutant embryos 
should have irregularly shaped nodes and defective endoderm development. Sutherland 
et al. (2013) used immunohistochemistry (IHC) and SEM to examine the node of Zic3-
null embryos and found that four of five Zic3-null embryos had an irregular shaped node 
with large cells partially covering the surface. Additionally, a single cilium was present on 
the small mesodermal cells of the node, although on average it was slightly shorter than 
that of wild-type embryos; similar to what we observed in the Bfc mutant embryos.  
Moreover, analysis of Zic3del/y;T-Cre+ nodes demonstrated that five out of six embryos 
had dysmorphic nodes, unlike the Cre-negative controls. This suggests that ZIC3 function 
is required in the nascent mesoderm of the primitive streak-stage embryo for proper 
node morphology. However, the stage of embryos analysed was not documented in 
Sutherland et al and it is difficult to directly compare the Zic3 null and Zic3del/y;T-Cre+ 
phenotype with the Bfc embryos analysed here. A detailed comparison of wild-type, Bfc 
and Zic3 null nodes in a carefully staged series of embryos spanning the stages of initial 
node formation through to early somitogenesis would be useful. This may shed light on 
whether an abnormal amount of endoderm is produced by mutant embryos or whether 
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defective motility is responsible for the finding of endoderm cells in the pit of the overt 
node. An examination of early somite nodes in Zic3-null and Bfc mutant embryos should 
include the determination of the expression pattern of crown cell-expressed 
genes/proteins that do not become asymmetric (such as Gdf1 and Pkd2), to distinguish 
between the general effect on crown cells and that on symmetric gene expression.  
Another group of molecules which, when mutated, produce dysmorphic, endoderm 
covered nodes are involved in extracellular matrix modification, cell migration and 
cytoskeletal dynamics, including the reorganisation of actin cytoskeleton (Migeotte et 
al., 2001, Lee et al., 2008; Lee et al., 2010, Pulina et al, 2011). These mutants also have 
defective midline patterning and aberrant left-right asymmetry, suggesting that correct 
node morphology is required for left-right axis formation. The overlap in phenotype may 
also suggest that excess Wnt signalling is associated with dysregulation of cell- 
extracellular matrix interactions, but this has not yet been investigated. 
The analysis of younger embryos presented in this chapter suggests that earlier events 
may alter node formation and potentially function in Ctnnb1Bfc/Bfc homozygotes. In 
particular, the node of these embryos is generally misshapen, endoderm cells persist in 
the pit of the node and the cilia of pit cells are significantly shorter than in wild-type, 
stage-matched embryos. Additionally, previous analysis of other Zic3 null alleles 
(Sutherland et al., 2013) and the Tcf7l1 null allele (Merrill et al., 2004) reveal similar 
perturbations in node and/or endoderm development suggesting that this may be a 
general yet previously unidentified feature of elevated Wnt signalling. The aberrant L-R 
axis formation in these strains may therefore be a secondary consequence of incorrect 
node and/or endoderm development during gastrulation. 
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3.3.5  Node development and endoderm cells 
The node first becomes apparent at mid-gastrulation at the distal tip of late streak stage 
embryos. Prior to node emergence, the entire embryonic portion of the embryo is 
covered by a layer of visceral endoderm cells and the precursor cells of the node are 
found in at the anterior primitive streak. A subset of cells in the anterior primitive streak 
begin to express Noto and adopt a node or trunk notochord fate. These cells delaminate 
and exit from the streak to reform as an epithelium with small apical surfaces beneath 
the endoderm layer (Yamanaka et al., 2007), where they begin to grow cilia (Sulik et al., 
1994). At the same time, some epiblast cells transit the primitive streak, begin to express 
Foxa2 and adopt a definitive endoderm fate. Definitive endoderm cells then replace the 
visceral endoderm cells via intercalation and displacement. Between the mid- and late-
streak stages of development, endoderm cells are gradually cleared from the site of the 
presumptive node and midline (Kwon et al., 2008, Viotti et al., 2014) revealing groups 
of columnar epithelial node cells. Consequently, after transitioning through a phase 
where node cells are still separated by squamous endoderm cells with lager surfaces, by 
the OB stage the node appears as a single field of cells with small apical surfaces and 
growing cilia. At the EHF stage, the node depresses to form the classical tear drop 
shaped pit of ciliated cells surrounded by ciliated crown cells. 
The clearing of endoderm cells and the emergence of the node cells to the ventral 
surface are thought to be coordinated (Sulik et al., 1994), however the molecular signals 
underlying the communication between these two layers is yet to be elucidated. The 
work in this chapter raises the possibility that Wnt signalling is involved either in 
endoderm differentiation, clearance from the node and/or communication between the 
node and endoderm cells. A survey of mouse mutants in which node shape and 
endoderm clearance are abnormal and associated with defects in L-R axis formation 
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provides clues to other molecules that may also be involved. Mutations of Noto (Beckers 
et al., 2007) and Oct4 (Hasenöder, 2015) transcription factors, Notch ligand Dll1 
(Przemeck et al., 2003) as well as the fibronectin signalling molecule FN1 and it is ligand 
Integrin α5β1 (Pulina et al., 2011, Pulina et al., 2014) all produce defective nodes similar 
to those seen when Wnt signalling is elevated. Evaluating the precise role and possible 
connections between these molecules is problematic because of inconsistent use of 
assays and stages analysed as well as inconsistent genetic backgrounds between the 
mutants. Moreover, in most cases the embryonic node is examined at stages beyond 
when the node is first emerging. It would be informative to carry out additional analyses 
on these mutant strains that compare the nodes (morphologically and via gene 
expression) at earlier time points, evaluate the level of Wnt signalling in each mutant, 
and track endoderm development, node formation and nodal flow in live embryos. This 
information could position mutants in a putative genetic pathway which could be tested 
by particular crosses.  
The growing number of mutants with defective L-R axis formation in which abnormal 
node shape is accompanied by the presence of endoderm in the node suggests 
causation; it is unclear precisely where L-R axis formation fails in these mutants. When 
examined in these mutants, cilia formation on the pit cells of the node has been found 
to be apparently normal (Pulina et al., 2014) or have relatively mild defects in cilia length 
(Beckers et al., 2007) as in the Bfc mutant examined here. Multiple studies suggest the 
direction and angle that cilia protrude from cells and rotate (rather than cilia length) are 
the main limiting factors behind flow generation (Smith et al. 2010; Cartwright et al. 
2004). Cilia direction and angle remain to be tested in both Bfc and Zic3 mutant embryos 
and should in the future be examined via visualisation of basal bodies with a α-
pericentrin antibody and cell membranes via F-actin staining (Mahaffey et al. 2013). 
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Another possibility that should be considered is that the presence of endoderm cells 
disrupts nodal flow and ideally nodal flow should be quantified via particle image 
velocimetry in the Bfc and Zic3 mutants. However, in conjunction with the finding that 
even a weak nodal flow is sufficient to initiate the left sided Nodal cascade (Shinohara 
et al. 2012), it remains possible that reduced nodal flow is insufficient to explain the 
defective L-R axis formation that accompanies elevated canonical Wnt pathway activity. 
An alternative explanation is that the presence of endoderm cells and/or the irregular 
node shape may prevent or diminish receipt of the nodal flow signal. It would be 
interesting to use calcium sensing reporters in the crown cells of Bfc and Zic3 mutants 
to evaluate flow reception. 
If the presence of endoderm cells in the node is implicated, it will be important to 
consider how elevated Wnt levels prevent endoderm clearance from the node. One 
option is that Wnt signalling controls the number of cells that differentiate into 
endoderm. This possibility is raised by the observation that Foxa2 is ectopically 
expressed in both Tcf7l1 and Zic3 null embryos (Merrill et al., 2004, Ahmed et al., 2013) 
and supported by the recent finding in the Arkell laboratory of a similar pattern of 
ectopic Foxa2 expression in the Bfc homozygotes (data not shown). Consistent with this 
idea, TCF7L1 has been shown to bind downstream of the Foxa2 gene to repress its 
expression in ES cells (Morrison et al., 2016). A working model is that ZIC3 and TCF7L1 
co-operate at this element to repress Foxa2 expression in the epiblast prior to 
gastrulation. When Wnt3 expression begins at the site of primitive streak formation 
early in gastrulation, a limited de-repression of Foxa2 expression occurs in cells close to 
this high Wnt activity, effectively setting the number of cells that differentiate into 
endoderm. When Wnt signalling is elevated early in gastrulation, Foxa2 expression is de-
repressed in additional cells and too much endoderm is formed. These cells then clog 
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the node, compromising nodal flow and/or crown cell receipt of the flow signal. To 
directly test this hypothesis, the relevant Foxa2 element could be deleted in mouse 
embryos via CRISPR mutagenesis. If the theory is correct, this should lead to precocious 
endoderm formation and L-R axis defects. 
3.3.6  Mutation of Zic3 causes L-R axis defects by a mechanism distinct to 
that of Zic2 mutation 
Previously, the Arkell laboratory showed that mutation of a closely related transcription 
factor, Zic2, also causes cardiac situs defects (Barratt et al., 2014). In the case of the 
kumba allele of Zic2, it appears the situs defects arise from a combination of perturbed 
nodal flow and reception, but which are not asscoaited with aberrant node shape nor 
with the presence of endoderm cells in the node pit (Barratt et al., 2014) . Whilst it 
appears that mutation of either Zic2 or Zic3 can lead to similar cardiac situs defects the 
origin of these defects appears divergent. Interestingly, assays in HEK293T cells show 
that whilst ZIC2 and ZIC3 are each able to inhibit Wnt signalling as measured by a 
TOPflash assay, the Zic3 katun mutation removes this ability (Ahmed et al., 2013) 
whereas the Zic2 kumba mutation (C370S) does not (Pourebrahim et al., 2011). Thus, 
whilst the Zic3 null phenotype may be attributed to a failure to inhibit canonical Wnt 
signalling and production of an elevated Wnt environment, this cannot be said for the 
phenotype of the Zic2 kumba mutants. 
3.4  CONCLUSION  
The level of activity along the canonical Wnt pathway is known to be important for a 
variety of processes during mammalian germ layer and axis formation. One unusual 
feature of the Wnt pathway is that mutations which generate a gain of pathway activity 
are relatively common. Evidently, negative regulation of this pathway is critical for 
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normal embryonic development and occurs at all levels of this signal transduction 
pathway (signal production, reception, transduction and transcription). The work in this 
chapter suggests that one previously unappreciated consequence of elevated Wnt 
signalling at gastrulation is a failure of L-R axis formation. It is possible that this defect 
can be traced to a role for Wnt signalling in endoderm differentiation and/or migration 
during gastrulation. One role of the ZIC3 transcription factor, mutation of which is 
known to be associated with defective L-R axis formation in both mouse and man, may 
be as a transcriptional co-repressor of Wnt/β-catenin mediated transcription. Additional 
experiments are warranted to confirm the data presented here and further explore the 
connections between Zic3, canonical Wnt signalling endoderm formation and L-R axis 
establishment. The work may ultimately provide the first molecular explanation of how 
ZIC3 loss-of-function causes heterotaxy in humans but also highlight a new set of 
candidate putative heterotaxy associated genes. 
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Chapter 4: The gastrulation screen; recombination 
mapping 
4.1 INTRODUCTION 
4.1.1 The Arkell laboratory gastrulation screen 
 A gastrulation screen (a genetic screen for N-ethyl-N-nitrosourea (ENU)-induced 
recessive mutations that alter gastrulation) conducted by the Arkell laboratory yielded 
eight pedigrees of interest (Table 4.1). Each pedigree exhibited one of three phenotypes: 
a failure to thrive, a failure to gastrulate, or defective patterning (Figure 4.1). The task 
now is to identify the causative mutations using the positional candidate cloning 
strategy described in Section 1.3.3 This process will be conducted in two separate stages. 
Firstly, linkage analysis will be conducted; microsatellite (MIT) markers will be used to 
create a low-resolution recombination map and localise the mutation to a single 
chromosomal interval (known as the minimal critical region: MCR). MIT markers 
polymorphic for the strains used in the gastrulation screen were already available from 
the Arkell laboratory. Secondly, exome sequencing of carrier animals will be performed 
and the MCR analysed for heterozygous single nucleotide variants. Whole-exome 
sequencing and data analysis will be performed at the Australian Phenomics Genotyping 
Facility at ANU. Further carrier animals will then be selected for sequencing experiments 
to validate the inheritance of putative causative variants and a genotyping assay 
established for colony maintenance and downstream phenotype analysis. 
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Table 4.1: Novel mouse pedigrees with ENU-induced mutations that cause gastrulation 
defects. The chromosomal location indicates the information available at the project start. 
*The ENU-11 pedigrees were obtained from preliminary ENU experiment animal at 
selecting the best strains. Recombination mapping for 11-23 and 11-68 was complete at 
the start of this project.  
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Figure 4.1: The gastrulation screen pedigrees. Lateral view of embryos dissected at 8.0 dpc. 
Each photo shows a single litter derived from one pedigree. The phenotypes can be divided 
into three classes. Class 1 mutant embryos have a small embryonic and extra-embryonic 
region and do not initiate gastrulation. This phenotype is evident in pedigrees 11-23 and 16-
5. Class 2 mutant embryos have a small embryonic region relative to their extra-embryonic 
region and do not initiate gastrulation. This phenotype is evident in pedigrees 16-7, 18-5, and 
18-19. Class 3 mutant embryos initiate gastrulation that proceeds incorrectly; this is seen in 
pedigrees 11-68, 18-10, and 18-22. Mutant embryos are circled. 
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4.1.2 Breeding strategy for the gastrulation screen 
As described in Section 1.3.3, ENU-induced recessive mutations can be isolated in a 
three-generation breeding protocol. The future identification of the causative mutation 
can be facilitated using different inbred strains within the breeding protocol. This 
prevents the need for a separate recombination mapping cross after mutant isolation. 
Additionally, the use of different strains introduces hybrid vigour; this generally results 
in an increased litter size, which is an important consideration for embryonic screens. 
Indeed, in the ENU-11 cross litter, the pregnancy rate was low; therefore, we looked for 
other strains. On the other hand, using two strains can confound the recovery of 
mutants because some phenotypes become incompletely penetrant or even lost owing 
to the modifying effects of the strain background on the phenotype (Montagutelli, 
2000). The genetic relationship between inbred strains has been studied using a large 
number of single nucleotide variants (SNVs, Figure 4.2) (Petkov et al., 2004). This study 
enabled us to identify fecund strains that are closely related (to minimise modifying 
effects on the phenotype), but still sufficiently distinct for high-resolution mapping. On 
this basis, the BALB/cJ and FVB/N strains were chosen. Additionally, published ENU 
mutagenesis protocols were already established for each strain (Nolan, 2000, Blewitt et 
al., 2005) and each has an above average litter size relative to other inbred strains 
(Festing, 1998). 
The breeding protocol used for the gastrulation screen is shown in Figure 4.3 A. Male 
mice of the mutagenised strain were treated with ENU and then bred with female mice 
of the mapping strain to produce G1 progeny, each of which carried a distinct set of 
newly induced mutations.  
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Figure 4.2: Mouse family tree. The 102 strains tested are organized into seven groups. 
Group 1, Bagg albino derivatives; Group 2, Swiss mice; Group 3, Japanese and New Zealand 
inbred strains; Group 4, C57/58 strains; Group 5, Castle's mice; Group 6, C. C. Little's DBA 
and related strains; Group 7, wild-derived strains. A detailed description of each group is 
included in the text. The length and angle of the branches have been optimized for printing 
and do not reflect the actual evolutionary distances between strains. Figure adapted from 
Petkov et al. (2004). 
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Based on the average efficiency of ENU mutagenesis, we can estimate that each G1 
progeny would be heterozygous for seventy new mutations (Noveroske et al., 2000). To 
make these mutations, homozygous G1 males are mated with females of the mapping 
strain to produce G2 progeny, half of which are heterozygous for each particular 
mutation. G2 daughters are then intercrossed (time-mated) with the G1 father and the 
females are sacrificed at 8.0 dpc. The G3 embryos are recovered and screened for overt 
phenotypes by visual inspection. If the G2 female is heterozygous for the mutation, 25% 
of the G3 embryos will be homozygous for the mutation, as determined by their 
abnormal phenotypes. If the G2 female did not carry the mutation, all (or less than 25%) 
of the embryos within the litter would be normal. Overall, 1/8 (12.5%) of G3 embryos 
produced using this backcross breeding strategy should be homozygous. In the 
gastrulation screen, we aimed to examine at least thirty progenies per pedigree from a 
minimum of four pregnant G2 females. A pedigree was deemed worthy of follow-up 
when a similar mutant phenotype was found in at least two separate litters from the 
same pedigree. If homozygous mutants arise with a frequency of 1/8 and at least two 
mutants are required for follow up, then (using the binomial function) the probability of 
missing a mutation in thirty potential homozygous embryos is 0.096, which we 
considered an acceptable limit. 
4.1.3 Low-resolution recombination mapping using interval haplotype analysis 
The pedigree production protocol shown in Figure 4.3 A also served to generate 
recombinant DNAs for the first step in the positional candidate approach to identify the 
causative mutation in each gastrulation screen pedigree. One technical challenge posed 
by the gastrulation screen is that small mutant embryos (such as in Figure 4.1) do not 
contain sufficient genomic DNA to enable a low-resolution genome scan to be 
performed, as this is a procedure that would typically require sufficient DNA for 50-100 
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PCR reactions. To circumvent this difficulty, DNA from G2 daughters identified as carriers 
was used for recombination mapping. As shown in Figure 4.3 A, G2 daughters were 
backcrossed with their F1 fathers (F0 founder males) and, if heterozygous for a newly 
induced mutation that impairs gastrulation, 25% of the recovered embryos should 
exhibit a phenotype. Rather than using the mutant embryos for recombination mapping, 
DNA was collected from the G2 daughters. This G2 animal is designated the N1 animal 
(where N stands for backcross), as they are derived from the cross between an F1 hybrid 
and one of the parental strains (i.e. the mapping strain). For each N1 female from the 
gastrulation screen, meiotic recombination events in the germ cells of the F1 father can 
be identified using markers that are polymorphic between the BALB/cJ and FVB/N 
strains. 
During the experiments designed to conduct low-resolution mapping of the causative 
variants in the gastrulation pedigrees, the F0 father would sometimes become too old 
for further breeding before sufficient N1 carrier females were identified for the mapping 
experiment. In these cases, the procedure shown in Figure 4.3 B was followed. G2 
females were intercrossed (time-mated) with G2 males and their litters dissected at 8.0 
dpc. If both were heterozygous for the mutation that impairs gastrulation, 25% of the 
recovered embryos should exhibit the (already known) phenotype. When this occurred, 
it retrospectively identified both the female as an N1 carrier suitable for the 
recombination mapping experiment and the male as a carrier suitable for breeding 
further progeny. As shown in Figure 4.4, this male was then mated with a wild-type 
female of the mapping strain and its female progeny assessed by backcross and 
dissection of litters at 8.0 dpc to identify N2 carrier females that could be used in the 
recombination mapping experiment. 
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Figure 4.4: The breeding strategy used once F0 males were no longer available 
for breeding. The identified N1 carrier male is mated with a wild-type female 
from the mapping strain to produce G3 animals. Female progeny are assessed 
by backcross and dissection of litters at 8.0 dpc to identify N2 carrier females; 
their DNA can be collected for use in the recombination mapping experiment. 
G: generation. 
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One commonly used method for low-resolution mapping is to infer a haplotype based 
on the analysis of a small panel of polymorphic markers. A haplotype refers to the 
combination of alleles that are inherited together along the length of a chromosome. 
The interval haplotype mapping strategy (Neuhaus et al., 1998) uses markers at the 
proximal and distal regions of all mouse autosomes (i.e. Mus musculus [Mmu] 
chromosomes 1–19), with additional medial markers tested on three larger 
chromosomes (Mmu 1, Mmu 2, and Mmu 3). This divides the murine genome into 
approximately 22 intervals and enables segregation of the mutation to be followed in 
carrier animals. As shown in Figure 4.5, each haplotype indicates whether the 
chromosomal region has been inherited from the mutagenised or mapping strain (Potter 
et al., 1995, Neuhaus et al., 1998). In heterozygous carriers, the mutation must be in a 
region inherited from the mutagenised strain (i.e. a non-recombinant region); this 
region will be heterozygous for the mutagenised and mapping genomes. Linkage is 
therefore established when one chromosomal region is heterozygous among all 
confirmed carriers of the newly introduced mutation. In contrast, regions of the genome 
that are unlinked from the introduced mutation can undergo recombination without 
loss of the causative mutation. Such unlinked chromosomal regions will therefore tend 
towards homozygosity for the mapping strain. The interval haplotype analysis method 
requires only a small number of animals (approximately thirteen when empirically 
determined from other mapping experiments) to map a mutation to a specific 
chromosome. Often, by using the same DNA—or a small number of additional DNA 
samples—and a small number of additional polymorphic markers, a smaller MCR can be 
defined for each pedigree (Neuhaus et al., 1998, Bogani et al., 2004). 
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Figure 4.5: The principle of interval haplotype analysis. Analysis of proximal and 
distal MIT markers can determine whether recombination has occurred between 
these markers in parental meiosis. If no recombination occurred, the animal will 
remain heterozygous for the mapping and mutagenised strains (purple) at each 
marker. If recombination did occur, the animal will be homozygous for the mapping 
strain (grey) at one or both markers. (A) The genotype of an animal at each marker 
in the panel is tested. (B) The haplotype is inferred from the genotype results. (C) 
The potential location of the ENU-induced mutation can be inferred from the 
haplotype. 
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4.1.4 An MIT marker panel suitable for analysis of the BALB/cJ and FVB/N 
pedigrees 
As previously stated, the gastrulation screen yielded eight novel mouse pedigrees that 
exhibited abnormal gastrulation phenotypes (Table 4.1). In the two pedigrees 
originating from the preliminary screen (11-23 and 11-68), the MCR had already been 
defined by other members of the Arkell laboratory. The location of the causative ENU-
induced mutation for the remaining six pedigrees (16-5, 16-7, 18-5, 18-10, 18-19, and 
18-22) was, however, unknown; linkage analysis was performed on each of these 
pedigrees. These pedigrees are referred to collectively as the BALB/cJ and FVB/N 
pedigrees. 
The Arkell laboratory previously validated a panel of MIT markers suitable for 
distinguishing BALB/cJ and FVB/N genomes. The mouse genome informatics (MGI) 
database identified 125 MIT markers that may be suitable for use with the gastrulation 
screen (Table 1 and Table 2 in Appendix A). PCR amplicons from BALB/cJ and FVB/N DNA, 
as well as from an F1 hybrid animal (F0 founder male) produced by an outcross of these 
two strains, were analysed by agarose gel electrophoresis. Sixty-two polymorphic MIT 
markers were identified between the FVB/N and BALB/cJ inbred strains (see Figure 4.6 
for a representative example of the analysis and Appendix B for optimised PCR 
conditions). To generate the MIT marker panel, one polymorphic marker at the proximal 
and distal regions of all autosomes (Mmu 1–19) was selected. A third intermediate 
marker was also selected for Mmu 1, Mmu 2, and Mmu 3 to give a panel of forty-one 
markers for the low-resolution mapping strategy (Figure 4.7). Eleven additional 
polymorphic markers were noted and subsequently used to increase the mapping 
resolution in chromosomal regions of interest. 
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Figure 4.6: Representative example of agarose electrophoresis analysis of 
polymorphic MIT markers between the FVB/N and BALB/cJ inbred mouse 
strains. Genomic DNA samples from the FVB/N, BALB/cJ, and a F1 hybrid between 
the FVB/N and BALB/cJ inbred strains were amplified by PCR. The products were 
resolved on a 3% agarose gel. FVB: FVB/N, NTC: no template control. 
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Figure 4.7: The FVB/N-BALB/cJ microsatellite marker panel. A total of forty-
one markers were selected at the proximal and distal regions of each 
autosome. Additional medial markers on Mmu 1, Mmu 2, and Mmu 3 were also 
selected.  
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4.1.5 Aims 
To identify genes that direct gastrulation, the overall aim of this chapter is to perform 
low-resolution recombination mapping on the six strains recovered from the BALB/cJ-
FVB/N mutagenesis screen. This will identify an MCR for each strain that will limit the 
analysis required for future whole-exome sequencing experiments. It will also test the 
feasibility of a genome-wide screen for recessive mutations that affect gastrulation by 
determining whether the recovered phenotypes can be readily traced to one region of 
the genome. 
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4.2 RESULTS  
4.2.1 Pedigree 16-5 
Pedigree 16-5 was isolated from the gastrulation screen via the interspecific backcross 
strategy (Figure 1.3). For this pedigree, the mutagenised strain was BALB/cJ and the 
mapping strain was FVB/N. Male G1 #9 was screened by backcross with five N1 females. 
Small embryos which failed to commence gastrulation were observed in three of the 
five litters examined, leading to an overall presumed homozygote frequency of 9% (N = 
55). Thus, the male was considered to harbour a new recessive mutation that prevents 
gastrulation and was designated F0 #9. A further twenty-three N1 females were 
examined by backcross to F0 #9; the litters of twelve females were found to contain 
embryos with the expected phenotype at a frequency of 15% (N = 218). Ten N1 carrier 
females were selected for recombination mapping (shown in orange in Table 4.2). 
BALB/FVB marker panel analysis identified only one chromosome with strong linkage to 
the newly introduced mutation: Mmu 9. This was the only chromosome for which all 
animals were non-recombinant (i.e. heterozygous for the mutagenised and mapping 
strain) for at least one marker on the chromosome (Table 4.2). More carrier females 
were needed to generate additional genomic DNA samples for recombination mapping. 
The F0 #9 male was too old for further breeding and, using the strategy shown in Figure 
4.3 B, additional male carriers (N1 #234, N1 #285, N1 #284, and N1 #287) were identified 
by intercross of the N1 progeny. The strategy shown in Figure 4.4 was then used to 
identify ten additional carrier N2 females from which genomic DNA could be isolated for 
further mapping. 
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These genomic DNA samples (shown in black in Table 4.2) were subjected to marker 
panel analysis; the results confirmed Mmu 9 as the most likely site of the mutation. Only 
one female (N2 #343) was recombinant at both the proximal and distal markers on Mmu 
9 (Table 4.2). 
Recombinant chromosomes can arise for two reasons: first, the N2 female may have 
been incorrectly assigned as a carrier, or second, a double recombination could have 
occurred. In N1 animals, in which the recombinant products from only one meiosis are 
examined, the frequency of double recombination should be low (<1%). In N2 animals, 
the result of two meioses is examined; even in linked regions, a double recombination 
could occur. To evaluate the possibility of double recombination in N2 female #343, 
additional Mmu 9 markers (D9Mit4, D9Mit12, and D9Mit347) were examined. As shown 
in Figure 4.8, this analysis indicated that a region of heterozygosity existed on Mmu 9 in 
this animal. In combination with the marker panel analysis of the additional females, the 
causative mutation was mapped to a 15.2 Mb interval of distal chromosome 9 between 
D9Mit12 and D9Mit214 (99.8–115 Mb). 
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4.2.2 Pedigree 16-7 
Pedigree 16-7 was isolated from the gastrulation screen via the interspecific backcross 
strategy (Figure 1.3) using BALB/cJ as the mutagenised strain and FVB/N as the mapping 
strain. Male G1 #11 was screened by backcross with four N1 females. Embryos with a 
small embryonic region and large extra-embryonic region were observed in two litters 
at an overall frequency of 15% (N = 40). Thus, the male (G1 #11) was considered to 
harbour a new recessive mutation that prevents the onset of gastrulation and was 
designated F0 #11. Genomic DNA was isolated from the four N1 carrier females for low-
resolution recombination mapping. A further twenty-one N1 females were examined by 
backcross to F0 #11 and eleven females were found to contain embryos with the 
expected phenotype at a frequency of 18% of the collected embryos (N = 203). 
Recombination mapping with these thirteen N1 carrier females (shown in orange in 
Table 4.3) and the BALB/FVB marker panel analysis identified two regions (Mmu 2 and 
Mmu 7) in which only one animal was recombinant at both the proximal and distal 
markers, indicating strong linkage to the newly introduced mutation (Table 4.3). 
Recombinant chromosomes may have arisen because the N1 female was incorrectly 
assigned as a carrier, or because a double recombination had occurred. To determine 
the cause of recombination, additional carrier females were identified. The F0 #11 male 
was too old for further breeding and additional carriers were identified by intercross of 
the N1 progeny (Figure 4.3 B). Each of four N1 males was test-mated with two N1 
females. Through this process, one male (N1 #175) and his tested females were 
identified as carriers, with 23% of embryos displaying the phenotype of interest.  
166 
 
 
(N1 #23 female x F0 #11 male )
(N1 #27 female x F0 #11male)
(N1 #37 female x F0 #11 male )
(N1 #38 female x F0 #11 male )
(N1 #170 female x F0 #11 male)
(N1 #171 female x F0 #11 male)
(N1 #173 female x F0 #11 male)
(N1 #181 female x F0 #11 male)
(N1 #182 female x F0 #11 male)
(N1 #184  female x F0 #11 male)
(N1 #185 female x F0 #11 male)
(N1 #186 female x F0 #11 male)
(N1 #187 female x F0 #11 male)
(N1 #191 female x N1 #175 male)
(N1 #226 female x N1 #175 male)
(N1 #23 female x F0 #11 male )
(N1 #27 female x F0 #11male)
(N1 #37 female x F0 #11 male )
(N1 #38 female x F0 #11 male )
(N1 #170 female x F0 #11 male)
(N1 #171 female x F0 #11 male)
(N1 #173 female x F0 #11 male)
(N1 #181 female x F0 #11 male)
(N1 #182 female x F0 #11 male)
(N1 #184  female x F0 #11 male)
(N1 #185 female x F0 #11 male)
(N1 #186 female x F0 #11 male)
(N1 #187 female x F0 #11 male)
(N1 #191 female x N1 #175 male)
(N1 #226 female x N1 #175 male)
C
hr
M
ar
ke
r
M
b
C
hr
M
ar
ke
r
M
b
Ch
r1
D1
M
it2
0
31
Ch
r1
0
D1
0M
it8
0
11
Ch
r1
D1
M
it4
6
76
Ch
r1
0
D1
0M
it7
0
10
4
Ch
r1
D1
M
it3
62
19
0
Ch
r1
1
D1
1M
it7
4
5.
2
Ch
r2
D2
M
it1
 
3.
8
Ch
r1
1
D1
1M
it4
1
90
Ch
r2
D2
M
it1
5
92
Ch
r2
D2
M
it1
48
17
9
Ch
r1
2
D1
2M
it2
40
11
Ch
r1
2
D1
2M
it1
8
11
4
Ch
r3
D3
M
it2
21
7.
9
Ch
r3
D3
M
it2
58
82
Ch
r1
3
D1
3M
it2
17
29
Ch
r3
D3
M
it2
57
14
2
Ch
r1
3
D1
3M
it7
6
11
1
Ch
r4
D4
M
it1
8
14
Ch
r1
4
D1
4M
it1
10
9
Ch
r4
D4
M
it1
89
14
6
Ch
r1
4
D1
4M
it2
66
11
2
Ch
r5
D5
M
it3
46
4.
8
Ch
r1
5
D1
5M
it1
50
14
Ch
r5
D5
M
it1
39
12
5
Ch
r1
5
D1
5M
it2
45
94
Ch
r6
D6
M
it2
35
23
Ch
r1
6
D1
6M
it3
4
16
Ch
r6
D6
M
it1
4
14
6
Ch
r1
6
D1
6M
it1
52
86
Ch
r7
D7
M
it7
6
20
Ch
r1
7
D1
7M
it2
73
9.
1
Ch
r7
D7
M
it2
38
10
7
Ch
r1
7
D1
7M
it2
21
91
Ch
r8
D8
M
it5
8
7.
1
Ch
r1
8
D1
8M
it2
29
12
Ch
r8
D8
M
it9
1
12
7
Ch
r1
8
D1
8M
it4
9
76
Ch
r9
D9
M
it2
97
34
Ch
r1
9
D1
9M
it1
13
19
Ch
r9
D9
M
it2
14
11
5
Ch
r1
9
D1
9M
it1
0
47
Pe
di
gr
ee
 1
6-
7
Animal
Animal
167 
 
Ta
bl
e 
4.
3:
 G
en
om
e-
w
id
e 
lo
w
-r
es
ol
ut
io
n 
m
ap
pi
ng
 o
f N
1 
ca
rr
ie
r 
fe
m
al
es
 fo
r 
pe
di
gr
ee
 1
6-
7.
 T
he
 g
en
ot
yp
e 
(h
om
oz
yg
ou
s 
FV
B/
N:
 
gr
ey
, o
r h
et
er
oz
yg
ou
s 
FV
B/
N
; B
AL
B/
cJ
: p
ur
pl
e)
 o
f e
ac
h 
an
im
al
 a
t e
ac
h 
M
IT
 m
ar
ke
r i
s 
sh
ow
n.
 T
he
 re
su
lts
 in
di
ca
te
 th
e 
ha
pl
ot
yp
e 
of
 
ea
ch
 a
ni
m
al
 fo
r a
ll 
au
to
so
m
es
 (M
m
u 
1–
19
). 
Tw
o 
re
gi
on
s 
(M
m
u 
2 
an
d 
M
m
u 
7)
 s
ho
w
ed
 s
tr
on
g 
lin
ka
ge
 to
 th
e 
m
ut
an
t p
he
no
ty
pe
 
ex
hi
bi
te
d 
in
 p
ed
ig
re
e 
16
-7
. 
H
et
er
oz
yg
ou
s
H
om
oz
yg
ou
s 
(M
ap
pi
ng
 s
tr
ai
n)
-
N
o 
re
su
lt
168 
 
Genomic DNA samples from the two females (shown in black in Table 4.3) were 
subjected to marker panel analysis; the results indicated that Mmu 7 was the most likely 
site of the mutation (Table 4.3). In parallel, additional markers  
 (D7Mit247, D7Mit69, and D7Mit276) were examined along Mmu 7 to evaluate the 
possibility of double recombination in N1 female #182. As shown in Figure 4.9, this 
analysis indicated that a region of heterozygosity existed on Mmu 7 (shown in green in 
Figure 4.9). In combination with the marker panel analysis of the additional females, this 
indicated a strong linkage to Mmu 7 (19.6–69.4 Mb, Figure 4.9). 
To confirm linkage of the 16-7 causative mutation to Mmu 7, putative homozygous 
embryos were collected from further intercross matings between N1 females and the 
male carrier N1 #175. The embryos were genotyped along Mmu 7 and all mutant 
embryos were found to be homozygous for the mutagenised strain (BALB/cJ), 
confirming that the causative mutation was mapped between D7Mit247 and D7Mit69 
(39–56.3 Mb, Figure 4.10). In contrast, normal embryos were homozygous for the 
mapping strain or heterozygous at the same tested markers. These findings indicate the 
mutation causing the abnormal gastrulation phenotype in pedigree 16-7 resides within 
the 49.8 Mb interval of Mmu 7. 
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4.2.3 Pedigree 18-5 
Pedigree 18-5 was isolated from the gastrulation screen via the interspecific backcross 
strategy (Figure 1.3). For this pedigree the mutagenised strain was FVB/N and the 
mapping strain was BALB/cJ. Male G1 #17 was screened by backcross with five N1 
females. Embryos which displayed a small embryonic region and large extra-embryonic 
region were apparent in two litters at a frequency of 16% (N = 56). Thus, the male (G1 
#17) was considered to harbour a new recessive mutation that prevents the onset of 
gastrulation and was designated F0 #17. An additional nine N1 females (from nineteen 
dissected) were found to contain embryos with the expected phenotype at an overall 
frequency of 16% (N = 197). Genomic DNA from the eleven N1 carrier females was used 
for low-resolution recombination mapping via the BALB/FVB marker panel (shown in 
orange in Table 4.4). Two chromosomes (Mmu 9 and Mmu 16) exhibited strong linkage, 
as all animals were non-recombinant for at least one marker on these chromosomes 
(Table 4.4). 
The F0 #17 male was too old for further breeding, and additional male carriers were 
identified by intercross of N2 animals, as shown in Figure 4.3 B. This process identified 
one male (N1 #114) and one N2 female as carriers. Genomic DNA from the female 
(shown in black in Table 4.4) was analysed with the mapping panel; the female was 
found to be recombinant at a marker on Mmu 9, suggesting that Mmu 16 is the most 
likely site of the mutation (Table 4.4). To investigate this theory, five additional markers 
were analysed along Mmu 9, revealing weak linkage between D9Mit1001 and D9Mit347 
from the genotyping of two identified N1 female carries (N1 #13 and N1 #17). Given the 
recombination in this region, as evidenced by the homozygosity, it is expected that the 
mutation is not linked to Mmu 9 (Figure 4.11). Chi square analysis of the markers on 
Mmu 9 (D9Mit1001 and D9Mit4) revealed a significant deviation from the frequency 
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expected in unlinked markers (Figure 4.11). However, given the haplotype analysis, it is 
expected that this significance was not due to linkage of these markers to the mutation 
of interest. 
As shown in Figure 4.12, three additional markers were examined along Mmu 9 and 16; 
this analysis confirmed linkage to Mmu 16 (15.9–53.9 Mb). This result was statistically 
significant, confirming that the causative mutation was mapped between D16Mit34 and 
D16Mit152 (Figure 4.12). These findings indicate that the mutation causing the 
abnormal gastrulation phenotype in pedigree 18-5 resides within the 38 Mb interval of 
Mmu 16. 
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4.2.4 Pedigree 18-10 
Pedigree 18-10 was isolated from the gastrulation screen via the interspecific backcross 
strategy (Figure 1.3). For this pedigree the mutagenised strain was FVB/N and the 
mapping strain was BALB/cJ. Male G1 #32 was screened by backcross with six N1 
females, two of which contained embryos with patterning errors at an overall frequency 
of 14% (N = 80). Thus, the male was considered to harbour a new recessive mutation 
that caused early patterning defects and was designated F0 #32. A further twenty-six 
litters from N1 females backcrossed to F0 #32 were examined and putative homozygous 
embryos were observed in six of these at an overall frequency of 8% (N = 236). This is 
lower than the 12.5% expected, and suggests that this mutation may not be fully 
penetrant. Genomic DNA samples were isolated from the eight N1 carrier females for 
low-resolution recombination mapping using the BALB/FVB marker panel analysis 
(shown in orange in Table 4.5). Two chromosomes (Mmu 5 and Mmu 12) exhibited 
strong linkage, since all animals were non-recombinant for at least one marker on these 
chromosomes (Table 4.5). 
Additional carrier females were sought to refine the linkage position. The F0 #32 male 
was too old for further breeding and additional male carriers were identified by 
intercross of the N1 progeny (Figure 4.3 B). This identified three males (N1 #252, N1 
#263, and N1 #265) and paired N1 females as carriers. When genomic DNA from the 
identified N1 carrier females (shown in black in Table 4.5) was subjected to the marker 
panel analysis, the results indicated that Mmu 12 was the most likely site of the mutation 
(Table 4.5). When one additional marker (D12Mit136) was examined, strong linkage to 
Mmu 12 was found, but did not further narrow the mapped interval (Figure 4.13). 
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4.2.5 Pedigree 18-19 
Pedigree 18-19 was isolated from the gastrulation screen via the interspecific backcross 
strategy (Figure 1.3), using FVB/N as the mutagenised strain and BALB/cJ as the mapping 
strain. Male G1 #24 was screened by backcross with four N1 females. Embryos with a 
small embryonic region and large extra-embryonic region were apparent in two litters 
at an overall frequency of 24%. Thus, the male was considered to harbour a new 
recessive mutation that caused a failure to gastrulate and was designated F0 #24. 
Subsequently, a further four N1 carrier females (from eight tested) were identified by 
backcross with F0 #24; an overall frequency of 15% putative homozygous embryos was 
observed (N = 60). Recombination mapping with five N1 carrier females and the 
BALB/FVB marker panel identified four regions (Mmu 4, Mmu 17, Mmu 18, and Mmu 
19) with strong linkage to the newly introduced mutation, since no animals were 
recombinant at both markers on these chromosomes (Table 4.6). 
Additional carrier females were needed to confirm on linkage to one of these 
chromosomes. As the F0 #24 male was too old for further breeding, additional carriers 
were identified by intercross of the N1 progeny. Three males (N1 #208, N1 #209, and N1 
#227) and paired females were identified as carriers. Additionally, the strategy shown in 
Figure 4.4 was used to generate N2 females for backcross with the newly identified N1 
carrier males. An additional seven carrier females were identified (shown in black in 
Table 4.6) and their genomic DNA subjected to marker panel analysis. The data indicated 
that Mmu 4 was the most likely site of the mutation (Table 4.6). One additional marker 
(D4Mit26) was examined along Mmu 4 to evaluate the strength of the linkage. As shown 
in Figure 4.14, in combination with the marker panel analysis of the additional females, 
results suggested the mutation causing the abnormal gastrulation phenotype in 
pedigree 18-19 resides within a 70 Mb interval of Mmu 4. 
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4.2.6 Pedigree 18-22 
Pedigree 18-22 was isolated from the gastrulation screen via the interspecific backcross 
strategy (Figure 1.3), using FVB/N as the mutagenised strain and BALB/cJ as the mapping 
strain. Male G1 #50 was screened by backcross with four N1 females. Embryos displaying 
gastrulation patterning errors were apparent in two litters at an overall frequency of 
18% (N = 38). Thus, the male was considered to harbour a new recessive mutation that 
caused defective patterning and was designated F0 #50. A further twenty-nine litters 
were examined; nine were found to contain embryos with the putative homozygous 
mutants at an overall frequency of 11% (N = 234). Less than 50% of females produced 
embryos with this phenotype, indicating the mutation may be incompletely penetrant. 
Genomic DNA was isolated from the eleven N1 carrier females for low-resolution 
recombination mapping using the BALB/FVB marker panel analysis (shown in orange in 
Table 4.7). Of the eleven females, only one showed recombination at both markers on 
Mmu 9, whereas all other autosomes had multiple fully recombinant animals. Mmu 9 
was considered to show the strongest linkage (Table 4.7). 
The recombinant Mmu 9 in female N1 #157 could have arisen if she was incorrectly 
assigned as a carrier, or because of a double recombination event. To distinguish these 
possibilities, additional markers (D9Mit4, D9Mit12, and D9Mit347) were examined 
along Mmu 9. This showed that the N1 #157 female was homozygous along the length 
of Mmu 9, which led to its exclusion from the analysis (Figure 4.15 A). Additional carrier 
females were needed to complete the recombination mapping. As the F0 #50 male was 
too old for further breeding, intercross of N1 progeny identified two males (N1 #160 and 
N1 #169) and paired N1 females as carriers. Additionally, N2 females were backcrossed 
with male carrier N1 #160 to isolate extra genomic DNA samples for recombination 
mapping (shown in black in Table 4.7). This analysis confirmed Mmu 9 as the only site 
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with strong linkage. The genomic DNA samples were then subjected to additional Mmu 
9 marker analysis (D9Mit4, D9Mit12, and D9Mit347), which indicated that the mutation 
causing the abnormal gastrulation phenotype in pedigree 18-22 resides within a 15 Mb 
interval of Mmu 9. 
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4.3 DISCUSSION  
4.3.1 Overview 
Despite the revolutionary use of ENU-based genetic screens in the mouse, a genome-
wide screen that directly aims to identify genes that act in gastrulation has not 
previously been attempted. Several factors appear to mitigate the possibility of success 
for such a screen, including the difficulty of recovering gastrulation stage embryos, the 
difficulty of distinguishing mutant embryos from resorptions and the small embryo size 
that leads to insufficient recovery of DNA for extensive molecular analysis. In this 
chapter, I have contributed to a direct test of the feasibility of a genome-wide screen for 
ENU-induced alleles that alter gastrulation. I attempted to use a haplotype interval 
strategy to perform low-resolution recombination mapping for six newly isolated mouse 
strains. Each strain was thought to be segregating a new, recessive ENU-induced variant 
that prevented normal gastrulation. In each case, genomic DNA from carrier animals 
(rather than presumed homozygous animals) was analysed with a panel of polymorphic 
markers. For all six strains, the mutations were localised to a single chromosome and 
the MCR was narrowed to a sub-chromosomal interval for five of the strains. This 
indicates that the associated phenotypes likely arise from a single DNA variant, rather 
than a combination of mutations. This discovery will facilitate the cloning of the 
causative variant in future studies. 
4.3.2 Phenotype classes at gastrulation 
The gastrulation pedigrees discussed in this chapter come from a limited genetic screen 
in which only eight pedigrees were extensively investigated. Despite this small number, 
it appears that the strains can be grouped into distinct classes based on their 
phenotypes. The eight pedigrees can be broadly grouped into three classes: 
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Class 1: failure to thrive 
In pedigrees 11-23 and 16-5, the mutant embryos exhibited a severe reduction in size 
compared to their presumed wild-type or heterozygous littermates, and both the 
embryonic and extra-embryonic regions were affected to a similar degree. These 
embryos mimicked those in which a gene required for embryo nutrition was mutated 
(EG); this class was designated ‘failure to thrive’. 
Class 2: failure to gastrulate 
Pedigrees 16-7, 18-5, and 18-19 all contained presumed homozygotes that, like the class 
1 embryos, were much smaller than their presumed wild-type or heterozygous 
littermates. In contrast to the class 1 mutants, the abnormal embryos in these pedigrees 
exhibited differential growth in the embryonic versus extra-embryonic regions. In all 
class 2 mutant pedigrees, the failure to grow was more severe in the embryonic region: 
the tissue from which all adult tissues are derived through gastrulation. Additionally, the 
mutant embryos lacked hallmarks of gastrulation such as an obvious primitive streak 
and evident anterior-posterior axis. Rather than a failure to thrive, these embryos 
appear to have not initiated gastrulation, and thus were designated ‘failure to 
gastrulate’. 
Class 3: patterning defects 
Pedigrees 11-68, 18-10, and 18-22 contained presumed homozygous embryos in which 
the process of gastrulation was clearly initiated, as judged by the presence of the 
primitive streak. The embryos, however, failed to grow at the normal rate through 
gastrulation (i.e. they remained smaller than their presumed wild-type or heterozygous 
littermates) and lacked evidence of early patterning events such as the formation of the 
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neural plate. These three phenotypes were therefore considered to have arisen from 
‘patterning defects’. 
Many patterning defects have been identified in other forward genetics experiments 
that examined later stages of embryogenesis (Kasarskis et al., 1998 and Herron et al., 
2002). It is possible that the embryos of pedigrees 11-68, 18-10, and 18-22 have survived 
long enough to be recovered and screened for later phenotypes. The remaining five 
pedigrees, however, exhibited phenotypes that would not have been recovered in 
screens that examine embryos at 9.5 dpc. 
4.3.3 Recombination mapping of the BALB/FVB pedigrees 
Six mouse strains were selected for low-resolution recombination mapping and via a 
combination of strategies and an MCR was defined for each of these. As shown in Table 
4.8, the size of the MCR varied from 15–103 Mb. In general, two factors influenced the 
size of the MCR: the density of polymorphic markers and the number of recombinant 
chromosomes. For any two inbred strains of mice, the density of polymorphic markers 
varied across the genome; this was evident in the present study. For example, in the 
case of pedigree 18-10, it was difficult to identify additional polymorphic markers at 
Mmu 12, which contributed to an inability to localise the mutation to a sub-
chromosomal interval. Similarly, for pedigree 18-19, a scarcity of polymorphic markers 
on Mmu 4 contributed to the large—70 Mb—MCR on that chromosome. The density of 
markers affected all pedigrees equally, as all mapping experiments were conducted 
between the same two inbred strains. 
The number of recombinant chromosomes also influenced the mapping outcomes, but 
this was a feature that affected the pedigrees to varying degrees; specifically, the ease  
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Table 4.8: Chromosomal location of the ENU-induced mutations in the gastrulation screens. 
In this study, a male mouse strain was mutagenised and crossed with a female mapping 
strain. The mutagenised and mapping strains are indicated for each of the eight isolated 
mouse pedigrees. 
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of correctly assigning carrier status varied across the strains. One feature that influences 
this is phenotype robustness. Phenotypes can vary with respect to penetrance and 
expressivity. The penetrance of a phenotype is defined as the proportion of individuals 
carrying a certain allele of a gene that also express an associated trait (the phenotype). 
When this proportion falls below 100%, the phenotype is said to have incomplete 
penetrance. The expressivity of a phenotype refers to the fact that not all phenotypes 
are manifested to the same extent in different individuals. Together, these two factors 
can lead to difficulty in inferring genotypes based on an observed phenotype; false 
negative conclusions can be reached (i.e. an individual that carries a mutant genotype 
could be assigned a non-carrier). In practical terms, the risk of false negative conclusions 
can be somewhat diminished by using mouse strains with large litter sizes. The cross 
between BALB/c and FVB/N animals routinely yielded litters with at least twelve 
embryos, in which the expected number of homozygotes was three. Even in pedigrees 
with incomplete penetrance and/or variable expressivity, more than one embryo with 
an overt phenotype would be expected. 
In the gastrulation screen, this problem of incorrectly assigning carrier status was 
compounded by the fact that the litters were examined when resorption of wild-type 
embryos was still occurring. In class 3 embryos, this can lead to false positive conclusions 
where resorbing embryos are identified as putative homozygous embryos. Additionally, 
homozygous mutant embryos could wrongly be designated as a resorbing wild-type 
embryo (leading to false negative carrier identification). 
Another aspect of robustness is how readily a phenotype can be shifted or modified. 
Modifying effects include environmental and genetic factors. The mouse genetic 
experiments in this chapter were conducted, as far as possible, under controlled and 
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consistent environmental conditions. The genetic background of each strain was, 
however, under constant flux because of continual backcrossing to the mapping strain. 
One recommendation, based on the recombination mapping described in this chapter, 
is that the number of pedigrees under analysis should be kept small to enable sufficient 
carrier females to be identified before the F0 male becomes too old for further mating 
(which requires carrier animals to be identified after another backcross). 
Over the course of the recombination mapping experiments, it was noted that 
difficulties with phenotype loss during backcross generations were encountered most 
often with the patterning mutants. This was reflected in the fact that an increased 
number of potential carriers needed to be screened to identify sufficient animals for 
mapping; this produced an overall frequency of presumed homozygotes of less than the 
expected 12.5%. This indicator of incomplete penetrance was noted for both patterning 
defect pedigrees mapped in this chapter (18-10 and 18-22), but not for any of the three 
failure to gastrulate pedigrees (16-7, 18-5, and 18-19). Although the sample size was 
small, it is possible that this observation reflects a real difference in the ease with which 
the phenotypes themselves can be detected and/or adapted. These phenotypes differed 
in their time-of-onset relative to the screening time, i.e. the block to gastrulation 
occurred some 36 hours before the 8.0 dpc screen and was therefore strongly evident 
by the time at which the embryos were assessed. In contrast, when examined at 8.0 dpc, 
the patterning defects were relatively subtle when compared with the expected effects 
of the same mutation at the stages usually used to assess patterning (i.e. 9.5–10.5 dpc). 
Hence, a small change in the aberrant patterning phenotype could lead to it being 
overlooked in an 8.0 dpc screen. A second reason for the apparent difference in 
phenotype stability between these classes is that they essentially scored different 
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classes of variables. Patterning is a continuous variable, and a genetic modifier that 
ameliorates the phenotype does not need to cause a large phenotype shift to render the 
phenotype undetectable in a gross morphology screen. In contrast, a failure to 
gastrulate can be better considered a discrete variable (gastrulation versus no 
gastrulation), and overcoming a complete block to the onset of gastrulation may require 
more genetic variation than it is possible to obtain from different inbred strains of mice. 
Overall, despite these difficulties, it was possible to map all pedigrees selected for this 
stage of the preliminary gastrulation screen. This indicates that, as in other reported 
ENU mutagenesis experiments, most phenotypes have a monogenic basis and should be 
amenable to the identification of the underlying genetic lesion. As shown in Figure 4.16, 
the recessive mutation that caused the abnormal phenotype in the eight pedigrees from 
the Arkell gastrulation screen localised to seven different chromosomal regions. The 
causative mutation in pedigrees 16-5 and 18-22 both mapped to distal chromosome 9; 
it is possible that these represent different alleles of the same gene. The 16-5 and 18-22 
mutants fell into separate classes (16-5 was a class 1, failure to thrive mutant and 18-22 
was a class 2, patterning defect mutant), which suggests they may have arisen from 
distinct mutations on Mmu 9. Moreover, there are more than 300 genes within this 
interval according to the MGI database (Blake et al., 2011); it is entirely possible that 
these mutations affected different genes. 
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Figure 4.16: The chromosomal positions for each ENU-induced mutation of the gastrulation 
screen. Seven distinct chromosomal regions have been mutagenised. On chromosome 9, the 
map position for pedigree 16-5 is shown in purple, and the map position for 18-22 is shown 
in orange. The chromosome number is indicated at the top. 
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4.4 Future work 
Each of the six pedigrees from the small-scale BALB/FVB gastrulation screen can now be 
subjected to the next phase of mutant identification, which aims to identify the relevant 
variant DNA sequence within the MCR. The work in this chapter has confirmed that low 
resolution mapping of strains obtained from a genetic screen for gastrulation mutants 
is feasible. It has also identified features of screening design and breeding strategies that 
should be incorporated into any larger-scale efforts to use ENU mutagenesis to identify 
genes required for mammalian gastrulation. 
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Chapter 5: The gastrulation screen: identifying the 
pathogenic variant 
5.1 INTRODUCTION  
As described in chapter 1 (section 1.3.3), following recombination mapping, the ENU-
induced pathogenic variant underlying a particular phenotype needs to be identified 
within the minimal critical region (MCR), which is generally accomplished through DNA 
sequencing of all exons and splice sites across the MCR. As the pilot gastrulation screen 
(i.e. experiment ENU-11) was being conducted, however, the development of lower-cost 
whole exome sequencing (WES) technologies presented an opportunity to decrease the 
resolution of the recombination mapping step and increase the number of exons and 
splice sites scanned by sequencing. At the time, this approach had been successful in 
identifying homozygous mutations mapped with high resolution using single-nucleotide 
polymorphism (SNP) panels. For the gastrulation screen, however, it was necessary to 
identify the mutation in a carrier (heterozygous) animal, since the homozygous embryos 
did not contain sufficient genomic DNA for WES. Additionally, because of cost 
considerations, it was desirable to commence WES after low resolution mapping and to 
use a small number of carrier animals. To determine if such a strategy was possible, the 
11-23 pedigree was selected for WES. 
As described in section 4.1.2, the ENU-11 experiment was conducted as a pilot screen to 
determine the best strategy for pedigree production. In this experiment, the 
mutagenized strain was C57BL/6J and the mapping strain was C3H/HeH. The reference 
strain was also C57BL/6J, which aided the analysis. The 11-23 strain exhibited a failure 
to thrive (Figure 4.1) and had already undergone low-resolution mapping at the 
beginning of this project. Using procedures similar to those described in chapter 4, a 
200 
 
total of thirteen N1 and N2 carrier animals were identified and subjected to marker 
analysis using an interval haplotype strategy. This identified one region of strong linkage 
on MMu3, with a ~70 Mb MCR between 87,174,449 and 154,440,247 Mb. 
5.2  RESULTS:  
5.2.1 WES of the 11-23 MCR 
The 11-23 MCR contains ~166 genes, and rather than using additional breeding to 
narrow the MCR, we applied next generation sequencing technologies. Based on the 
mutagenic frequency of ENU, the number of true exonic SNVs within a mutated genome 
is expected to be low (approximately 70 exonic SNVs in the F0 animal) (Keays et al., 
2006). Furthermore, this number should be reduced by ~50% in each generation during 
the initial mapping phase of our experiment. Typically, however, raw WES data included 
many more SNVs than the expected number. The additional variant calls can be 
attributed to multiple sources, including genetic drift of the C57BL/6J mouse strain 
versus the reference genome, known strain-specific polymorphisms for the mapping 
C3H strain, and the frequency of sequencing errors in massively parallel sequencing 
(Andrews et al., 2012). To reduce the raw variant calls to a smaller number, highly 
enriched for ENU-induced mutations, a series of filters can be applied to remove known 
variants (present in dbSNP) and/or recurrent, platform–specific, false-positive variants. 
As the majority of causative ENU-induced alleles have been shown to be exonic, WES 
was selected as a suitable procedure for detecting the 11-23 causative mutation. 
The whole exom sequencing and the single nucleotide variants were preformed at 
Australia Phenomic Genotyping Core Facility (APF, Australia National University). and 
The presumed homozygous embryos contained insufficient DNA for WES, and instead, 
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two confirmed carrier animals (G3 carrier males 18 and 54) were selected for the 
analysis. Genomic DNA was isolated from the kidneys, which were collected when the 
animals were euthanized at the end of the mapping experiment. The sequence reads 
were mapped to the NCBIM37 assembly of the reference mouse genome, and the 
identified SNVs were filtered to include those that occurred in exons and splice 
donor/acceptor sites and exclude known strain-specific and platform-specific variants. 
The resulting variant lists from each animal were constrasted, and a total of 33 
heterozygous SNVs were common between the two datasets (Table 5.1). Three of the 
SNVs fell within the mapped interval (shown in blue). To determine which of the three 
variants within the MCR was likely to be causative, the functional annotations associated 
with each gene were investigated and the mutagenic potential of each identified SNV 
was assessed. The SNV identified at position 93,019,569 lies within the filaggrin family 
member 2 gene (Flg2; MGI: 3645678). It  is one of five members of the S100 fused-type 
protein (SFTP) gene family,which also includes the protien trichohyalin (TCHH) (Lee et 
al., 1993), hornerin (HRNR) (Makino et al., 2001, Wu et al., 2009b), repetin (RPTN) (Krieg 
et al., 1997, Huber et al., 2005), and cornulin (CRNN) (Xu et al., 2000, Contzler et al., 
2005) in human and mice. The S100 genes encode a family of EF-hand calcium-binding 
proteins involved in the regulation of various cellular processes including cell growth, 
cell cycle regulation, differentiation, transcription, and motility (Zhao et al., 1997, 
Marenholz et al., 2004).  
FLG2 is involved in epithelial homoeostasis and expressed in several tissues, including 
healthy human skin, where it is required for proper cornification (Smith et al., 2006, Wu 
et al., 2009a). In addition, the protein functions in skin barrier protection (Dale et al., 
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1985, Brown et al., 2012, Kezic et al., 2014). Not surprisingly, defects in FLG2 are 
associated with skin diseases (Smith et al., 2006, Makino et al., 2014). 
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Table 5.1: Validated potential SNVs detected in 11-23 pedigree exome sequencing.  
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1 90108967 C T C:T:A:N:.:G_82:50:0:0:0:0 132 39 H->Y 0 
1 90131829 G A G:A:T:N:C:._71:48:0:0:0:0 119 37 C->Y Heatr7b1 
1 158296543 G T T:G:A:N:C:._10:9:0:0:0:0 19 37 R->L 0 
1 46086035 G A G:A:T:N:C:._8:5:0:0:0:0 13 37 P->S Gm4776 
1 11738127 A C A:C:T:N:.:G_8:4:0:0:0:0 12 38 H->P A830018L16Rik 
1 58703760 C T T:C:A:N:.:G_6:3:0:0:0:0 9 40 L->F AC118698.1 
2 14141002 T A A:T:N:C:.:G_39:23:0:0:0:0 62 39 I->N Fam23a 
2 32778609 A G A:G:T:N:C:._22:13:0:0:0:0 35 36 R->G Fam129b 
3 24232140 G A G:A:C:T:N:._34:31:1:0:0:0 66 38 G->S AC139675.1 
3 24232150 G T G:T:A:N:C:._34:31:0:0:0:0 65 38 G->V AC139675.1 
3 37613895 G C G:C:A:T:N:._8:5:0:0:0:0 13 40 P->A 0 
3 93019569 A T A:T:N:C:.:G_22:18:0:0:0:0 40 37 Q->L Flg2 
3 101394617 A T T:A:N:C:.:G_17:15:0:0:0:0 32 38 V->E Atp1a1 
3 93979673 G A A:G:T:N:C:._13:13:0:0:0:0 26 38 A->V Gm10696 
4 145126763 A G A:G:C:T:N:._149:140:59:0:0:0 348 39.5 I->V 0 
4 145126997 C T T:C:A:N:.:G_15:12:0:0:0:0 27 39 L->F 0 
6 132157741 G C G:C:A:T:N:._77:40:0:0:0:0 117 38 P->A Prb1 
6 130072166 C T C:T:A:N:.:G_57:33:0:0:0:0 90 39 G->S 0 
6 41564308 C A A:C:T:N:.:G_17:14:0:0:0:0 31 27 Y->* Ephb6 
6 132262491 T G T:G:A:N:C:._5:4:0:0:0:0 9 39 Q->H Prpmp5 
7 46663474 G C C:G:A:T:N:._45:38:0:0:0:0 83 38 P->R Gm5114 
7 24417780 T G T:G:A:N:C:._15:8:0:0:0:0 23 36 V->G Vmn1r171 
7 24417789 G C G:C:T:A:N:._11:8:2:1:1:0 23 36 R->P Vmn1r171 
8 26564987 C T C:T:A:N:.:G_48:25:0:0:0:0 73 38 D->N 0 
8 41910115 G A G:A:T:N:C:._23:19:0:0:0:0 42 36.5 R->Q Adam39 
10 117642845 G A A:G:T:N:C:._21:12:0:0:0:0 33 38 V->I Il22 
12 24759537 C A C:A:T:N:.:G_25:14:0:0:0:0 39 37 S->I 0 
14 51301112 C A A:C:T:N:.:G_7:4:0:0:0:0 11 40 A->S Olfr747 
14 54089653 C T C:T:A:N:.:G_4:2:0:0:0:0 6 40 S->L TRAV8-1 
15 76545859 A C A:C:T:N:.:G_22:21:0:0:0:0 43 38 D->E 0 
15 91564504 G A G:A:T:N:C:._16:9:0:0:0:0 25 39 C->Y Lrrk2 
17 53647836 C T T:C:A:N:.:G_2:2:0:0:0:0 4 36.5 R->K 0 
19 60543644 A G A:G:T:N:C:._30:13:0:0:0:0 43 36 F->S Prlhr 
 
Ch, chromosome; coord, coordinate; Ref_base, C57BL/6J reference genome base; var_base, 
most common variant base from sequencing; base read_depth, the absolute read depth; 
median_base_quality, median of the quality scores from the raw sequence data; aa, amino 
acid. 
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FLG2 expression is restricted to the epidermis (Wu, 2009a). FLG2 mRNA was detected in 
thymus, stomach, tonsils, testis and placenta. The localisation of FLG2 in the epidermis 
and hair follicles is different from hornerin and trichohyalin, and similar to filaggrin, 
although filiggrin and FLG2 do not completely colocalise (Ishida-Yamamoto et al., 1997, 
Wu et al., 2009a, Wu et al., 2009b). It has been suggested by Wu et al. (2009a) that FLG2 
and filaggrin may play similar roles in skin biology, but may not directly cross-link with 
each other.  
As there was no avaliable in situ data for this gene family in murine gastrulation, I used 
iTranscriptome, a database of genes expressed at the mid-gastrulation stage (7.0 dpc) 
designed by Chen et al., (2017) to detect Flg2 expression. Briefly, Chen et al., (2017) 
collected data from C57BL/6 embryos that were serially cyro-sectioned in the plane 
transverse to the proximal-distal axis. From a total of 22 sections, cells were sampled 
from 11 alternating sections. From each section, approximately 20 cells were isolated 
by laser capture microdissection (LCM) from epiblasts in each of the quadrants: anterior 
(A), posterior (P), left lateral (L), and right lateral (R), except for the distal-most section, 
where only anterior and posterior halves were sampled (Chen et al., 2017). The 
methodology, which utilises geographical position sequencing (Geo-seq), combines LCM 
with single-cell RNA-seq technology. This allows study of the transcriptome of small 
samples, using as few as ten cells from defined locations in the embryo. Although Geo-
seq cannot accurately report expression in individual cells, it can report gene expression 
in a specific region, indicating whether the gene is required for normal gastrulation or 
not. As shown in Figure 5.1, Flg2 expression was barely detectable at mid-gastrulation, 
with only one cluster of cells in the L anterior epiblast (red) displaying high expression 
(Figure 5.1 A), and a group of cells in the distal epiblast  
205 
 
 
 
 
 
 
 
 
Figure 5.1: Predicted expression patterns of Flg2, Gm10696, and Atp1a1 of mid-
gastrulation. The corn plots represent the gene expression of the three potential causative 
mutation-carrying genes at mid-gastrulation in 2D format. (A) Flg2 was highly expressed only 
in the proximal left lateral section (red) and very low expression was observed in the distal 
left lateral section (light green) of the embryo. (B) Gm10696 was highly expressed only in the 
distal left lateral section (red) with low expression observed in the ventral left lateral section 
(light green) of the embryo. (C) The transcription of Atp1a1 was observed throughout the 
anterior and posterior epiblast. A, anterior; P, posterior; L, left lateral; and R, right lateral. 
The colour scale indicates expression, with red indicating high expression and light green 
indicating low expression. Numbers indicate the 11 alternating sections. This figure was 
adapted from iTranscriptome. 
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(light green) displaying low expression. This suggests that Flg2 is not essential during 
gastrulation. In addition, the predictive online software Protein Variation Effect Analyser 
(PROVEAN) (Choi et al., 2012, Choi et al., 2015) suggests that this mutation has no effect 
on the function of the protien. Thus, it was excluded as the gene carrying the causative 
mutation for the gastrulation phenotype in the 11-23 pedigree.  
The SNV identified at position 93,979,673 lies within predicted gene 10696 (Gm10696, 
MGI: 3702972). As shown in Figure 1.5 B, iTranscriptome predicted low expression of 
Gm10696 throughout the embryo during gastrulation. One cluster of cells at the distal 
left lateral epiblast (indicated in red) displayed high expression, but the cells adjacent to 
it (indicated in light green) displayed very low expression. These observations were not 
specific to individual cells, making it difficult to interpret the data. Protein Variation 
Effect Analyser (PROVEAN) (Choi et al., 2012, Choi et al., 2015) suggests that this 
mutation has an effect on the function of the protien. However, because of the predicted 
lack of expression, this gene was excluded as a potential causative factor of the 
abnormal gastrulation phenotype in the 11-23 pedigree. 
The SNV identified at position 101,394,617 lies within the ATPase, Na+/K+ transporting 
alpha 1 polypeptide gene (Atp1a, MGI: 88105). This protein is one of several isoforms of 
the α subunit of the Na+/K+-ATPase, an integral membrane protein complex that is 
responsible for establishing and maintaining Na+ and K+ ion gradients across the plasma 
membrane via active transport (Figure 5.2) . These gradients are essential for a variety 
of crucial cellular functions such as osmoregulation, sodium coupled transport of a 
variety of molecules, and the electrical excitability of nerve and muscle (Xie et al., 1989, 
Levenson, 1994, James et al., 1999, Chang et al., 2012, Reinhard et al., 2013).  
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Figure 5.2: The Na+/K+ ATPase. This membrane pump uses the energy from ATP 
hydrolysis to actively pump sodium and potassium ions against their 
concentration gradients. The binding of three sodium ions to internal binding 
sites on the cytoplasmic side and phosphorylation of the pump induces a 
conformational change that releases Na+ into the extracellular fluid. The 
subsequent binding of two extracellular potassium ions to the pump within the 
synapse, followed by dephosphorylation, causes it to return to its original 
confirmation and release the potassium ions into the cytoplasm. The Na+/K+ 
ATPase is expressed in almost all cell types, and the ionic gradient that it creates 
is used to carry out numerous important cellular processes, such as the transport 
of other molecules across membranes. Figure adapted from R. Arkell. 
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The enzyme is composed of two subunits; the large α subunit is the catalytic subunit, 
and the smaller β subunit is a glycoprotein that controls the assembly of the α/β 
heterodimer. Both subunits of the Na+/K+-ATPase are encoded by multiple genes. The 
critical role of Na+/K+-ATPase activity in embryogenesis has been previously 
demonstrated, as embryos that are homozygous for the null allele of Atp1a1 die at the 
pre-implantation stage, before gastrulation (Barcroft et al., 2004). Atp1a1 expression 
was detected at the pre-implantation stage (3.5 dpc) in wild-type embryos, specifically 
in the basolateral (but not apical) membranes of the mural and polar trophectoderm, 
and the membranes of the inner cell mass (Figure 5.3) (MacPhee et al., 2000). In 
addition, a significant focus has been placed upon exploring the activity of Na+/K+-
ATPase in pre-implantation embryos. However, the role of Na+/K+-ATPase activity or 
Atp1a1 during gastrulation is poorly defined (Baltz et al., 1997). Therefore, it will be 
important to assess the expression and activity of the Na+/K+-ATPase α1 subunit in 
gastrulation stage embryos. It is recommended that whole-mount and sectioned 
gastrulation stage embryos be examined for Na+/K+-ATPase α1 subunit expression, 
through confocal immunofluorescence microscopy or immunoblot analysis (MacPhee et 
al., 2000). Unlike Flg2 and Gm10696, Atp1a1 expression was predicted by 
iTranscriptome to be very high throughout the embryo at mid-gastrulation (Figure 5.1 
C). The identified SNV (a T to A transition in exon 8) results in a missense mutation 
causing a valine to glutamate substitution at amino acid 259 (V259E). As shown in Figure 
5.4, this amino acid lies within one of the cytoplasmic loop domains of the α subunit. 
The predictive program Protein Variation Effect Analyser (PROVEAN) (Choi et al., 2012, 
Choi et al., 2015) suggests that this mutation could interfere with ATP1A1 protien 
function. Therefore, we determined that Atp1a1 is the likely mutation-carrying gene 
causing the gastrulation phenotype in the 11-23 pedigree.  
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Figure 5.3: Na+/K+ ATPase expression during the pre-implantation stage. Localisation of 
the Na+/K+-ATPase a1 subunit in pre-implantation embryos by confocal 
immunofluorescence microscopy. Stages shown are (A) 4-cell, (B) 8-cell, (C) morula, and 
(D) blastocyst. The embryos were immunostained with an antibody. Nuclear staining was 
an artefact of the secondary antibody that was especially prominent in 8-cell embryos. 
The scale bar indicates 25 µm. Figure adapted from (MacPhee et al., 2000). TR, 
trophectoderm; ICM, inner cell mass. 
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Figure 5.4: The α and β subunits of Na+/K+-ATPase. The 
approximate position of the V259E mutation, which may result 
in loss-of-function, is indicated by the red circle on one of the α 
loops.  
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5.2.2 Atp1a1V259E allele validation via sequencing 
Based on the known functions and expression patterns of the three candidate genes, 
the SNV in Atp1a1, at position 101,394,617 of MMu3, was considered the most likely 
causative variant. To determine whether this mutation segregated with the 11-23 
phenotype, the relevant portion of Atp1a1 was sequenced in two additional carrier 
animals (females 48 and 270) along with two non-carrier animals (females 4 and 14). 
DNA was extracted from a total of 27 carrier and non-carrier animals, but the data 
presented here was derived from carrier female #270 and non-carrier female #14. As 
shown in Figure 5.5, sequencing of female mouse #270, which was mated with a carrier, 
male #271, produced several dysmorphic embryos, confirming that she was 
heterozygous for the Atp1a1V259E mutation. Additionally, DNA was extracted from the 
normal and dysmorphic embryos produced by carrier female #270 (Figure 5.5). The 
sequencing of these embryos, as expected, produced three clearly defined results: wild-
type (Atp1a1+/+), heterozygous (Atp1a1V259E/+), and homozygous Atp1a1V259E/V259E. The 
abnormal embryos were all Atp1a1V259E/V259E (Figure 5.5 B), confirming that these 
gastrulation mutant embryos were carriers of this SNP mutation, and suggesting 
causation. Conversely, the non-carrier female mouse #14, which was mated with carrier 
male #8, produced only normal embryos that did not carry the mutation (Figure 5.5). In 
all cases, the expected sequence was found. The data indicate that the Atp1a1V259E 
mutation causes the abnormal phenotype in the 11-23 pedigree (Figure 5.5). 
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Figure 5.5: The identified Atp1a1V259E mutation in the 11-23 pedigree. (A-B) 
Lateral views of dissected mouse embryos. Anterior view is shown on the left side 
in all images. (A) Dissected embryos at gastrulation from carrier female #270, 
including dysmorphic embryos (in red circle). (A’) A sequence trace from exon 8 
of the Atp1a1 gene of female #270 displays both an A and a T at nucleotide 
position 775, confirming her heterozygosity. (A’’) Sequence traces from the 
dissected embryos (in panel A). Normal gastrula embryos were wild-type or 
heterozygous for the Atp1a1 gene, and abnormal embryos were homozygous for 
the Atp1a1 mutant allele, indicating that abnormal gastrulation was due to the 
Atp1a1V259E mutation. (B) Normal gastrulation stage embryos produced by a non-
carrier female #14. (B’’) A sequence trace from female #14 displayed a T at 
position 775 of the Atp1a1 gene. In all traces, arrows indicate the affected base 
(T to A).  
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5.2.3 Genotyping of the Atp1a1V259E mutation 
An allelic discrimination assay was optimised using the TaqMan® SNP system to identify 
Atp1a1V259E. All gastrulation stage embryos (a total of 240) were tested and genotyped 
by TaqMan® SNP genotyping. Primers that amplify the region of interest were used 
together with two different fluorescent probes: one that specifically binds to the wild-
type allele (Caruana et al.) and another that binds to the mutant allele (VIC; see section 
2.1.6 for primer design and section 2.2.4.2 for probes used for allelic discrimination). 
Changes in fluorescence associated with each probe were measured. Embryos at 
gastrulation did not contain sufficient genomic DNA, and there was slight maternal 
contamination; however, samples were still distinguishable. This assay allowed the 
identification of three distinct populations in the 11-23 pedigree: wild-type (Atp1a1+/+), 
heterozygous (Atp1a1V259E/+), and homozygous (Atp1a1V259E/V259E) embryos (Figure 5.6 
A-C). The FAM probe fluoresced when the wild-type allele was amplified, whereas only 
slight fluorescence was recorded from the VIC probe. When Atp1a1V259E/+ embryonic 
DNA was present, both probes fluoresced at equal levels. When 
Atp1a1V259E/V259 homozygous embryonic DNA was present, the VIC probe fluoresced 
while only slight fluorescence was recorded for the FAM probe. The allelic discrimination 
plot (Figure 5.6 D) displays the sorting of samples into one of three groups based on the 
fluorescence produced from each probe. Therefore, the allelic discrimination assay 
successfully differentiated homozygous and heterozygous carriers embryos of the 
Atp1a1V259E mutation from the wild-type embryos.  
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Figure 5.6: Genotyping of Atp1a1V259E mutant embryos using allelic discrimination. 
Amplicons were generated using Atp1a1-specific primers. Wild-type and mutant alleles 
were distinguished using separate probes for each allele: FAM for wild-type (green 
traces) and VIC for Atp1a1 mutants (blue traces). (A-C) The amplification plots displayed 
normalised fluorescence from each probe at each cycle. In wild-type (Atp1a1+/+) embryos 
(A) fluorescence was detected from the FAM probe. In heterozygous (Atp1a1V259E/+) 
embryos (B), fluorescence was detected from both probes. In homozygous 
(Atp1a1V259E/V259E) embryos (C), fluorescence was detected from the VIC probe. (D) The 
allelic discrimination plot displaying normalised fluorescence from the VIC probe against 
the FAM probe. Genotyping results using unknown embryos from the 11-23 intercross 
specific mating produced three distinct populations: wild-type (red), heterozygous 
(green), and homozygous (blue). The black square at the bottom left of the graph 
represents a no-template control. 
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5.2.4 Protein modelling of the Atp1a1V259E allele 
The α subunit of ATP1A1 catalyses ATP hydrolysis, binds both sodium and potassium 
ions, and drives these ions across the plasma membrane (Levenson, 1994). Valine, a 
hydrophobic amino acid, is typically buried inside proteins while glutamate, which is 
hydrophilic, tends to be on protein surfaces (Figure 5.7). It is more energetically 
favourable for a hydrophobic residue, such as valine, to be buried and minimally 
exposed to solvent. Thus, the V to E substitution may alter the hydrophobicity of the 
mutation site. Therefore, this change may cause nearby residues to be arranged 
differently in the protein. Additionally, this change may make the protein unstable or 
mislocalised. Thus, a V to E mutation may perturb the backbone of the ATP1A1 protein, 
which alters the activity of the charged side chain or changes the folding of the protein. 
Further experimentation, however, is needed to investigate the effect of this mutation 
on Na+/K+-ATPase activity. 
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Figure 5.7: Crystal structure of porcine α-, β- and γ subunits of Na+/K+-ATPase (PDB ID: 
3WGU). (A) The structures of valine and glutamate. (B) The Na+/K+-ATPase complex backbone 
is shown as a ribbon diagram. α subunit, teal; β subunit, lavender; V259 mutation, red; 
phosphatidylcholine, yellow sticks; Na+/K+ ATPase γ subunit transcript variant a, grey; sodium 
ions, pink spheres; N-acetyl-D-glucosamine, green; ADP, sticks with Corey, Pauling, Koltun 
colour scheme; magnesium ions, pink spheres. 3D image constructed in PyMOL Molecular 
Graphics System. 
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5.3 DISCUSSION 
5.3.1 Overview 
The advent of next-generation sequencing technologies has vastly altered the prospects 
for identifying causative point mutations in large genomes. In this chapter, I directly 
evaluate whether WES provides a useful method for identification of mutations in the 
gastrulation screen. I find that by conducting WES across the genome of two 
heterozygous carrier animals and applying filters for common and platform-specific 
variants, it is possible to readily identify the causative mutation, demonstrating the 
utility of this approach. The causative mutation lies in the Atp1a1 gene, which encodes 
the α subunit of the Na+/K+-ATPase complex that energises the transport of ions and 
solutes across cell membranes. The Atp1a1 gene has previously been shown to be 
essential for the peri-implantation stage of murine embryogenesis (Barcroft et al., 
2004). The data indicate that WES can be used to circumvent the need for fine 
recombination mapping of ENU-induced mutations that affect gastrulation. 
Simultaneously, by identifying all exonic mutations across the MCR, WES reduces the 
need for complementation studies traditionally used to ensure that the phenotype is 
not caused by a closely linked, alternative mutation. 
5.3.2 Mutation of Atp1a1 underlies the 11-23 phenotype 
Several lines of evidence suggest that the Atp1a1 mutation is causative. First, WES 
enabled the detection of all SNVs in the critical interval and revealed three putative 
variants within the MCR. Of the three altered genes, Atp1a1 is the only one which is 
both expressed during gastrulation and predicted to cause a damaging protein 
alteration. Second, the Atp1a1 gene has previously been disrupted via gene targeting in 
mice (James et al., 1999), and embryos lacking ATP1A1 function die sometime between 
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3.5 and 8.5 dpc (Barcroft et al., 2004), consistent with the 11-23 phenotype. Third, 
analysis using mutation prediction programs suggests that the non-conservative V295E 
substitution within the catalytic domain of the Na+/K+-ATPase complex is damaging. 
Finally, following the establishment of a genotyping assay, we found non-segregation of 
the phenotype and mutation in 843 meiosis samples. 
Additional evidence that the Atp1a1 V295E mutation underlies the phenotype can be 
obtained via complementation testing between 11-23 and the null Atp1a1 allele. 
Complementation is the name given to the phenomenon whereby two strains of an 
organism, both of which have a homozygous recessive mutation that gives rise to the 
same phenotype, produce offspring with a wild-type phenotype when crossed. In 
general, complementation will occur if the two mutations are in separate genes. In 
contrast, if the two mutations are in the same gene, the homozygous mutant phenotype 
will generally be recapitulated, and the two strains are said to ‘fail to complement’ one 
another or be ‘non-complementing’. In traditional positional cloning approaches, 
mutation scanning does not cover the entire MCR but generally is limited to candidate 
genes in the interval. In this case, complementation testing can be employed to rule out 
the possibility that a phenotype is caused by a closely linked, but unidentified mutation. 
The work in this chapter shows how WES can eliminate the need for complementation 
testing. By identifying and evaluating the likely pathogenicity of each mutation within 
the MCR, the possibility of an unrevealed, second-site causative mutation is minimised. 
In the case of Atp1a1, a search for available murine alleles showed that the Atp1a1 
targeted strain (Atp1a1tm1Ling) was no longer available but that frozen stocks (embryos) of 
a gene trap allele (Atp1a1Gt(OST31117)Lex) could be imported. Given the time and cost of 
importing, animating, and crossing this strain along with the strong evidence that the 
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other two exonic variants were unlikely to affect gastrulation, the decision was made 
not to proceed with an Atp1a1 complementation test. 
A second method that would provide additional support for the mutagenic potential of 
the V295E allele is the direct measurement of the Na+/K+-ATPase activity of this protein 
variant and the comparison to that of the wild-type protein. Na+/K+-ATPase activity can 
be measured by a variety of colourimetric assays (Sarkar, 2002) or by rubidium-86 influx 
assays, where K+ influx is deduced by determining the rate of release of Pi from ATP (Xie 
et al., 1989, Herrera et al.,1990, Liang et al., 2006). These assays can be conducted in 
cell-free systems, an approach which would require the expression and purification of 
the V295E variant. Alternatively, they can be adapted for cell-based systems, which 
would require the generation of a cell line that either transiently or stably expresses 
wild-type or variant ATP1A1. In vitro systems for the measurement of Na+/K+-ATPase 
activity also exist; for example, activity can be measured in isolated intact skeletal 
muscles or in digests of these muscles (Clausen, 2013). This approach cannot be used 
with the homozygous embryos due to early lethality, but it may be possible to discern a 
difference between the muscles of heterozygous animals and those of wild-type 
animals. Given that the aim of the work in this chapter was to determine whether WES 
was suitable for identifying putative mutations in the MCR, these experiments were not 
deemed necessary to meet the project objectives. If, however, the 11-23 strain is used 
in the future to investigate the cellular and molecular roles of the ATP1A1 protein, these 
experiments should be performed. 
One question raised by the work in this chapter is whether the phenotype of the 11-23 
strain is different from that of the targeted null allele (Atp1a1tm1Ling) (James et al., 1999, 
Barcroft et al., 2004). Previous characterisation of this allele spanned, but did not 
directly investigate, the immediate post-implantation period. Homozygous embryos 
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were recovered at the expected proportion at 3.5 dpc (Barcroft et al., 2004), but none 
were recovered at 8.5 dpc (James et al., 1999), illustrating that they died between these 
time points. Barcroft et al., (2004) further investigated the viability of Atp1a1-null 
preimplantation embryos via culture of isolated eight-cell embryos or blastocysts. In 
each case, embryo culture adversely affected homozygous-null embryos (but not their 
wild-type or heterozygous littermates) as evidenced by premature cell dissociation and 
(in the case of the blastocysts) a failure to attach to cultureware and form trophoblast 
outgrowths. The researchers therefore concluded that Atp1a1-null embryos would not 
implant. The work presented in this chapter suggests that a severe mutation of Atp1a1 
may be compatible with implantation, but not with gastrulation. There are however two 
caveats to this inference: one is that the V295E allele may be hypomorphic, and the 
second is that a genetic background difference could lead to phenotype differences. 
There is some support for the notion that genetic background may influence the Atp1a1 
mutant phenotype since over the course of the experiments reported in this chapter, 
the phenotype of the homozygous embryos became more severe. After the 11-23 strain 
was backcrossed into the C3H strain, embryos recovered at 7.5 dpc showed little 
evidence of epiblast formation and were in the process of resorbing. In contrast, 
phenotype onset was delayed by outcrossing the C3H strain with C57BL/6 animals, 
suggesting that the C57BL/6 background moderates the phenotype. 
5.3.3 WES is useful for the gastrulation screen 
The WES analysis presented in this chapter indicates that it should be the method of 
choice for the gastrulation screens of the remaining pedigrees. Not only were a small 
number of exonic variants documented in the MCR by WES, but also resources such as 
the iTransriptome (Chen et al., 2017) now enable the rapid assessment of the expression 
pattern of candidate genes. It seems likely that even when the MCR remains relatively 
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large, there will be only one or two realistic putative causative SNVs, and (as shown here 
with Atp1a1) these can be rapidly discriminated by Sanger sequencing across the 
variants in stored DNAs from the multi-generation pedigrees generated during the 
mapping process. Additionally, this is now the method of choice for many other ENU 
mutagenesis screens (Andrews et al., 2012, Caruana et al., 2013, Potter et al., 2016). 
Many of the remaining pedigrees did not involve the C57BL/6 reference strain, but this 
should not confound their analysis because of mouse resequencing efforts (Keane et al., 
2011) and because the drop in the cost of genome sequencing means that (if required) 
additional carrier animals can be sequenced to validate putative de novo variants. 
5.3.4 The gastrulation screen 
One feature of the gastrulation screen is that even though only a small number of 
pedigrees were isolated (eight in total), these appeared to fall into three phenotype 
classes (Figure 4.1): Failure to thrive, Failure to gastrulate, and Patterning defects. Each 
class appears to correspond to failure at a particular time point (pre-gastrulation, onset 
of gastrulation, and during gastrulation, respectively). It is tempting to speculate that 
each class may be enriched for a particular type of molecule. For example, the mutation 
of housekeeping genes may be expected to lead to a failure to thrive, whereas the 
mutation of genes involved in signalling pathways that regulate the timing of 
gastrulation may lead to a failure to gastrulate. The finding that the Atp1a1 gene is 
mutated in 11-23 (classified as a Failure to thrive) appears, on the surface, to support 
this hypothesis since Atp1a1 is thought to be ubiquitously expressed and critical for the 
maintenance of basic cellular processes. Recently, however, the intracellular domains of 
the Na+/K+-ATPase have been shown to bind to an array of proteins involved in cell 
signalling pathways such as the PI3K, Src, and MAPK pathways (Reinhard et al., 2013). 
The V259E missense mutation occurs within the cytoplasmic domain in a region 
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implicated in these protein-protein interactions, and it is possible that the ENU-induced 
allele interferes with a more specific docking function of ATP1A1. Further understanding 
of the phenotype classes described here awaits the identification of the causative 
mutations in the other pedigrees. 
Another noteworthy feature of the gastrulation screen is the high rate of recovery of 
pedigrees of interest. The eight lines reported in this thesis were recovered from a 
screen of forty-three pedigrees. This represents a recovery rate of 18%, which is very 
similar to the ~20% recovery rate reported in other genome-wide screens for recessive 
mutations that alter other stages of embryogenesis (see Caruana et al., 2013 for 
discussion). This demonstrates that gastrulation, as with other stages of embryogenesis, 
represents a rich source of phenotypes that could reveal genes and protein domains 
critical to this process.  
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Chapter 6: Future Perspectives 
The overall aim of this project was to determine if a genome-wide screen for genes 
required for gastrulation is possible and would likely contribute to our understanding of 
mammalian gastrulation. In chapter 3, I analysed the Katun mouse strain (a null allele of 
Zic3) and the batface mouse strain (a gain of function allele of Ctnnb1). The phenotypes 
of both these strains are first easily observed at 9.5 dpc, yet the likely cause of these 
phenotypes occurs during gastrulation. Moreover, other alleles of these genes have long 
been available (in the case of Zic3, the first allele called Bent tail (Bn) was published in 
1952 (Garber, 1952), yet careful observation of the associated phenotypes has yielded 
novel information and hypotheses on the role of these genes during gastrulation. A 
search for additional ENU-induced mouse mutants with phenotypes that inform our 
understanding of gastrulation appears warranted. 
The advent of CRISPR targeted mutagenesis has led to questions regarding the 
usefulness of ENU screens in the mouse. For many biological processes, there has been 
a shift in focus towards using next-generation sequencing technologies to identify 
variants in humans with certain diseases or disorders. The variants are then filtered with 
respect to functional annotations and likely disease involvement before CRISPR 
mutagenesis is used to introduce an analogous mutation in mice. The resulting animals 
are then analysed to determine whether the mutation appears pathogenic. Although 
useful for a wide range of diseases and disorders, the utility of this approach for the 
study of gastrulation is less clear. In humans, mutations that severely compromise 
gastrulation are lethal at ~ 7 weeks of gestation and may not be detected until routine 
scans that generally are scheduled for ~12 weeks of gestation – by which time the 
embryo has been resorbed. In contrast, the work presented in this thesis demonstrates 
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that a genome-wide ENU mutagenesis screen for phenotypes that affect gastrulation 
would be a sensible addition to efforts to understand the molecular basis of this process 
in mammals. 
The progress in sequencing technologies and corresponding decrease in associated costs 
suggest that even the approach used in this thesis (low-resolution recombination 
mapping followed by WES sequencing of two carrier animals) has now been superseded. 
To carry out a further genome-wide screen for ENU-induced mutations that inform our 
study of mammalian gastrulation, the following procedure is recommended. 
• Mutagenise males from either the BALB/c or FVB strain (since both have been 
well characterised for their response to ENU, are highly fecund, and have been 
re-sequenced). 
• Cross mutagenised males with females of the same strain (it is no longer 
necessary to use a second mapping strain in the experiment) and designate male 
progeny as Founder animals for test mating. 
• Cross a Founder male with a wild-type female (of the same inbred strain as the 
mutagenised male) until twenty G2 females have been produced. 
• Screen four G2 females by backcrossing with the founder male, keeping tissues 
for future DNA extraction from each female. 
• If two or more females produce embryos with the same phenotype, then the 
pedigree is ‘of interest’. 
• Screen additional G2 females by backcrossing with the founder male until a total 
of four putative carrier females have been identified. 
• Extract DNA from an ear biopsy of the founder male (estimated 70 exonic 
variants) and from the reserved tissue of each G2 carrier female (estimated 35 
exonic variants) and perform WES on each of the five DNAs. 
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• Filter variants against known strain- and platform-specific variants. 
• Intersect the variants across each G2 female and by comparison to the founder 
male (estimated 4 exonic variants common to all carriers). 
• Sanger sequence putative variants in the remaining G2 females and formulate 
carrier hypotheses. 
• Test the carrier hypotheses by backcrossing with the founder and examining the 
litters. 
• Sanger sequence putative variants in affected (i.e. presumed homozygous) 
embryos (estimated 1 variant common between homozygous embryos and 
carrier females). 
• Genotype G2 males to identify carriers for colony maintenance. 
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Supplementary Information 
Appendix A 
 
Table 1: The selected MIT markers at most the proximal, distal 
and the central regions of all autosomes. TD: touchdown PCR 
programme, B: buffer, D: DNA segment, Mit: Massachusetts 
Institute of Technology. 
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Table2: The additional MIT markers used to narrow down the regions of interest. 
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